Disease by body system or component
MONDO:7770006A grouping class for human diseases classified by the body system or anatomical component primarily affected.
93739 clinical trials for this condition and its sub-types, 0 tagged with Disease by body system or component itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Disease by body system or component
-
Nervous system disorder 245 trials · 26,588 incl. sub-types
72 sub-types
- Central nervous system disorder 119 trials · 20,397 incl. sub-types Sub-types →
- Hereditary neurological disease 6 trials · 5,772 incl. sub-types Sub-types →
- Neurovascular disorder 5 trials · 4,196 incl. sub-types Sub-types →
- Nervous system neoplasm 8 trials · 2,580 incl. sub-types Sub-types →
- Perceptual disorders 22 trials · 2,382 incl. sub-types Sub-types →
- Neuromuscular disease 112 trials · 2,344 incl. sub-types Sub-types →
- Peripheral nervous system disorder 121 trials · 2,284 incl. sub-types Sub-types →
- Neurological pain disorder 1 trial · 1,830 incl. sub-types Sub-types →
- Nervous system injury 24 trials · 1,317 incl. sub-types Sub-types →
- Neurodevelopmental disorder 161 trials · 1,128 incl. sub-types Sub-types →
- Autoimmune disorder of the nervous system 47 trials · 1,060 incl. sub-types Sub-types →
- Retinal disorder 89 trials · 959 incl. sub-types Sub-types →
- Movement disorder 108 trials · 805 incl. sub-types Sub-types →
- Cranial nerve neuropathy 4 trials · 390 incl. sub-types Sub-types →
- Congenital nervous system disorder 1 trial · 284 incl. sub-types Sub-types →
- Infectious disorder of the nervous system 4 trials · 231 incl. sub-types Sub-types →
- Neurocutaneous syndrome 2 trials · 171 incl. sub-types Sub-types →
- Atactic disorder 5 trials · 148 incl. sub-types Sub-types →
- AL amyloidosis 92 trials · 98 incl. sub-types Sub-types →
- Neuromyelitis optica 85 trials Sub-types →
- Primary orthostatic hypotension 12 trials · 83 incl. sub-types Sub-types →
- Developmental disability 81 trials Sub-types →
- Toxic encephalopathy 28 trials · 74 incl. sub-types Sub-types →
- Specific learning disability 19 trials · 66 incl. sub-types Sub-types →
- Central nervous system malformation 5 trials · 51 incl. sub-types Sub-types →
- Restless legs syndrome 45 trials
- Neuroendocrine disorder 0 trials · 42 incl. sub-types Sub-types →
- Qualitative or quantitative protein defects in neuromuscular diseases 0 trials · 30 incl. sub-types Sub-types →
- Neuronitis 20 trials
- Paraneoplastic neurologic syndrome 1 trial · 15 incl. sub-types Sub-types →
- Stiff-person syndrome 12 trials Sub-types →
- Locked-in syndrome 11 trials
- Exercise-induced malignant hyperthermia 9 trials
- Persistent idiopathic facial pain 9 trials
- Serotonin syndrome 6 trials
- Synaptopathy 0 trials · 6 incl. sub-types Sub-types →
- Barre-Lieou syndrome 3 trials
- AA amyloidosis 2 trials
- Balint syndrome 2 trials
- Dopa-responsive dystonia 1 trial · 2 incl. sub-types Sub-types →
- Drug-induced akathisia 2 trials
- Drug-induced dyskinesia 2 trials
- Neurosarcoidosis 2 trials Sub-types →
- Periodic paralysis 1 trial · 2 incl. sub-types Sub-types →
- Sensory ganglionopathy 2 trials Sub-types →
- Wallerian degeneration 1 trial
- Diplegia of upper limb 1 trial
- Neuroleptic malignant syndrome 1 trial
- Prepubertal anorexia nervosa 1 trial
- Radiculitis 1 trial
- Gerstmann syndrome 0 trials
- KIF1A related neurological disorder 0 trials Sub-types →
- Sydenham chorea 0 trials
- Worster-Drought syndrome 0 trials
- Cerebellar hypoplasia-tapetoretinal degeneration syndrome 0 trials
- Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids 0 trials
- Corneal-cerebellar syndrome 0 trials
- Duplication of the pituitary gland 0 trials
- Hypothalamic adipsic hypernatraemia syndrome 0 trials
- Idiopathic recurrent stupor 0 trials
- Meningitis-retention syndrome 0 trials
- Neonatal brainstem dysfunction 0 trials
- Pachygyria-intellectual disability-epilepsy syndrome 0 trials
- Perineural cyst 0 trials
- Porencephaly-cerebellar hypoplasia-internal malformations syndrome 0 trials
- Post 5-alpha-reductase inhibitors treatment syndrome 0 trials
- Post-selective serotonin reuptake inhibitor sexual dysfunction 0 trials
- Rippling muscle disease with myasthenia gravis 0 trials
- Spontaneous periodic hypothermia 0 trials
- Symmetrical thalamic calcifications 0 trials
- Tubulinopathy 0 trials Sub-types →
- Wet beriberi 0 trials
-
Digestive system disorder 168 trials · 16,300 incl. sub-types
31 sub-types
- Digestive system cancer 267 trials · 7,054 incl. sub-types Sub-types →
- Pancreas disorder 44 trials · 5,580 incl. sub-types Sub-types →
- Intestinal disorder 70 trials · 5,432 incl. sub-types Sub-types →
- Hepatobiliary disorder 10 trials · 3,893 incl. sub-types Sub-types →
- Stomach disorder 4 trials · 1,623 incl. sub-types Sub-types →
- Upper digestive tract disorder 6 trials · 1,226 incl. sub-types Sub-types →
- Autoimmune disorder of gastrointestinal tract 0 trials · 936 incl. sub-types Sub-types →
- Digestive system infectious disorder 4 trials · 605 incl. sub-types Sub-types →
- Neoplasm of oropharynx 3 trials · 279 incl. sub-types Sub-types →
- Digestive system neuroendocrine neoplasm 52 trials · 167 incl. sub-types Sub-types →
- Diarrheal disease 80 trials · 117 incl. sub-types Sub-types →
- Peptic ulcer disease 26 trials · 67 incl. sub-types Sub-types →
- Gastrointestinal mucositis 3 trials · 52 incl. sub-types Sub-types →
- Benign digestive system neoplasm 0 trials · 41 incl. sub-types Sub-types →
- Hereditary mixed polyposis syndrome 5 trials · 6 incl. sub-types Sub-types →
- Juvenile polyposis syndrome 5 trials Sub-types →
- Gastrointestinal polyp 0 trials · 3 incl. sub-types Sub-types →
- Cronkhite-Canada syndrome 1 trial
- Hyperplastic polyposis syndrome 1 trial Sub-types →
- Meckel diverticulum 0 trials
- Moyamoya disease with early-onset achalasia 0 trials
- Caudal duplication 0 trials
- Common mesentery 0 trials
- Congenital enteropathy due to enteropeptidase deficiency 0 trials
- Congenital peritoneal encapsulation 0 trials
- Digestive duplication 0 trials
- Diverticulosis of bowel, hernia, and retinal detachment 0 trials
- Diverticulosis, small-intestinal 0 trials
- Growth retardation-mild developmental delay-chronic hepatitis syndrome 0 trials
- Thoraco-abdominal enteric duplication 0 trials
- Umbilical cord ulceration-intestinal atresia syndrome 0 trials
-
Cardiovascular disorder 1,115 trials · 15,366 incl. sub-types
6 sub-types
- Vascular disorder 141 trials · 10,696 incl. sub-types Sub-types →
- Heart disorder 310 trials · 6,754 incl. sub-types Sub-types →
- Congenital anomaly of cardiovascular system 5 trials · 595 incl. sub-types Sub-types →
- Cardiovascular neoplasm 0 trials · 277 incl. sub-types Sub-types →
- Autoimmune disorder of cardiovascular system 0 trials · 3 incl. sub-types Sub-types →
- Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome 0 trials
-
Immune system disorder 151 trials · 12,959 incl. sub-types
47 sub-types
- Autoimmune disease 313 trials · 4,033 incl. sub-types Sub-types →
- Leukocyte disorder 6 trials · 3,572 incl. sub-types Sub-types →
- Immune system cancer 0 trials · 3,121 incl. sub-types Sub-types →
- Bone marrow disorder 18 trials · 1,761 incl. sub-types Sub-types →
- Inflammatory bowel disease 429 trials · 1,079 incl. sub-types Sub-types →
- Hypersensitivity reaction disease 32 trials · 1,022 incl. sub-types Sub-types →
- Immunodeficiency disease 55 trials · 776 incl. sub-types Sub-types →
- Lymphoid system disorder 1 trial · 744 incl. sub-types Sub-types →
- Psoriasis 379 trials Sub-types →
- Inborn error of immunity 121 trials · 343 incl. sub-types Sub-types →
- Graft versus host disease 186 trials · 300 incl. sub-types Sub-types →
- Thymus gland disorder 1 trial · 240 incl. sub-types Sub-types →
- Spondyloarthropathy 121 trials · 198 incl. sub-types Sub-types →
- Thrombocytopenic purpura 8 trials · 116 incl. sub-types Sub-types →
- Granulomatosis with polyangiitis 95 trials · 115 incl. sub-types Sub-types →
- Phagocytic cell dysfunction 1 trial · 76 incl. sub-types Sub-types →
- Cytokine release syndrome 33 trials
- T-cell large granular lymphocyte leukemia 18 trials
- Immunoproliferative disorder 18 trials
- Familial Mediterranean fever 15 trials Sub-types →
- Immunodeficiency-related disorder 1 trial · 15 incl. sub-types Sub-types →
- Twin to twin transfusion syndrome 14 trials Sub-types →
- 22q11.2 deletion syndrome 7 trials · 13 incl. sub-types Sub-types →
- Immune reconstitution inflammatory syndrome 11 trials
- Cryopyrin-associated periodic syndrome 10 trials Sub-types →
- Acquired immunodeficiency 5 trials Sub-types →
- TNF receptor 1-associated periodic fever syndrome 4 trials
- Anti-HLA hyperimmunization 3 trials
- Hyperimmunoglobulinemia D with periodic fever 2 trials
- Proteosome-associated autoinflammatory syndrome 2 trials Sub-types →
- Roifman syndrome 1 trial
- Aggressive insulitis 1 trial
- Growth hormone insensitivity with immune dysregulation 1, autosomal recessive 1 trial
- Transcobalamin II deficiency 1 trial
- CADINS disease 0 trials
- Vici syndrome 0 trials
- Autoinflammation, panniculitis, and dermatosis syndrome 0 trials Sub-types →
- Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis 0 trials
- Autosomal recessive osteopetrosis 7 0 trials
- Benign insulitis 0 trials
- Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0 trials
- Cytokine receptor deficiency 0 trials
- Early-onset autoimmunity-autoinflammation-immunodeficiency syndrome 0 trials
- Epidermodysplasia verruciformis 0 trials Sub-types →
- Erythroderma desquamativum 0 trials
- Immune system organ benign neoplasm 0 trials Sub-types →
- Pyogenic arthritis-pyoderma gangrenosum-acne syndrome 0 trials
-
Endocrine system disorder 78 trials · 12,469 incl. sub-types
48 sub-types
- Pancreas disorder 44 trials · 5,580 incl. sub-types Sub-types →
- Liver disorder 323 trials · 3,604 incl. sub-types Sub-types →
- Endocrine gland neoplasm 8 trials · 3,332 incl. sub-types Sub-types →
- Gonadal disorder 3 trials · 1,635 incl. sub-types Sub-types →
- Autoimmune disorder of endocrine system 1 trial · 925 incl. sub-types Sub-types →
- Thyroid gland disorder 96 trials · 538 incl. sub-types Sub-types →
- Adrenal gland disorder 9 trials · 352 incl. sub-types Sub-types →
- Thymus gland disorder 1 trial · 240 incl. sub-types Sub-types →
- Polycystic ovary syndrome 200 trials
- Hereditary endocrine growth disease 26 trials · 195 incl. sub-types Sub-types →
- Pituitary gland disorder 18 trials · 175 incl. sub-types Sub-types →
- Non-neoplastic bile duct disorder 0 trials · 172 incl. sub-types Sub-types →
- Parathyroid gland disorder 14 trials · 164 incl. sub-types Sub-types →
- Beta thalassemia 73 trials · 99 incl. sub-types Sub-types →
- Pituitary deficiency 0 trials · 96 incl. sub-types Sub-types →
- Polyendocrinopathy 0 trials · 81 incl. sub-types Sub-types →
- Neuroendocrine disorder 0 trials · 42 incl. sub-types Sub-types →
- Hyperinsulinemic hypoglycemia 2 trials · 14 incl. sub-types Sub-types →
- Parneoplastic endocrine syndrome 0 trials · 11 incl. sub-types Sub-types →
- Inherited obesity 8 trials · 9 incl. sub-types Sub-types →
- Acquired hypothalamic obesity 7 trials
- Disorder of GNAS inactivation 0 trials · 7 incl. sub-types Sub-types →
- Disorders of vitamin D metabolism 0 trials · 3 incl. sub-types Sub-types →
- Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome 3 trials
- NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types Sub-types →
- Familial hypocalciuric hypercalcemia 0 trials · 1 incl. sub-types Sub-types →
- 17,20-lyase deficiency, isolated 0 trials
- 17-alpha-hydroxylase/17,20-lyase deficiency, combined complete 0 trials
- 17-alpha-hydroxylase/17,20-lyase deficiency, combined partial 0 trials
- Bamforth-Lazarus syndrome 0 trials
- Leydig cell hypoplasia 0 trials Sub-types →
- Wolfram-like syndrome 0 trials
- Blepharophimosis - intellectual disability syndrome, SBBYS type 0 trials
- Campomelic dysplasia 0 trials
- Diencephalic syndrome 0 trials
- Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome 0 trials
- Duplication of the pituitary gland 0 trials
- Endocrine tuberculosis 0 trials Sub-types →
- Estrogen resistance syndrome 0 trials
- Genito-palato-cardiac syndrome 0 trials
- Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome 0 trials
- Hypoinsulinemic hypoglycemia and body hemihypertrophy 0 trials
- Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 0 trials
- Hypothalamic adipsic hypernatraemia syndrome 0 trials
- Muscular pseudohypertrophy-hypothyroidism syndrome 0 trials
- Neonatal iodine exposure 0 trials
- Short stature, microcephaly, and endocrine dysfunction 0 trials
- Thyroid hormone metabolism, abnormal 0 trials Sub-types →
-
Musculoskeletal system disorder 220 trials · 12,013 incl. sub-types
22 sub-types
- Skeletal system disorder 4 trials · 9,715 incl. sub-types Sub-types →
- Muscle tissue disorder 57 trials · 2,419 incl. sub-types Sub-types →
- Musculoskeletal system cancer 2 trials · 1,968 incl. sub-types Sub-types →
- Autoimmune disorder of musculoskeletal system 0 trials · 795 incl. sub-types Sub-types →
- Musculoskeletal system benign neoplasm 0 trials · 224 incl. sub-types Sub-types →
- Disease of the tendon 126 trials · 192 incl. sub-types Sub-types →
- Synovium disorder 0 trials · 149 incl. sub-types Sub-types →
- Fasciitis 7 trials · 97 incl. sub-types Sub-types →
- Ligament disorder 8 trials · 15 incl. sub-types Sub-types →
- Klippel-Feil syndrome 14 trials Sub-types →
- CINCA syndrome 4 trials
- Enthesopathy 2 trials · 4 incl. sub-types Sub-types →
- Ramon syndrome 0 trials
- Short stature, Dauber-Argente type 0 trials
- Upington disease 0 trials
- Auriculoosteodysplasia 0 trials
- Chondrodysplasia with joint dislocations, gPAPP type 0 trials
- Hypertrophic osteoarthropathy, primary, autosomal dominant 0 trials
- Osteoporosis-oculocutaneous hypopigmentation syndrome 0 trials
- Short stature, Brussels type 0 trials
- Synovial chondromatosis 0 trials
- Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia 0 trials
-
Respiratory system disorder 150 trials · 10,848 incl. sub-types
59 sub-types
- Lower respiratory tract disorder 18 trials · 7,938 incl. sub-types Sub-types →
- Respiratory system cancer 6 trials · 4,516 incl. sub-types Sub-types →
- Respiratory tract neoplasm 32 trials · 4,437 incl. sub-types Sub-types →
- Upper respiratory tract disorder 5 trials · 1,848 incl. sub-types Sub-types →
- Respiratory tract infectious disorder 174 trials · 1,330 incl. sub-types Sub-types →
- Sleep apnea syndrome 214 trials · 600 incl. sub-types Sub-types →
- Disorder of pharynx 3 trials · 596 incl. sub-types Sub-types →
- Cystic fibrosis 283 trials Sub-types →
- Allergic respiratory disease 2 trials · 218 incl. sub-types Sub-types →
- Paranasal sinus disorder 12 trials · 162 incl. sub-types Sub-types →
- Perinatal asphyxia 152 trials
- Pulmonary tuberculosis 107 trials · 110 incl. sub-types Sub-types →
- Bronchopulmonary dysplasia 96 trials
- Diaphragm disorder 27 trials · 91 incl. sub-types Sub-types →
- Altitude sickness 54 trials · 56 incl. sub-types Sub-types →
- Alpha 1-antitrypsin deficiency 44 trials
- Pertussis 39 trials
- Primary ciliary dyskinesia 34 trials Sub-types →
- Severe acute respiratory syndrome 30 trials
- Infantile apnea 5 trials · 22 incl. sub-types Sub-types →
- Recurrent respiratory papillomatosis 8 trials · 9 incl. sub-types Sub-types →
- Respiratory or thoracic malformation 0 trials · 8 incl. sub-types Sub-types →
- Respiratory system benign neoplasm 1 trial · 8 incl. sub-types Sub-types →
- Pulmonary hypoplasia 7 trials
- Reactive airway disease 5 trials
- Autoimmune interstitial lung disease-arthritis syndrome 3 trials Sub-types →
- Congenital pulmonary airway malformation 3 trials Sub-types →
- Young syndrome 2 trials
- Diffuse alveolar hemorrhage 2 trials
- Plastic bronchitis 2 trials
- Middle East respiratory syndrome 1 trial
- Bronchogenic cyst 1 trial
- Congenital pulmonary sequestration 1 trial Sub-types →
- 16q24.1 microdeletion syndrome 0 trials
- IgG4-related mediastinitis 0 trials
- Mounier-Kuhn syndrome 0 trials
- Siegler-Brewer-Carey syndrome 0 trials
- Williams-Campbell syndrome 0 trials
- Acinar dysplasia 0 trials Sub-types →
- Bronchiectasis and nasal polyposis 0 trials
- Congenital bronchobiliary fistula 0 trials
- Congenital pulmonary lymphangiectasia 0 trials
- Eosinophilic granuloma 0 trials Sub-types →
- Familial primary pulmonary hypoplasia 0 trials
- Growth delay-hydrocephaly-lung hypoplasia syndrome 0 trials
- Hereditary sclerosing poikiloderma with tendon and pulmonary involvement 0 trials
- Isolated left bronchial isomerism 0 trials
- Laryngo-onycho-cutaneous syndrome 0 trials
- Lung agenesis-heart defect-thumb anomalies syndrome 0 trials
- Mucopolysaccharidosis-plus syndrome 0 trials
- Pulmonary agenesis 0 trials
- Pulmonary alveolar proteinosis with hypogammaglobulinemia 0 trials
- Pulmonary nodular lymphoid hyperplasia 0 trials
- Pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis 0 trials
- Staphylococcal necrotizing pneumonia 0 trials
- Sudden infant death-dysgenesis of the testes syndrome 0 trials
- Tracheal agenesis 0 trials
- Tracheobronchopathia osteochondroplastica 0 trials
- Transient hyperammonemia of the newborn 0 trials
-
Reproductive system disorder 15 trials · 8,533 incl. sub-types
30 sub-types
- Reproductive system neoplasm 0 trials · 4,651 incl. sub-types Sub-types →
- Female reproductive system disorder 27 trials · 3,567 incl. sub-types Sub-types →
- Male reproductive system disorder 11 trials · 2,826 incl. sub-types Sub-types →
- Sexually transmitted disease 127 trials · 1,703 incl. sub-types Sub-types →
- Gonadal disorder 3 trials · 1,635 incl. sub-types Sub-types →
- Infertility disorder 361 trials · 544 incl. sub-types Sub-types →
- Physiological sexual disorder 78 trials · 197 incl. sub-types Sub-types →
- Pituitary gland disorder 18 trials · 175 incl. sub-types Sub-types →
- Pelvic organ prolapse 125 trials
- Dysplasia of cervix 55 trials · 105 incl. sub-types Sub-types →
- Hypospadias 35 trials Sub-types →
- Habitual spontaneous abortion 28 trials
- Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency 20 trials Sub-types →
- Currarino triad 1 trial
- Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency 1 trial
- Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency 1 trial
- Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency 1 trial
- Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency 1 trial
- NR5A1-related sex development disorder 0 trials Sub-types →
- Aromatase excess syndrome 0 trials
- Cortisone reductase deficiency 0 trials Sub-types →
- Diethylstilbestrol syndrome 0 trials
- Double uterus-hemivagina-renal agenesis syndrome 0 trials
- Estrogen resistance syndrome 0 trials
- Female genital tuberculosis 0 trials
- Hand-foot-genital syndrome 0 trials
- Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 0 trials
- Mullerian duct anomalies-limb anomalies syndrome 0 trials
- Short stature, microcephaly, and endocrine dysfunction 0 trials
- Spondylocostal dysostosis-anal and genitourinary malformations syndrome 0 trials
-
Hematologic disorder 174 trials · 8,503 incl. sub-types
27 sub-types
- Hematopoietic and lymphoid system neoplasm 692 trials · 6,319 incl. sub-types Sub-types →
- Leukocyte disorder 6 trials · 3,572 incl. sub-types Sub-types →
- Bone marrow disorder 18 trials · 1,761 incl. sub-types Sub-types →
- Anemia 258 trials · 975 incl. sub-types Sub-types →
- Erythrocyte disorder 7 trials · 616 incl. sub-types Sub-types →
- Blood coagulation disease 54 trials · 539 incl. sub-types Sub-types →
- Hemorrhagic disease 108 trials · 508 incl. sub-types Sub-types →
- Blood platelet disease 18 trials · 369 incl. sub-types Sub-types →
- Splenic disorder 3 trials · 248 incl. sub-types Sub-types →
- Thymus gland disorder 1 trial · 240 incl. sub-types Sub-types →
- Autoimmune disorder of blood 0 trials · 152 incl. sub-types Sub-types →
- Congenital hematological disorder 1 trial · 101 incl. sub-types Sub-types →
- Monoclonal gammopathy 24 trials · 68 incl. sub-types Sub-types →
- Premalignant hematological system disease 3 trials · 25 incl. sub-types Sub-types →
- Paraneoplastic hematological syndrome 0 trials · 9 incl. sub-types Sub-types →
- Parasitemia 5 trials
- Blood group incompatibility 2 trials Sub-types →
- L-ferritin deficiency 1 trial
- Deafness-lymphedema-leukemia syndrome 1 trial
- Hyperamylasemia 1 trial
- Bloom syndrome 0 trials
- GATA1-Related X-Linked Cytopenia 0 trials Sub-types →
- Alpha thalassemia-intellectual disability syndrome type 1 0 trials
- Alpha-thalassemia-myelodysplastic syndrome 0 trials
- Dyskeratosis congenita, autosomal dominant 6 0 trials
- Polyclonal hyperviscosity syndrome 0 trials
- Septicemic plague 0 trials
-
Syndromic disease 25 trials · 7,133 incl. sub-types
1,182 sub-types
- Neoplastic syndrome 1 trial · 1,430 incl. sub-types Sub-types →
- Obstructive sleep apnea syndrome 516 trials · 517 incl. sub-types Sub-types →
- Acute respiratory distress syndrome 298 trials · 417 incl. sub-types Sub-types →
- Abdominal obesity-metabolic syndrome 301 trials · 357 incl. sub-types Sub-types →
- Acute coronary syndrome 298 trials
- Fibromyalgia 279 trials
- Dry eye syndrome 253 trials · 254 incl. sub-types Sub-types →
- Toxic shock syndrome 224 trials Sub-types →
- Irritable bowel syndrome 221 trials
- Autoinflammatory syndrome 21 trials · 207 incl. sub-types Sub-types →
- Psoriatic arthritis 188 trials · 201 incl. sub-types Sub-types →
- Polycystic ovary syndrome 200 trials
- Sjogren syndrome 166 trials
- Temporomandibular joint dysfunction syndrome 85 trials
- Progressive supranuclear palsy 73 trials · 77 incl. sub-types Sub-types →
- Myalgic encephalomeyelitis/chronic fatigue syndrome 73 trials
- Syndromic dyslipidemia 0 trials · 73 incl. sub-types Sub-types →
- Nephrotic syndrome 47 trials · 71 incl. sub-types Sub-types →
- Cushing syndrome 42 trials · 66 incl. sub-types Sub-types →
- Myotonic syndrome 11 trials · 61 incl. sub-types Sub-types →
- Antiphospholipid syndrome 58 trials · 59 incl. sub-types Sub-types →
- Substance withdrawal syndrome 30 trials · 59 incl. sub-types Sub-types →
- Hemophagocytic syndrome 38 trials · 58 incl. sub-types Sub-types →
- Multiple organ dysfunction syndrome 50 trials
- Hypereosinophilic syndrome 19 trials · 49 incl. sub-types Sub-types →
- Ehlers-Danlos syndrome 20 trials · 46 incl. sub-types Sub-types →
- Ectodermal dysplasia syndrome 3 trials · 45 incl. sub-types Sub-types →
- Alpha 1-antitrypsin deficiency 44 trials
- Tourette syndrome 41 trials
- Guillain-Barre syndrome 23 trials · 39 incl. sub-types Sub-types →
- Type 2 collagenopathy 0 trials · 39 incl. sub-types Sub-types →
- Syndromic intellectual disability 2 trials · 38 incl. sub-types Sub-types →
- Behcet disease 37 trials
- X-linked ichthyosis syndrome 0 trials · 37 incl. sub-types Sub-types →
- Syndromic agammaglobulinemia 7 trials · 37 incl. sub-types Sub-types →
- Fragile X syndrome 34 trials Sub-types →
- Primary ciliary dyskinesia 34 trials Sub-types →
- Dialysis disequilibrium syndrome 33 trials
- Eosinophilic granulomatosis with polyangiitis 33 trials
- Exfoliation syndrome 32 trials
- Prader-Willi syndrome 31 trials Sub-types →
- Rett syndrome 31 trials
- Complex regional pain syndrome type 1 31 trials
- Acute chest syndrome 30 trials
- Polymyalgia rheumatica 30 trials
- Syndromic congenital heart disease 0 trials · 30 incl. sub-types Sub-types →
- Long QT syndrome 22 trials · 29 incl. sub-types Sub-types →
- Turner syndrome 28 trials Sub-types →
- Corticobasal degeneration disorder 28 trials
- Familial developmental dysphasia 28 trials
- Lennox-Gastaut syndrome 26 trials · 27 incl. sub-types Sub-types →
- Takayasu arteritis 27 trials
- Posterior leukoencephalopathy syndrome 27 trials
- Piriformis syndrome 25 trials
- Noonan syndrome 21 trials · 24 incl. sub-types Sub-types →
- Mucopolysaccharidosis type 2 24 trials Sub-types →
- Post-cardiac arrest syndrome 24 trials
- Central sleep apnea syndrome 21 trials · 23 incl. sub-types Sub-types →
- Sick sinus syndrome 22 trials Sub-types →
- Syndromic craniosynostosis 1 trial · 22 incl. sub-types Sub-types →
- Marfan syndrome 21 trials Sub-types →
- Cardiovascular-kidney-metabolic syndrome 21 trials
- Paraneoplastic syndrome 1 trial · 20 incl. sub-types Sub-types →
- Persian gulf syndrome 20 trials
- Angelman syndrome 19 trials Sub-types →
- Evans syndrome 19 trials
- Atypical hemolytic-uremic syndrome 19 trials Sub-types →
- Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 16 trials · 19 incl. sub-types Sub-types →
- Dumping syndrome 19 trials
- Infantile spasms 8 trials · 19 incl. sub-types Sub-types →
- Alport syndrome 17 trials · 18 incl. sub-types Sub-types →
- Williams syndrome 18 trials
- Cardio-renal syndrome 18 trials
- Complex regional pain syndrome type 2 18 trials
- Mucopolysaccharidosis type 3 7 trials · 18 incl. sub-types Sub-types →
- Fetal alcohol syndrome 17 trials
- Progressive familial intrahepatic cholestasis 16 trials · 17 incl. sub-types Sub-types →
- Usher syndrome 14 trials · 16 incl. sub-types Sub-types →
- Alagille syndrome 15 trials Sub-types →
- Netherton syndrome 15 trials
- Arts syndrome 14 trials
- Erdheim-Chester disease 14 trials
- MELAS syndrome 13 trials · 14 incl. sub-types Sub-types →
- Compartment syndrome 14 trials Sub-types →
- Fetal cytomegalovirus syndrome 14 trials
- HELLP syndrome 13 trials
- Familial chylomicronemia syndrome 11 trials · 13 incl. sub-types Sub-types →
- Hepatorenal syndrome 13 trials
- Stiff-person syndrome 12 trials Sub-types →
- Syndromic oculocutaneous albinism 0 trials · 12 incl. sub-types Sub-types →
- Simpson-Golabi-Behmel syndrome 11 trials Sub-types →
- Autoimmune polyendocrinopathy 3 trials · 11 incl. sub-types Sub-types →
- Syndromic microphthalmia 0 trials · 11 incl. sub-types Sub-types →
- Thoracic outlet syndrome 11 trials Sub-types →
- Brugada syndrome 10 trials Sub-types →
- Marinesco-Sjogren syndrome 10 trials
- Phelan-McDermid syndrome 10 trials Sub-types →
- Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 10 trials
- Mucopolysaccharidosis type 4 2 trials · 10 incl. sub-types Sub-types →
- Post-infectious syndrome 5 trials · 10 incl. sub-types Sub-types →
- Mayer-Rokitansky-Kuster-Hauser syndrome 8 trials · 9 incl. sub-types Sub-types →
- Stevens-Johnson syndrome 9 trials
- Burning mouth syndrome 9 trials Sub-types →
- Calciphylaxis 9 trials Sub-types →
- Hand-foot syndrome 9 trials
- Sickle cell-beta-thalassemia disease syndrome 5 trials · 9 incl. sub-types Sub-types →
- IRF6-related condition 0 trials · 8 incl. sub-types Sub-types →
- Leriche syndrome 8 trials
- Breast implant illness 8 trials
- Developmental and/or epileptic encephalopathy with spike-wave activation in sleep 8 trials Sub-types →
- Mucopolysaccharidosis type 6 8 trials Sub-types →
- Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types Sub-types →
- Bardet-Biedl syndrome 6 trials · 7 incl. sub-types Sub-types →
- Silver-Russell syndrome 7 trials Sub-types →
- Wolfram syndrome 7 trials Sub-types →
- Complex hereditary spastic paraplegia 1 trial · 7 incl. sub-types Sub-types →
- Cystinuria 7 trials Sub-types →
- Miliaria 7 trials Sub-types →
- Sickle cell-hemoglobin c disease syndrome 7 trials
- DICER1-related tumor predisposition 1 trial · 6 incl. sub-types Sub-types →
- Duane retraction syndrome 6 trials Sub-types →
- Hurler syndrome 6 trials
- Loeys-Dietz syndrome 6 trials Sub-types →
- Angioosteohypertrophic syndrome 6 trials
- Carcinoid syndrome 6 trials Sub-types →
- Channelopathy-associated congenital insensitivity to pain, autosomal recessive 6 trials
- Growth hormone insensitivity syndrome 0 trials · 6 incl. sub-types Sub-types →
- Neonatal aspiration syndrome 1 trial · 6 incl. sub-types Sub-types →
- Tethered spinal cord syndrome 6 trials
- CLOVES syndrome 5 trials
- Cornelia de Lange syndrome 4 trials · 5 incl. sub-types Sub-types →
- Eisenmenger syndrome 5 trials
- IMAGe syndrome 5 trials
- Kearns-Sayre syndrome 5 trials
- MERRF syndrome 5 trials
- McCune-Albright syndrome 5 trials
- Menkes disease 5 trials
- Shwachman-Diamond syndrome 5 trials Sub-types →
- Central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease 5 trials
- Cerebellar ataxia, intellectual disability, and dysequilibrium 5 trials Sub-types →
- Congenital myasthenic syndrome 5 trials Sub-types →
- Craniofacial microsomia 5 trials Sub-types →
- Drug rash with eosinophilia and systemic symptoms 5 trials
- Pelvis syndrome 5 trials
- Boerhaave syndrome 4 trials
- CHARGE syndrome 4 trials Sub-types →
- Fanconi renotubular syndrome 4 trials Sub-types →
- Kenny-Caffey syndrome 0 trials · 4 incl. sub-types Sub-types →
- SUNCT syndrome 4 trials
- Stickler syndrome 2 trials · 4 incl. sub-types Sub-types →
- Hypoplastic right heart syndrome 0 trials · 4 incl. sub-types Sub-types →
- Mitochondrial neurogastrointestinal encephalomyopathy 4 trials Sub-types →
- Nephronophthisis 1 4 trials
- Trisomy 13 4 trials Sub-types →
- Barre-Lieou syndrome 3 trials
- Hutchinson-Gilford progeria syndrome 3 trials
- Kallmann syndrome 3 trials Sub-types →
- Noonan syndrome with multiple lentigines 3 trials Sub-types →
- Pearson syndrome 3 trials
- Pitt-Hopkins syndrome 3 trials
- Cannabinoid hyperemesis syndrome 3 trials
- Facial hemiatrophy 3 trials
- Hereditary alpha tryptasemia syndrome 3 trials
- Inclusion body myopathy with Paget disease of bone and frontotemporal dementia 1 trial · 3 incl. sub-types Sub-types →
- Iridocorneal endothelial syndrome 1 trial · 3 incl. sub-types Sub-types →
- Mitochondrial DNA depletion syndrome 4a 3 trials
- Oculocerebrorenal syndrome 3 trials
- Ornithine translocase deficiency 3 trials
- Triple-A syndrome 3 trials
- Trisomy 18 3 trials Sub-types →
- Trisomy X 3 trials
- Aicardi syndrome 2 trials
- Birt-Hogg-Dube syndrome 2 trials Sub-types →
- Charles bonnet syndrome 2 trials
- Cri-du-chat syndrome 2 trials
- Hurler-Scheie syndrome 2 trials
- Joubert syndrome 2 trials Sub-types →
- Kabuki syndrome 2 trials Sub-types →
- Mobius syndrome 2 trials Sub-types →
- Pallister-Hall syndrome 0 trials · 2 incl. sub-types Sub-types →
- Poland syndrome 2 trials
- Susac syndrome 2 trials
- Werner syndrome 2 trials
- Acrocallosal syndrome 2 trials
- Cauda equina syndrome 2 trials Sub-types →
- Celiac trunk compression syndrome 2 trials
- Congenital cardiovascular shunt 2 trials
- Craniofacial and skeletal defects 2 trials
- Dilated cardiomyopathy 1A 2 trials
- Disappearing bone disease 0 trials · 2 incl. sub-types Sub-types →
- Engraftment syndrome 2 trials
- Enlarged vestibular aqueduct syndrome 2 trials
- Gas bloat syndrome 2 trials
- Hantavirus pulmonary syndrome 2 trials
- Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome 2 trials
- Jaw-winking syndrome 2 trials Sub-types →
- Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome 2 trials
- Nail-patella syndrome 2 trials
- Polydactyly-myopia syndrome 2 trials
- Retrograde cricopharyngeus dysfunction 2 trials
- Short rib-polydactyly syndrome 0 trials · 2 incl. sub-types Sub-types →
- Superior mesenteric artery syndrome 2 trials
- Superior vena cava syndrome 2 trials
- Sweet syndrome 2 trials
- Vertebral artery insufficiency 2 trials
- Xeroderma pigmentosum-Cockayne syndrome complex 1 trial · 2 incl. sub-types Sub-types →
- Aagenaes syndrome 1 trial
- Adams-Stokes syndrome 1 trial
- Alstrom syndrome 1 trial
- Axenfeld-Rieger syndrome 1 trial Sub-types →
- BNAR syndrome 1 trial
- Capgras syndrome 1 trial
- Caroli syndrome 1 trial
- Charcot-Marie-Tooth disease-hearing loss-intellectual disability syndrome 1 trial
- Coffin-Siris syndrome 1 trial Sub-types →
- Currarino triad 1 trial
- DNA ligase IV deficiency 1 trial
- Denys-Drash syndrome 1 trial
- Duane-radial ray syndrome 1 trial Sub-types →
- EEC syndrome 1 trial Sub-types →
- Freeman-Sheldon syndrome 1 trial Sub-types →
- Fryns syndrome 1 trial
- German syndrome 1 trial
- Holmes-Adie syndrome 1 trial
- Joubert syndrome with oculorenal defect 1 trial Sub-types →
- Lesch-Nyhan syndrome 1 trial Sub-types →
- Liddle syndrome 1 trial Sub-types →
- MPI-congenital disorder of glycosylation 1 trial
- Meckel syndrome 0 trials · 1 incl. sub-types Sub-types →
- Meier-Gorlin syndrome 1 trial Sub-types →
- NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types Sub-types →
- Potocki-Lupski syndrome 1 trial
- Potter sequence 1 trial
- RHYNS syndrome 1 trial
- RNU4ATAC spectrum disorder 1 trial Sub-types →
- Reunion island Larsen syndrome 1 trial
- Scheie syndrome 1 trial
- Seckel syndrome 0 trials · 1 incl. sub-types Sub-types →
- Sotos syndrome 1 trial
- Tolosa-Hunt syndrome 1 trial
- Waardenburg syndrome 1 trial Sub-types →
- Wernicke-Korsakoff syndrome 1 trial Sub-types →
- X-linked dominant chondrodysplasia, Chassaing-Lacombe type 1 trial
- Acute radiation syndrome 1 trial
- Arthrogryposis-renal dysfunction-cholestasis syndrome 1 trial Sub-types →
- Atlanto-axial fusion 1 trial
- Bidirectional tachycardia 1 trial
- Capillary leak syndrome 1 trial
- Cleidocranial dysplasia 1 1 trial
- Congenital amputation 1 trial
- Congenital insensitivity to pain syndrome, Marsili type 1 trial
- Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome 1 trial
- Craniofrontonasal syndrome 1 trial
- Deafness-infertility syndrome 1 trial
- Deafness-lymphedema-leukemia syndrome 1 trial
- Epidermal nevus syndrome 1 trial
- Epilepsy with myoclonic atonic seizures 1 trial
- Gastrointestinal defects and immunodeficiency syndrome 1 1 trial
- Human HOXA1 syndromes 1 trial Sub-types →
- Hypoparathyroidism-deafness-renal disease syndrome 1 trial
- Ichthyosis prematurity syndrome 1 trial
- Levator syndrome 1 trial
- Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss 1 trial
- Metaphyseal chondrodysplasia, Jansen type 1 trial
- Microcephalic osteodysplastic primordial dwarfism types I and III 0 trials · 1 incl. sub-types Sub-types →
- Microtia with meatal atresia and conductive deafness 1 trial
- Monoclonal mast cell activation syndrome 1 trial
- Neuroleptic malignant syndrome 1 trial
- Orofaciodigital syndrome I 1 trial
- Palindromic rheumatism 1 trial
- Pituitary stalk interruption syndrome 1 trial
- Postaxial acrofacial dysostosis 1 trial
- Prune belly syndrome 1 trial
- Septooptic dysplasia 1 trial Sub-types →
- Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency 1 trial
- Subclavian steal syndrome 1 trial
- Tarsal tunnel syndrome 1 trial
- Thalidomide embryopathy 1 trial
- Thrombocytopenia-absent radius syndrome 1 trial
- Visceral heterotaxy 1 trial Sub-types →
- 3-M syndrome 0 trials Sub-types →
- 46,XX disorder of sex development-anorectal anomalies syndrome 0 trials
- 48,XXXY syndrome 0 trials
- 48,XXYY syndrome 0 trials
- 48,XYYY syndrome 0 trials
- 49,XXXXY syndrome 0 trials
- 6q terminal deletion syndrome 0 trials
- 8p23.1 microdeletion syndrome 0 trials
- AIDS dysmorphic syndrome 0 trials
- ANE syndrome 0 trials
- Abruzzo-Erickson syndrome 0 trials
- Achard syndrome 0 trials
- Achard-Thiers syndrome 0 trials
- Achenbach syndrome 0 trials
- Acrootoocular syndrome 0 trials
- Ahumada Del Castillo syndrome 0 trials
- Aksu von Stockhausen syndrome 0 trials
- Al-Gazali syndrome 0 trials
- Alfadhel syndrome 0 trials
- Alice in Wonderland syndrome 0 trials
- Alkuraya-Kucinskas syndrome 0 trials
- Aloi Tomasini Isaia syndrome 0 trials
- Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome 0 trials Sub-types →
- Alsahan-Harris syndrome 0 trials
- Apert-like polydactyly syndrome 0 trials
- Armfield syndrome 0 trials
- Arnold stickler bourne syndrome 0 trials
- Atkin-Flaitz syndrome 0 trials
- Ayme-Gripp syndrome 0 trials
- B-cell immunodeficiency, distal limb anomalies, and urogenital malformations 0 trials
- BD syndrome 0 trials
- BRESEK syndrome 0 trials
- Bamforth-Lazarus syndrome 0 trials
- Baraitser-Winter cerebrofrontofacial syndrome 0 trials Sub-types →
- Barnicoat Baraitser syndrome 0 trials
- Bartter syndrome 0 trials Sub-types →
- Basedow's coma 0 trials
- Basilicata-Akhtar syndrome 0 trials
- Beardwell syndrome 0 trials
- Bencze syndrome 0 trials
- Bernard-Soulier syndrome 0 trials Sub-types →
- Bloom syndrome 0 trials
- Bonnemann-Meinecke-Reich syndrome 0 trials
- Bonnevie-Ullrich syndrome 0 trials
- Brachymorphism-onychodysplasia-dysphalangism syndrome 0 trials
- Brown-Sequard syndrome 0 trials
- Bruck syndrome 0 trials Sub-types →
- Brunsting-Perry syndrome 0 trials
- Buschke-Ollendorff syndrome 0 trials
- CADDS 0 trials
- CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome 0 trials
- CEDNIK syndrome 0 trials
- CODAS syndrome 0 trials
- COG1-congenital disorder of glycosylation 0 trials
- COG5-congenital disorder of glycosylation 0 trials
- CREST syndrome 0 trials
- CRYAB-related myofibrillar myopathy-cataract-cardiomyopathy spectrum disorder 0 trials Sub-types →
- Camurati-Engelmann disease 0 trials Sub-types →
- Cantu Sanchez-Corona Fragoso syndrome 0 trials
- Cantu Sanchez-Corona Garcia-Cruz syndrome 0 trials
- Cantu Sanchez-Corona Hernandez syndrome 0 trials
- Carnevale hernandez castillo syndrome 0 trials
- Cartwright Nelson Fryns syndrome 0 trials
- Cerebrorenodigital syndrome 0 trials
- Christian Demyer Franken syndrome 0 trials
- Christian Johnson angenieta syndrome 0 trials
- Christianson syndrome 0 trials
- Cohen Lockood Wyborney syndrome 0 trials
- Cole-Carpenter syndrome 0 trials Sub-types →
- Collins-Sakati syndrome 0 trials
- Colver Steer Godman syndrome 0 trials
- Combarros Calleja Leno syndrome 0 trials
- Cormier Rustin Munnich syndrome 0 trials
- Cortes Lacassie syndrome 0 trials
- Cramp-fasciculation syndrome 0 trials
- Crandall syndrome 0 trials
- Crigler-Najjar syndrome 0 trials Sub-types →
- Czeizel-Losonci syndrome 0 trials
- DK1-congenital disorder of glycosylation 0 trials
- DOORS syndrome 0 trials
- Davenport-Donlan syndrome 0 trials
- Davis Lafer syndrome 0 trials
- Dennis-Fairhurst-Moore syndrome 0 trials
- Diamond-Blackfan anemia 2 0 trials
- Donohue syndrome 0 trials
- Drachtman Weinblatt Sitarz syndrome 0 trials
- Duane anomaly-myopathy-scoliosis syndrome 0 trials
- Dubin-Johnson syndrome 0 trials
- Duker-Weiss-Siber syndrome 0 trials
- Dursun syndrome 0 trials
- Dursun-Ozgul neurodevelopmental syndrome 0 trials
- Dyggve-Melchior-Clausen disease 0 trials Sub-types →
- EDICT syndrome 0 trials
- Eagle syndrome 0 trials
- Elliott ludman Teebi syndrome 0 trials
- Elsahy-Waters syndrome 0 trials
- Engelhard Yatziv syndrome 0 trials
- FG syndrome 0 trials Sub-types →
- FICUS syndrome 0 trials
- FRAXF syndrome 0 trials
- Fanconi-like syndrome 0 trials Sub-types →
- Faye-Petersen-Ward-Carey syndrome 0 trials
- Feingold syndrome 0 trials Sub-types →
- Feingold trainer syndrome 0 trials
- Felty syndrome 0 trials
- Finnish type amyloidosis 0 trials
- Fitz-Hugh-Curtis syndrome 0 trials
- Fliedner-Zweier syndrome 0 trials
- Fontaine farriaux blanckaert syndrome 0 trials
- Frank-Ter Haar syndrome 0 trials
- Fraser Jequier Chen syndrome 0 trials
- Fraser syndrome 0 trials Sub-types →
- Frasier syndrome 0 trials
- Freiberg disease 0 trials
- Friedman Goodman syndrome 0 trials
- Froelich syndrome 0 trials
- Fryns Fabry Remans syndrome 0 trials
- Fryns Smeets Thiry syndrome 0 trials
- Fuchs atrophia gyrata chorioideae et retinae 0 trials
- Fuchs heterochromic iridocyclitis 0 trials
- Fukuda-Miyanomae-Nakata syndrome 0 trials
- Fuqua Berkovitz syndrome 0 trials
- GMS syndrome 0 trials
- Galloway-Mowat syndrome 0 trials Sub-types →
- Gamstorp-Wohlfart syndrome 0 trials
- Garret-Tripp syndrome 0 trials
- Gaucher ichthyosis restrictive dermopathy 0 trials
- Ghose-Sachdev-Kumar syndrome 0 trials
- Gilbert syndrome 0 trials
- Gitelman syndrome 0 trials
- Goldberg-Shprintzen syndrome 0 trials
- Greig cephalopolysyndactyly syndrome 0 trials Sub-types →
- Grisel syndrome 0 trials
- Grubben-de Cock-Borghgraef syndrome 0 trials
- Guillouet-Gordon syndrome 0 trials
- Guttmacher syndrome 0 trials
- HEC syndrome 0 trials
- Harel-Tora neurodevelopmental syndrome 0 trials
- Hartsfield-Bixler-Demyer syndrome 0 trials
- Hennekam syndrome 0 trials Sub-types →
- Hernández-Aguirre Negrete syndrome 0 trials
- Hirschsprung disease-ganglioneuroblastoma syndrome 0 trials
- Hirschsprung disease-hearing loss-polydactyly syndrome 0 trials
- Hirschsprung disease-nail hypoplasia-dysmorphism syndrome 0 trials
- Hirschsprung disease-type D brachydactyly syndrome 0 trials
- Ho-Kaufman-McAlister syndrome 0 trials
- Holzgreve-Wagner-Rehder syndrome 0 trials
- Houge-Janssens syndrome 0 trials Sub-types →
- Hoxha-Aliu syndrome 0 trials
- Hughes-Stovin syndrome 0 trials
- ICHAD syndrome 0 trials
- IFAP syndrome 0 trials Sub-types →
- Imerslund-Grasbeck syndrome 0 trials Sub-types →
- Jaberi-Elahi syndrome 0 trials
- Jacobsen syndrome 0 trials
- Jaffer-Beighton syndrome 0 trials
- Joubert syndrome with ocular defect 0 trials Sub-types →
- Judge Misch wright syndrome 0 trials
- KAT6B-related multiple congenital anomalies syndrome 0 trials
- KINSSHIP syndrome 0 trials
- KLHL7-related Bohring-Opitz-like syndrome 0 trials
- KLHL7-related cold-induced sweating-like syndrome 0 trials
- Karayol-Borroto-Haghshenas neurodevelopmental syndrome 0 trials
- Kariminejad neurodevelopmental syndrome 0 trials
- Kashani-Strom-Utley syndrome 0 trials
- Kasznica-Carlson-Coppedge syndrome 0 trials
- Katsantoni-Papadakou-Lagoyanni syndrome 0 trials
- Kleine-Levin syndrome 0 trials
- Kluver-Bucy syndrome 0 trials
- Kocher-debre-Semelaigne syndrome 0 trials
- Koone-Rizzo-Elias syndrome 0 trials
- Kousseff syndrome 0 trials
- Kozlowski Brown Hardwick syndrome 0 trials
- Kozlowski Ouvrier syndrome 0 trials
- Kozlowski Rafinski Klicharska syndrome 0 trials
- Kozlowski Warren Fisher syndrome 0 trials
- Krauss Herman Holmes syndrome 0 trials
- Krieble Bixler syndrome 0 trials
- Kuster Majewski Hammerstein syndrome 0 trials
- Kuster syndrome 0 trials
- Landau-Kleffner syndrome 0 trials
- Landy-Donnai syndrome 0 trials
- Laugier-Hunziker syndrome 0 trials
- Laurence-Moon syndrome 0 trials
- Laurence-Prosser-Rocker syndrome 0 trials
- Leigh syndrome, mitochondrial 0 trials
- Lenz-Majewski hyperostotic dwarfism 0 trials
- Li-Takada-Miyake syndrome 0 trials
- Liberfarb syndrome 0 trials
- Long-Olsen-Distelmaier syndrome 0 trials
- Lopes-Maciel-Rodan syndrome 0 trials
- Lowe-Kohn-Cohen syndrome 0 trials
- Lown-Ganong-Levine syndrome 0 trials
- Lui-Jee-Baron syndrome 0 trials
- Luscan-Lumish syndrome 0 trials
- MEDNIK syndrome 0 trials
- MIRAGE syndrome 0 trials
- MYT1L-related developmental delay-intellectual disability-obesity syndrome 0 trials
- Mallory-Weiss syndrome 0 trials
- Marinesco-Sjogren-like syndrome 0 trials
- Marshall-Smith syndrome 0 trials
- Mauriac syndrome 0 trials
- Meacham syndrome 0 trials
- Meester-Loeys syndrome 0 trials
- Melhem-Fahl syndrome 0 trials
- Melkersson-Rosenthal syndrome 0 trials
- Mietens syndrome 0 trials
- Mikati-Najjar-Sahli syndrome 0 trials
- Miller Fisher syndrome 0 trials
- Miller-Dieker lissencephaly syndrome 0 trials
- Milner-Khallouf-Gibson syndrome 0 trials
- Morimoto-Ryu-Malicdan neuromuscular syndrome 0 trials
- Muggenthaler-Chowdhury-Chioza syndrome 0 trials
- NDUFB11-related disorders 0 trials Sub-types →
- Nager acrofacial dysostosis 0 trials
- Nathalie syndrome 0 trials
- Neu-Laxova syndrome 0 trials Sub-types →
- Norman-Roberts syndrome 0 trials
- Opitz G/BBB syndrome 0 trials Sub-types →
- PAGOD syndrome 0 trials
- PCWH syndrome 0 trials
- PEHO syndrome 0 trials
- PMP22-RAI1 contiguous gene duplication syndrome 0 trials
- Pallister-W syndrome 0 trials
- Pan-Chung-Bellen syndrome 0 trials
- Parana hard-skin syndrome 0 trials
- Parinaud syndrome 0 trials
- Pavone Fiumara Rizzo syndrome 0 trials
- Pendred syndrome 0 trials
- Perlman syndrome 0 trials
- Perry syndrome 0 trials
- Peters plus syndrome 0 trials
- Pfeiffer Tietze Welte syndrome 0 trials
- Pierre Robin sequence with pectus excavatum and rib and scapular anomalies 0 trials
- Plummer-Vinson syndrome 0 trials
- Potocki-Shaffer syndrome 0 trials
- Primrose syndrome 0 trials
- Qazi Markouizos syndrome 0 trials
- RAC2-related combined immunodeficiency-bronchiectasis-cancer-predisposing syndrome 0 trials Sub-types →
- Rabson-Mendenhall syndrome 0 trials
- Rahman syndrome 0 trials
- Ramond-Elliott neurodevelopmental syndrome 0 trials
- Reye syndrome 0 trials
- Roberts-SC phocomelia syndrome 0 trials
- Robinow syndrome 0 trials Sub-types →
- Roussy-Levy syndrome 0 trials
- Rubinstein Taybi like syndrome 0 trials
- Ruvalcaba syndrome 0 trials
- Ruzicka-Goerz-Anton syndrome 0 trials
- SCARF syndrome 0 trials
- SHORT syndrome 0 trials
- STAD syndrome 0 trials
- Saal-Bulas syndrome 0 trials
- Sackey-Sakati-Aur syndrome 0 trials
- Sammartino-Decreccio syndrome 0 trials
- Samson-Gardner syndrome 0 trials
- Samson-Viljoen syndrome 0 trials
- Sanderson-Fraser syndrome 0 trials
- Sandhaus-Ben-Ami syndrome 0 trials
- Sandifer syndrome 0 trials
- Saul-Wilkes-Stevenson syndrome 0 trials
- Say-Barber-Miller syndrome 0 trials
- Schilbach-Rott syndrome 0 trials
- Schlegelberger-Grote syndrome 0 trials
- Schmid metaphyseal chondrodysplasia 0 trials
- Schrander-stumpel-Theunissen-Hulsmans syndrome 0 trials
- Schwartz-Cohen-addad-Lambert syndrome 0 trials
- Schwartz-Jampel syndrome 0 trials Sub-types →
- Seckel like syndrome majoor-krakauer type 0 trials
- Sheehan syndrome 0 trials
- Sillence syndrome 0 trials
- Skraban-Deardorff syndrome 0 trials
- Slti-Salem syndrome 0 trials
- Spigelian hernia-cryptorchidism syndrome 0 trials
- Stankiewicz-Isidor syndrome 0 trials
- Sweeney-Cox syndrome 0 trials
- Tan-Almurshedi syndrome 0 trials
- Tayoun-Maawali syndrome 0 trials
- Tietze syndrome 0 trials
- Townes-Brocks syndrome 0 trials Sub-types →
- Treacher-Collins syndrome 0 trials Sub-types →
- VACTERL with hydrocephalus 0 trials Sub-types →
- VACTERL/vater association 0 trials Sub-types →
- Valence-Farazi cerebellar ataxia syndrome 0 trials
- Ververi-Brady syndrome 0 trials Sub-types →
- Vici syndrome 0 trials
- Waterhouse-Friderichsen syndrome 0 trials
- Weaver syndrome 0 trials
- Weill-Marchesani syndrome 0 trials Sub-types →
- Wiedemann-Rautenstrauch syndrome 0 trials
- Wildervanck syndrome 0 trials
- Wissler syndrome 0 trials
- Wolcott-Rallison syndrome 0 trials
- Wolf-Hirschhorn syndrome 0 trials
- X-linked central congenital hypothyroidism with late-onset testicular enlargement 0 trials
- X-linked corneal dermoid 0 trials
- X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability 0 trials
- X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome 0 trials
- X-linked lissencephaly with abnormal genitalia 0 trials
- X-linked mandibulofacial dysostosis 0 trials
- X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome 0 trials
- X-linked myotubular myopathy-abnormal genitalia syndrome 0 trials
- X-linked spasticity-intellectual disability-epilepsy syndrome 0 trials
- XFE progeroid syndrome 0 trials
- Yuksel-Vogel-Bauer syndrome 0 trials
- Yunis-Varon syndrome 0 trials
- Zadik-Barak-Levin syndrome 0 trials
- Zazam Sheriff Phillips syndrome 0 trials
- Zerres Rietschel Majewski syndrome 0 trials
- Zinner syndrome 0 trials
- Ablepharon macrostomia syndrome 0 trials
- Achalasia-alacrima syndrome 0 trials
- Acral dysostosis dyserythropoiesis syndrome 0 trials
- Acrofrontofacionasal dysostosis 2 0 trials
- Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome 0 trials
- Acute lymphoblastic leukemia congenital sporadic aniridia 0 trials
- Aglossia and situs inversus 0 trials
- Agnathia-microstomia-synotia 0 trials
- Agyria pachygyria polymicrogyria 0 trials
- Agyria-pachygyria type 1 0 trials
- Alacrima, achalasia, and intellectual disability syndrome 0 trials
- Alopecia - intellectual disability syndrome 0 trials Sub-types →
- Alopecia congenita keratosis palmoplantaris 0 trials
- Alopecia-epilepsy-pyorrhea-intellectual disability syndrome 0 trials
- Alpha thalassemia-intellectual disability syndrome type 1 0 trials
- Alpha-mannosidosis type 1 0 trials
- Alpha-thalassemia-myelodysplastic syndrome 0 trials
- Aluminosis 0 trials
- Amelia cleft lip palate hydrocephalus iris coloboma 0 trials
- Angioosteohypotrophic syndrome 0 trials
- Aniridia - intellectual disability syndrome 0 trials
- Aniridia-absent patella syndrome 0 trials
- Aniridia-cerebellar ataxia-intellectual disability syndrome 0 trials
- Aniridia-ptosis-intellectual disability-familial obesity syndrome 0 trials
- Aniridia-renal agenesis-psychomotor retardation syndrome 0 trials
- Ankle defects short stature 0 trials
- Ankyloblepharon filiforme adnatum-cleft palate syndrome 0 trials
- Ankyloblepharon filiforme imperforate anus 0 trials
- Ankyloblepharon filiforme-imperforate anus syndrome 0 trials
- Annular constricting bands 0 trials
- Anophthalmia cleft palate micrognathia 0 trials
- Anophthalmia esophageal atresia cryptorchidism 0 trials
- Anophthalmia plus syndrome 0 trials
- Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome 0 trials
- Anotia facial palsy cardiac defect 0 trials
- Anterior spinal artery syndrome 0 trials
- Aortic dissection lentiginosis 0 trials
- Aplasia cutis congenita-intestinal lymphangiectasia syndrome 0 trials
- Aplasia of lacrimal and salivary glands 0 trials
- Arachnodactyly-intellectual disability-dysmorphism syndrome 0 trials
- Arakawa syndrome 2 0 trials
- Arena syndrome 0 trials
- Arterial tortuosity-bone fragility syndrome 0 trials
- Arthrogryposis IUGR thoracic dystrophy 0 trials
- Arthrogryposis multiplex congenita CNS calcification 0 trials
- Arthrogryposis spinal muscular atrophy 0 trials
- Asternia 0 trials
- Ataxia - telangiectasia variant 0 trials
- Ataxia-photosensitivity-short stature syndrome 0 trials
- Atrioventricular defect-blepharophimosis-radial and anal defect syndrome 0 trials
- Atrophoderma of Pierini and Pasini 0 trials
- Auroneurodental syndrome 0 trials
- Autism-facial port-wine stain syndrome 0 trials
- Autosomal dominant cataract 0 trials Sub-types →
- Autosomal dominant chondrodysplasia punctata 0 trials Sub-types →
- Autosomal dominant deafness - onychodystrophy syndrome 0 trials
- Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome 0 trials
- Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome 0 trials
- Autosomal recessive multiple pterygium syndrome 0 trials Sub-types →
- Axial mesodermal dysplasia spectrum 0 trials
- Baetz-greenwalt syndrome 0 trials
- Bagatelle Cassidy syndrome 0 trials
- Baker Vinters syndrome 0 trials
- Basilar artery insufficiency 0 trials
- Benign exophthalmos syndrome 0 trials
- Bhaskar jagannathan syndrome 0 trials
- Bilirubin induced brain injury in the newborn 0 trials
- Black locks with albinism and deafness syndrome 0 trials
- Blepharo naso facial syndrome van Maldergem type 0 trials
- Blepharophimosis - intellectual disability syndrome, SBBYS type 0 trials
- Blepharophimosis-intellectual disability syndrome/genitopatellar overlap syndrome 0 trials
- Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome 0 trials
- Bobble-head doll syndrome 0 trials
- Bone dysplasia corpus callosum agenesis 0 trials
- Brachydactyly absence of distal phalanges 0 trials
- Brachydactyly anonychia 0 trials
- Brachydactyly small stature face anomalies 0 trials
- Brachydactyly tibial hypoplasia 0 trials
- Brachydactyly type A2 0 trials
- Brachydactyly-arterial hypertension syndrome 0 trials
- Brachydactyly-nystagmus-cerebellar ataxia syndrome 0 trials
- Brachytelephalangy-dysmorphism-Kallmann syndrome 0 trials
- Brain abnormalities-severe developmental delay-facial dysmorphism-intellectual disability syndrome due to MEF2C mutation 0 trials
- Brain malformation renal syndrome 0 trials
- Branchio-oto-renal syndrome 0 trials Sub-types →
- Branchiootic syndrome 0 trials Sub-types →
- Brittle bone syndrome lethal type 0 trials
- Bronchiectasis oligospermia 0 trials
- Bruyn scheltens syndrome 0 trials
- Burn goodship syndrome 0 trials
- Campomelia, Cumming type 0 trials
- Camptodactyly joint contractures and facial skeletal dysplasia 0 trials
- Camptodactyly vertebral fusion 0 trials
- Camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye 0 trials
- Camptomelic syndrome, long-limb type 0 trials
- Carbon baby syndrome 0 trials
- Cardiac hydatid cysts with intracavitary expansion 0 trials
- Cardiac, facial, and digital anomalies with developmental delay 0 trials
- Cardiocutaneous syndrome 0 trials
- Cardioectodermal syndrome 0 trials Sub-types →
- Cardioencephalomyopathy 0 trials
- Cardiofacial syndrome short limbs 0 trials
- Cardiomelic syndrome stratton Koehler type 0 trials
- Cardiomyopathy and deafness due to tRNA lysine gene mutation 0 trials
- Cardiomyopathy diabetes deafness 0 trials
- Cardiomyopathy hypogonadism collagenoma syndrome 0 trials
- Cardiomyopathy hypogonadism metabolic anomalies 0 trials
- Cardiomyopathy spherocytosis 0 trials
- Cardiomyopathy-cataract-hip spine disease syndrome 0 trials
- Carpo tarsal osteolysis recessive 0 trials
- Cat-eye syndrome 0 trials
- Cataract - microcornea syndrome 0 trials
- Cataract skeletal anomalies 0 trials
- Cataract, alopecia, oral mucosal disorder, and psoriasis-like syndrome 0 trials
- Cataract-deafness-hypogonadism syndrome 0 trials
- Cataract-glaucoma syndrome 0 trials
- Cataract-intellectual disability-anal atresia-urinary defects syndrome 0 trials
- Cataract-nephropathy-encephalopathy syndrome 0 trials
- Cataracts, hearing impairment, nephrotic syndrome, and enterocolitis 0 trials Sub-types →
- Caudal duplication 0 trials
- Caudal regression-sirenomelia spectrum 0 trials Sub-types →
- Cennamo gangemi syndrome 0 trials
- Central nervous system calcification-deafness-tubular acidosis-anemia syndrome 0 trials
- Cerebellar agenesis 0 trials
- Cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome 0 trials
- Cerebello-olivary atrophy 0 trials
- Cerebral calcification cerebellar hypoplasia 0 trials
- Cerebral calcifications opalescent teeth phosphaturia 0 trials
- Cerebrocostomandibular syndrome 0 trials
- Childhood aortic valve stenosis 0 trials
- Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome 0 trials
- Chondrodysplasia 0 trials Sub-types →
- Chondrodysplasia-pseudohermaphroditism syndrome 0 trials
- Choreoacanthocytosis amyotrophic 0 trials
- Chorioretinopathy dominant form microcephaly 0 trials
- Chromosome 13q14 deletion syndrome 0 trials
- Chromosome 16p12.1 deletion syndrome, 520kb 0 trials
- Chromosome 18p deletion syndrome 0 trials
- Chromosome 18q deletion syndrome 0 trials Sub-types →
- Chromosome 3 duplication syndrome 0 trials
- Chronic atrial and intestinal dysrhythmia 0 trials
- Chronic demyelinizing neuropathy with IgM monoclonal 0 trials
- Ciliary dyskinesia-bronchiectasis 0 trials
- Circumscribed cutaneous aplasia of the vertex 0 trials
- Circumscribed disseminated keratosis Jadassohn lew type 0 trials
- Cleft lip and palate malrotation cardiopathy 0 trials
- Cleft lip and/or palate with mucous cysts of lower 0 trials
- Cleft lip palate dysmorphism kumar type 0 trials
- Cleft lip palate intellectual disability corneal opacity 0 trials
- Cleft lip palate oligodontia syndactyly pili torti 0 trials
- Cleft lip palate pituitary deficiency 0 trials
- Cleft lip palate-tetraphocomelia 0 trials
- Cleft lip-retinopathy syndrome 0 trials
- Cleft lip/palate-deafness-sacral lipoma syndrome 0 trials
- Cleft lower lip cleft lateral canthi chorioretinal 0 trials
- Cleft palate cardiac defect ectrodactyly 0 trials
- Cleft palate colobomata radial synostosis deafness 0 trials
- Cleft palate heart disease polydactyly absent tibia 0 trials
- Cleft palate-congenital heart defect-intellectual disability syndrome 0 trials Sub-types →
- Cleft tongue 0 trials
- Cleidorhizomelic syndrome 0 trials
- Cloacal exstrophy 0 trials
- Coarse face hypotonia constipation 0 trials
- Cochleosaccular degeneration-cataract syndrome 0 trials
- Coloboma porencephaly hydronephrosis 0 trials
- Colobomata unilobar lung heart defect 0 trials
- Colobomatous macrophthalmia-microcornea syndrome 0 trials
- Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome 0 trials
- Colonic malakoplakia 0 trials
- Complement receptor deficiency 0 trials
- Congenital absence of the sternocleidomastoid muscle 0 trials
- Congenital acardia 0 trials Sub-types →
- Congenital aneurysms of the great vessels 0 trials
- Congenital aphakia-iris hypoplasia-microphthalmia-microcornea syndrome 0 trials
- Congenital articular rigidity 0 trials
- Congenital benign spinal muscular atrophy dominant 0 trials
- Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome 0 trials
- Congenital cataract-ichthyosis syndrome 0 trials
- Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome 0 trials
- Congenital contractures 0 trials
- Congenital craniosynostosis maternal hyperthyroiditis 0 trials
- Congenital cystic eye 0 trials Sub-types →
- Congenital generalized hypercontractile muscle stiffness syndrome 0 trials
- Congenital heart disease ptosis hypodontia craniostosis 0 trials
- Congenital heart disease radio ulnar synostosis intellectual disability 0 trials
- Congenital hereditary facial paralysis-variable hearing loss syndrome 0 trials Sub-types →
- Congenital ichthyosis-microcephalus-tetraplegia syndrome 0 trials
- Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome 0 trials
- Congenital laryngeal web 0 trials
- Congenital mumps 0 trials
- Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0 trials
- Congenital stenosis of cervical medullary canal 0 trials
- Congenital unilateral pulmonary hypoplasia 0 trials
- Congenital vagal hyperreflexivity 0 trials
- Congenital varicella syndrome 0 trials
- Corneal crystals myopathy neuropathy 0 trials
- Corneal dystrophy ichthyosis microcephaly intellectual disability 0 trials
- Corneal dystrophy pigmentary anomaly malabsorption 0 trials
- Corneal dystrophy-perceptive deafness syndrome 0 trials
- Corneal-cerebellar syndrome 0 trials
- Corpus callosum agenesis of blepharophimosis robin type 0 trials
- Corpus callosum agenesis-abnormal genitalia syndrome 0 trials
- Corpus callosum agenesis-double urinary collecting system syndrome 0 trials
- Corpus callosum dysgenesis X-linked recessive 0 trials
- Corpus callosum dysgenesis cleft spasm 0 trials
- Corpus callosum dysgenesis hypopituitarism 0 trials
- Cortada Koussef Matsumoto syndrome 0 trials
- Cortical blindness-intellectual disability-polydactyly syndrome 0 trials
- Cortical dysplasia-focal epilepsy syndrome 0 trials
- Craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 0 trials Sub-types →
- Craniofacial dysostosis arthrogryposis progeroid appearance 0 trials
- Craniofaciocardiohepatic syndrome 0 trials
- Craniofrontonasal syndrome Teebi type 0 trials
- Craniostenosis with congenital heart disease intellectual disability 0 trials
- Craniosynostosis-facial dysmorphism-chiari-1 malformation-developmental and language delay syndrome 0 trials
- Craniosynostosis-scoliosis syndrome 0 trials
- Crawfurd syndrome 0 trials
- Cutis gyratum acanthosis nigricans craniosynostosis 0 trials
- Cutis laxa osteoporosis 0 trials
- Cystic fibrosis-gastritis-megaloblastic anemia syndrome 0 trials
- De Hauwere Leroy adriaenssens syndrome 0 trials
- De Sanctis-Cacchione syndrome 0 trials
- Deafness conductive stapedial ear malformation facial palsy 0 trials
- Deafness goiter stippled epiphyses 0 trials
- Deafness hypospadias metacarpal and metatarsal syndrome 0 trials
- Deafness mesenteric diverticula of small bowel neuropathy 0 trials
- Deafness peripheral neuropathy arterial disease 0 trials
- Deafness progressive cataract autosomal dominant 0 trials
- Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome 0 trials
- Deafness-hypogonadism syndrome 0 trials
- Deafness-intellectual disability, Martin-Probst type syndrome 0 trials
- Dermatocardioskeletal syndrome boronne type 0 trials
- Dermochondrocorneal dystrophy 0 trials
- Developmental and speech delay due to SOX5 deficiency 0 trials
- Developmental delay, hypotrophy, and dysmorphic features without moebius syndrome 0 trials
- Developmental delay-immunodeficiency-leukoencephalopathy-hypohomocysteinemia syndrome 0 trials
- Dextrocardia with situs inversus 0 trials
- Diabetes persistent mullerian ducts 0 trials
- Diabetes, deafness, developmental delay, and short stature syndrome 0 trials
- Diaphragmatic agenesis radial aplasia omphalocele 0 trials
- Diaphragmatic defect-limb deficiency-skull defect syndrome 0 trials
- Diaphragmatic hernia exomphalos corpus callosum agenesis 0 trials
- Diaphragmatic hernia upper limb defects 0 trials
- Diaphragmatic hernia-short bowel-asplenia syndrome 0 trials
- Die Smulders droog van dijk syndrome 0 trials
- Diencephalic syndrome 0 trials
- Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome 0 trials
- Diffuse infiltrative lymphocytosis syndrome 0 trials
- Digital anomalies-intellectual disability-short stature syndrome 0 trials
- Dilated cardiomyopathy 1E 0 trials
- Diomedi bernardi placidi syndrome 0 trials
- Diphallus rachischisis imperforate anus 0 trials
- Distal monosomy 13q 0 trials
- Distal trisomy 14q 0 trials
- Distichiasis heart congenital anomalies 0 trials
- Diverticulosis of bowel, hernia, and retinal detachment 0 trials
- Double discordia 0 trials
- Double uterus-hemivagina-renal agenesis 0 trials
- Double uterus-hemivagina-renal agenesis syndrome 0 trials
- Duodenal atresia tetralogy of fallot 0 trials
- Duplication of leg mirror foot 0 trials
- Duplication of the thumb unilateral biphalangeal 0 trials
- Dupont sellier chochillon syndrome 0 trials
- Dwarfism bluish sclerae 0 trials
- Dwarfism deafness retinitis pigmentosa 0 trials
- Dwarfism lethal type advanced bone age 0 trials
- Dwarfism thin bones multiple fractures 0 trials
- Dyschondrosteosis-nephritis syndrome 0 trials
- Dyschromatosis, ichthyosis, deafness, and atopic disease 0 trials
- Dysmorphism cleft palate loose skin 0 trials
- Dyssegmental dysplasia-glaucoma syndrome 0 trials
- Dystonia-aphonia syndrome 0 trials
- Early-onset obesity-hyperphagia-severe developmental delay syndrome 0 trials
- Ectrodactyly cardiopathy dysmorphism 0 trials
- Ectrodactyly-polydactyly syndrome 0 trials
- Empty sella syndrome 0 trials
- Enamel hypoplasia cataract hydrocephaly 0 trials
- Encephalocele anencephaly 0 trials
- Encephalopathy, recurrent, of childhood 0 trials
- Enchondromatosis dwarfism deafness 0 trials
- Epidermal nevus vitamin D resistant rickets 0 trials
- Epidermolysis bullosa simplex 5B, with muscular dystrophy 0 trials
- Epimetaphyseal dysplasia cataract 0 trials
- Epiphyseal dysplasia dysmorphism camptodactyly 0 trials
- Epiphyseal dysplasia-hearing loss-dysmorphism syndrome 0 trials
- Ermine phenotype 0 trials
- Esophageal atresia coloboma talipes 0 trials
- Estrogen resistance syndrome 0 trials
- Euthyroid sick syndrome 0 trials
- Even-plus syndrome 0 trials
- Extrasystoles short stature hyperpigmentation microcephaly 0 trials
- Eyebrow duplication-syndactyly syndrome 0 trials
- Facial clefting corpus callosum agenesis 0 trials
- Facio digito genital syndrome recessive form 0 trials
- Facio skeletal genital syndrome rippberger type 0 trials
- Faciodigitogenital syndrome 0 trials Sub-types →
- Familial capillaro-venous leptomeningeal angiomatosis 0 trials
- Familial episodic pain syndrome with predominantly lower limb involvement 0 trials
- Familial infantile bilateral striatal necrosis 0 trials Sub-types →
- Familial intestinal malrotation-facial anomalies syndrome 0 trials
- Familial osteodysplasia, Anderson type 0 trials
- Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome 0 trials
- Feigenbaum Bergeron syndrome 0 trials
- Ferro-cerebro-cutaneous syndrome 0 trials
- Fetal akinesia deformation sequence 0 trials Sub-types →
- Fetal brain disruption sequence 0 trials
- Fetal enterovirus syndrome 0 trials
- Fetal hydantoin syndrome 0 trials
- Fetal parainfluenza virus type 3 syndrome 0 trials
- Fetal phenothiazine syndrome 0 trials
- Fetal valproate syndrome 0 trials
- Fibrogenesis imperfecta ossium 0 trials
- Fibromatosis multiple non ossifying 0 trials
- Fibrosis, neurodegeneration, and cerebral angiomatosis 0 trials
- Fibula aplasia complex brachydactyly 0 trials
- Fibular aplasia-ectrodactyly syndrome 0 trials
- Fibular hypoplasia scapulo pelvic dysplasia absent 0 trials
- Finger hyperphalangy - toe anomalies - severe pectus excavatum syndrome 0 trials
- Focal alopecia congenital megalencephaly 0 trials
- Focal or multifocal malformations in neuronal migration 0 trials
- Foix chavany Marie syndrome 0 trials
- Foveal hypoplasia - optic nerve decussation defect - anterior segment dysgenesis syndrome 0 trials
- Fragile X-associated tremor/ataxia syndrome 0 trials
- Frontofacionasal dysplasia 0 trials
- Frontonasal dysplasia Klippel feil syndrome 0 trials
- Frontonasal dysplasia phocomelic upper limbs 0 trials
- Frontonasal dysplasia-bifid nose-upper limb anomalies syndrome 0 trials
- Frontonasal malformation cloacal exstrophy 0 trials
- Genitopatellar syndrome 0 trials
- Gershinibaruch Leibo syndrome 0 trials
- Gigantism advanced bone age hoarse cry 0 trials
- Gingival fibromatosis-facial dysmorphism syndrome 0 trials
- Glaucoma-sleep apnea syndrome 0 trials
- Global developmental delay-osteopenia-ectodermal defect syndrome 0 trials
- Glossopalatine ankylosis micrognathia ear anomalies 0 trials
- Goldstein hutt syndrome 0 trials
- Goniodysgenesis intellectual disability short stature 0 trials
- Gray platelet syndrome 0 trials
- Green sandford davison syndrome 0 trials
- Grix Blankenship Peterson syndrome 0 trials
- Growth delay-hydrocephaly-lung hypoplasia syndrome 0 trials
- Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy 0 trials
- Growth retardation-mild developmental delay-chronic hepatitis syndrome 0 trials
- Hair defect with photosensitivity and intellectual disability syndrome 0 trials
- Hand-foot-genital syndrome 0 trials
- Hearing impairment and infertile male syndrome 0 trials
- Hearing loss-familial salivary gland insensitivity to aldosterone syndrome 0 trials
- Heart-hand syndrome 0 trials Sub-types →
- Hepatic fibrosis-renal cysts-intellectual disability syndrome 0 trials
- Hereditary benign intraepithelial dyskeratosis 0 trials
- Hereditary continuous muscle fiber activity 0 trials
- Hereditary persistence of fetal hemoglobin-intellectual disability syndrome 0 trials
- Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome 0 trials
- Hereditary sensory and autonomic neuropathy with deafness and global delay 0 trials
- High myopia-sensorineural deafness syndrome 0 trials
- Holoprosencephaly 0 trials Sub-types →
- Holoprosencephaly-postaxial polydactyly syndrome 0 trials
- Hydrocephalus-blue sclerae-nephropathy syndrome 0 trials
- Hydrocephalus-obesity-hypogonadism syndrome 0 trials
- Hydrocephaly-cerebellar agenesis syndrome 0 trials
- Hypergonadotropic hypogonadism-cataract syndrome 0 trials
- Hypertrichotic osteochondrodysplasia Cantu type 0 trials
- Hypogonadism-mitral valve prolapse-intellectual disability syndrome 0 trials
- Hypogonadotropic hypogonadism-retinitis pigmentosa syndrome 0 trials
- Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 0 trials
- Hypoparathyroidism-retardation-dysmorphism syndrome 0 trials
- Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome 0 trials
- Hypospadias-intellectual disability, Goldblatt type syndrome 0 trials
- Hypotonia-cystinuria syndrome 0 trials Sub-types →
- Hypotrichosis-deafness syndrome 0 trials
- Hypotrichosis-intellectual disability, Lopes type 0 trials
- Hypotrichosis-lymphedema-telangiectasia syndrome (grouping) 0 trials Sub-types →
- Ichthyosis linearis circumflexa 0 trials
- Ichthyosis-cheek-eyebrow syndrome 0 trials
- Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome 0 trials
- Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome 0 trials
- Ichthyosis-oral and digital anomalies syndrome 0 trials
- Immune dysregulation, neurodevelopmental defects, and colitis 0 trials
- Imperforate oropharynx-costo vetebral anomalies syndrome 0 trials
- Infantile choroidocerebral calcification syndrome 0 trials
- Infantile convulsions and choreoathetosis 0 trials
- Infantile striato thalamic degeneration 0 trials
- Infundibulopelvic stenosis-multicystic kidney syndrome 0 trials
- Intellectual disability, autosomal dominant 29 0 trials
- Intellectual disability, autosomal dominant 30 0 trials
- Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome 0 trials
- Intellectual disability-cataracts-kyphosis syndrome 0 trials
- Intellectual disability-epilepsy-extrapyramidal syndrome 0 trials
- Intellectual disability-hypotonia-skin hyperpigmentation syndrome 0 trials
- Intellectual disability-microcephaly-phalangeal-facial abnormalities syndrome 0 trials
- Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome 0 trials
- Intellectual disability-strabismus syndrome 0 trials
- Intrauterine growth restriction-congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome 0 trials
- Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome 0 trials
- Ischio-vertebral syndrome 0 trials
- Isotretinoin syndrome 0 trials
- Joint laxity, short stature, and myopia 0 trials
- Keratosis follicularis-dwarfism-cerebral atrophy syndrome 0 trials
- Laryngeal abductor paralysis-intellectual disability syndrome 0 trials
- Laryngo-onycho-cutaneous syndrome 0 trials
- Lateral medullary syndrome 0 trials
- Le Marec-Bracq-Picaud syndrome 0 trials
- Lethal congenital contracture syndrome 1 0 trials
- Lethal hemolytic anemia-genital anomalies syndrome 0 trials
- Lethal multiple pterygium syndrome 0 trials Sub-types →
- Limb body wall complex 0 trials
- Linkeropathy 0 trials Sub-types →
- Loin pain hematuria syndrome 0 trials
- Lower limb deficiency-hypospadias syndrome 0 trials
- Lung agenesis-heart defect-thumb anomalies syndrome 0 trials
- Lymphedema-atrial septal defects-facial changes syndrome 0 trials
- Lymphedema-cerebral arteriovenous anomaly syndrome 0 trials
- Lymphedema-distichiasis syndrome 0 trials
- Macrocephaly-short stature-paraplegia syndrome 0 trials
- Macrogyria, pseudobulbar palsy and intellectual disability 0 trials
- Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome 0 trials
- Mandibulofacial dysostosis with alopecia 0 trials
- Megacystis-microcolon-intestinal hypoperistalsis syndrome 0 trials Sub-types →
- Megalencephaly-polydactyly syndrome 0 trials
- Merlob grunebaum reisner syndrome 0 trials
- Mesomelic dwarfism-cleft palate-camptodactyly syndrome 0 trials
- Metaphyseal chondrodysplasia-retinitis pigmentosa syndrome 0 trials
- Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome 0 trials
- Methimazole embryofetopathy 0 trials
- Microcephalic primordial dwarfism due to RTTN deficiency 0 trials Sub-types →
- Microcephalic primordial dwarfism, Alazami type 0 trials
- Microcephalic primordial dwarfism, Toriello type 0 trials
- Microcephaly and chorioretinopathy 1 0 trials
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Microcephaly-brachydactyly-kyphoscoliosis syndrome 0 trials
- Microcephaly-brain defect-spasticity-hypernatremia syndrome 0 trials
- Microcephaly-capillary malformation syndrome 0 trials
- Microcephaly-complex motor and sensory axonal neuropathy syndrome 0 trials
- Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome 0 trials
- Microcephaly-microcornea syndrome, Seemanova type 0 trials
- Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome 0 trials
- Microgastria-limb reduction defect syndrome 0 trials
- Microlissencephaly-micromelia syndrome 0 trials
- Microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome 0 trials
- Mirror polydactyly-vertebral segmentation-limbs defects syndrome 0 trials
- Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria 0 trials
- Monosomy 13q34 0 trials
- Motor developmental delay due to 14q32.2 paternally expressed gene defect 0 trials Sub-types →
- Mulibrey nanism 0 trials
- Mullerian derivatives-lymphangiectasia-polydactyly syndrome 0 trials
- Mullerian duct anomalies-limb anomalies syndrome 0 trials
- Multicentric osteolysis, nodulosis, and arthropathy 0 trials
- Multicentric reticulohistiocytosis 0 trials
- Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome 0 trials
- Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome 0 trials
- Multiple synostoses syndrome 0 trials Sub-types →
- Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome 0 trials
- Muscular fibrosis multifocal obstructed vessels 0 trials
- Muscular pseudohypertrophy-hypothyroidism syndrome 0 trials
- Myelofibrosis, congenital, with anemia, neutropenia, developmental delay, and ocular abnormalities 0 trials
- Myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 2 0 trials
- Myopathy-growth delay-intellectual disability-hypospadias syndrome 0 trials
- Nasopalpebral lipoma-coloboma syndrome 0 trials
- Neonatal diabetes, congenital sensorineural hearing loss and congenital cataracts 0 trials
- Neonatal ichthyosis-sclerosing cholangitis syndrome 0 trials
- Nephrogenic diabetes insipidus-intracranial calcification syndrome 0 trials
- Nephropathy - deafness - hyperparathyroidism syndrome 0 trials
- Nephrosis-deafness-urinary tract-digital malformations syndrome 0 trials
- Neurodegeneration, infantile-onset, with optic atrophy and brain abnormalities 0 trials
- Neurodevelopmental disorder with dysmorphic facies, absent speech and ambulation, and brain abnormalities 0 trials
- Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 0 trials
- Neurodevelopmental disorder with variable familial hypercholanemia 0 trials
- Nodular neuronal heterotopia 0 trials Sub-types →
- Obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome 0 trials
- Oculo digital syndrome 0 trials
- Oculo-skeletal-renal syndrome 0 trials
- Oculocerebrodental syndrome 0 trials
- Oculocerebrofacial syndrome, Kaufman type 0 trials
- Oculodental syndrome, Rutherfurd type 0 trials
- Oculogastrointestinal-neurodevelopmental syndrome 0 trials
- Oculomaxillofacial dysostosis 0 trials Sub-types →
- Oculovertebral syndrome 0 trials
- Olivopontocerebellar atrophy-deafness syndrome 0 trials
- Orofacial clefting-cardiac anomalies-facial dysmorphism syndrome 0 trials
- Oromandibular-limb anomalies syndrome 0 trials Sub-types →
- Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome 0 trials
- Osteopenia-intellectual disability-sparse hair syndrome 0 trials
- Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome 0 trials
- Osteoporosis-pseudoglioma syndrome 0 trials
- Osteosclerosis-ichthyosis-premature ovarian failure syndrome 0 trials
- Otopalatodigital syndrome type 1 0 trials
- Painful legs and moving toes syndrome 0 trials
- Palmoplantar keratoderma-esophageal carcinoma syndrome 0 trials
- Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome 0 trials Sub-types →
- Pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0 trials
- Paraplegia-intellectual disability-hyperkeratosis syndrome 0 trials
- Parkinsonism-dystonia, infantile 0 trials Sub-types →
- Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome 0 trials
- Pentasomy X 0 trials
- Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome 0 trials
- Pfeiffer rockelein syndrome 0 trials
- Phosphoribosylpyrophosphate synthetase deficiency 0 trials
- Piepkorn karp hickok syndrome 0 trials
- Pili torti-developmental delay-neurological abnormalities syndrome 0 trials
- Podder-tolmie syndrome 0 trials
- Pointer syndrome 0 trials
- Polydactyly-macrocephaly syndrome 0 trials
- Polyendocrine-polyneuropathy syndrome 0 trials
- Polyneuropathy-intellectual disability-acromicria-premature menopause syndrome 0 trials
- Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome 0 trials
- Posterior fusion of lumbosacral vertebrae-blepharoptosis syndrome 0 trials
- Primary hypergonadotropic hypogonadism-partial alopecia syndrome 0 trials
- Primary hypertrophic osteoarthropathy 0 trials Sub-types →
- Primary hypomagnesemia-generalized seizures-intellectual disability-obesity syndrome 0 trials
- Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome 0 trials
- Progeria-short stature-pigmented nevi syndrome 0 trials
- Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 0 trials
- Prostatic malacoplakia associated with prostatic abscess 0 trials
- Proximal tubulopathy-diabetes mellitus-cerebellar ataxia syndrome 0 trials
- Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa 0 trials
- Psoriatic arthritis-pyoderma gangrenosum-acne-hidradenitis suppurativa syndrome 0 trials
- Ptosis-strabismus-ectopic pupils syndrome 0 trials
- Ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome 0 trials
- Ptosis-vocal cord paralysis syndrome 0 trials
- Pyoderma gangrenosum-acne-hidradenitis suppurativa-ankylosing spondylitis syndrome 0 trials
- Radial hypoplasia-triphalangeal thumbs-hypospadias-maxillary diastema syndrome 0 trials
- Radial ray hypoplasia-choanal atresia syndrome 0 trials
- Radio-digito-facial dysplasia 0 trials
- Radioulnar synostosis-microcephaly-scoliosis syndrome 0 trials
- Ragopathy 0 trials
- Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome 0 trials
- Renal caliceal diverticuli-deafness syndrome 0 trials
- Renal coloboma syndrome 0 trials
- Renal cysts and diabetes syndrome 0 trials
- Retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome 0 trials
- Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome 0 trials
- Retinitis pigmentosa-intellectual disability-deafness-hypogenitalism syndrome 0 trials
- Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome 0 trials
- Richieri-costa guion-almeida cohen syndrome 0 trials
- Ring chromosome 10 0 trials
- Ring chromosome 13 0 trials
- Ruvalcaba churesigaew myhre syndrome 0 trials
- Scalp defects-postaxial polydactyly syndrome 0 trials
- Schisis association 0 trials
- Severe dermatitis-multiple allergies-metabolic wasting syndrome 0 trials
- Severe intellectual disability-hypotonia-strabismus-coarse face-planovalgus syndrome 0 trials
- Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion 0 trials
- Shone complex 0 trials
- Short fifth metacarpals-insulin resistance syndrome 0 trials
- Short limb dwarf lethal colavita kozlowski type 0 trials
- Short stature contractures hypotonia 0 trials
- Short stature, microcephaly, and endocrine dysfunction 0 trials
- Short stature-deafness-neutrophil dysfunction-dysmorphism syndrome 0 trials
- Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome 0 trials
- Shoulder and girdle defects-familial intellectual disability syndrome 0 trials
- Sickle cell-hemoglobin E disease syndrome 0 trials
- Sickle cell-hemoglobin d disease syndrome 0 trials
- Skeletal dysplasia-epilepsy-short stature syndrome 0 trials
- Skin fragility-woolly hair-palmoplantar keratoderma syndrome 0 trials
- Spastic ataxia-corneal dystrophy syndrome 0 trials
- Spastic paraparesis-cataracts-speech delay syndrome 0 trials
- Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome 0 trials
- Spina bifida-hypospadias syndrome 0 trials
- Spondylocostal dysostosis-anal and genitourinary malformations syndrome 0 trials
- Spondylocostal dysostosis-hypospadias-intellectual disability syndrome 0 trials
- Subaortic stenosis-short stature syndrome 0 trials
- Subcortical band heterotopia 0 trials Sub-types →
- Syndactyly-polydactyly-ear lobe syndrome 0 trials
- Syndactyly-telecanthus-anogenital and renal malformations syndrome 0 trials
- Syndromic congenital sodium diarrhea 0 trials
- Syndromic microspherophakia 0 trials
- Syndromic orbital border hypoplasia 0 trials
- Syngnathia multiple anomalies 0 trials
- Tall stature-scoliosis-macrodactyly of the great toes syndrome 0 trials
- Telangiectasia, impaired intellectual development, microcephaly, metaphyseal dysplasia, eye abnormalities, and short stature 0 trials
- Tempi syndrome 0 trials
- Temtamy preaxial brachydactyly syndrome 0 trials
- Tetrasomy 12p 0 trials
- Thickened earlobes with conductive deafness from incus-stapes abnormalities 0 trials
- Thoraco-abdominal enteric duplication 0 trials
- Thyrocerebrorenal syndrome 0 trials
- Torticollis-keloids-cryptorchidism-renal dysplasia syndrome 0 trials
- Trigeminal trophic syndrome 0 trials
- Trigonocephaly-short stature-developmental delay syndrome 0 trials
- Tubular renal disease-cardiomyopathy syndrome 0 trials
- Tubulointerstitial nephritis and uveitis syndrome 0 trials
- Ulnar hypoplasia-split foot syndrome 0 trials
- Ulnar-mammary syndrome 0 trials
- Umbilical cord ulceration-intestinal atresia syndrome 0 trials
- Van den Bosch syndrome 0 trials
- Vitamin K-antagonist embryofetopathy 0 trials
- Warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome 0 trials
- Weinstein kliman scully syndrome 0 trials
- White matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome 0 trials
- Wooly hair-hypotrichosis-everted lower lip-outstanding ears syndrome 0 trials
- Xerosis and growth failure with immune and pulmonary dysfunction syndrome 0 trials
- Yellow nail syndrome 0 trials
-
Urinary system disorder 72 trials · 5,523 incl. sub-types
20 sub-types
- Kidney disorder 223 trials · 4,032 incl. sub-types Sub-types →
- Urinary system neoplasm 21 trials · 1,690 incl. sub-types Sub-types →
- Urinary bladder disorder 24 trials · 1,152 incl. sub-types Sub-types →
- Urolithiasis 119 trials · 312 incl. sub-types Sub-types →
- Urinary tract infection 156 trials · 250 incl. sub-types Sub-types →
- Ureteral disorder 2 trials · 95 incl. sub-types Sub-types →
- Urethral disorder 1 trial · 70 incl. sub-types Sub-types →
- Urinary tract obstruction 12 trials · 27 incl. sub-types Sub-types →
- Bacteriuria 11 trials
- Idiopathic hypercalciuria 3 trials
- Paraneoplastic renal syndrome 0 trials · 3 incl. sub-types Sub-types →
- Congenital urachal anomaly 0 trials Sub-types →
- Hypercalciuria, absorptive, 1 0 trials
- Hypercalciuria, absorptive, 2 0 trials
- Hyperglycinuria 0 trials
- Megacystis-megaureter syndrome 0 trials
- Meningitis-retention syndrome 0 trials
- Postorgasmic illness syndrome 0 trials
- Pyuria 0 trials
- Urothelial hyperplasia 0 trials Sub-types →
-
Breast disorder 25 trials · 4,686 incl. sub-types
15 sub-types
- Breast neoplasm 3,261 trials · 4,628 incl. sub-types Sub-types →
- Lactation disease 18 trials · 24 incl. sub-types Sub-types →
- Hypertrophy of breast 7 trials · 15 incl. sub-types Sub-types →
- Mastitis 11 trials Sub-types →
- Breast fibrocystic disease 7 trials · 10 incl. sub-types Sub-types →
- Breast implant illness 8 trials
- Breast abscess 5 trials
- Familial juvenile hypertrophy of the breast 4 trials
- Syndromic breast hypoplasia/aplasia 0 trials · 2 incl. sub-types Sub-types →
- Breast adenosis 0 trials · 1 incl. sub-types Sub-types →
- Isolated congenital breast hypoplasia/aplasia 0 trials · 1 incl. sub-types Sub-types →
- Benign mammary dysplasia 0 trials
- Breast angiomatosis 0 trials
- Fat necrosis of breast 0 trials
- Supernumerary breasts 0 trials Sub-types →
-
Connective tissue disorder 70 trials · 4,637 incl. sub-types
16 sub-types
- Connective tissue neoplasm 1 trial · 2,404 incl. sub-types Sub-types →
- Rheumatic disorder 90 trials · 1,792 incl. sub-types Sub-types →
- Hereditary disorder of connective tissue 0 trials · 1,311 incl. sub-types Sub-types →
- Disease of the tendon 126 trials · 192 incl. sub-types Sub-types →
- Benign connective and soft tissue neoplasm 0 trials · 101 incl. sub-types Sub-types →
- Fasciitis 7 trials · 97 incl. sub-types Sub-types →
- Collagenopathy 3 trials · 42 incl. sub-types Sub-types →
- Interstitial cystitis 39 trials
- Periostitis 0 trials · 16 incl. sub-types Sub-types →
- Overlapping connective tissue disease 2 trials · 15 incl. sub-types Sub-types →
- Synovitis 15 trials Sub-types →
- Panniculitis 3 trials · 6 incl. sub-types Sub-types →
- Enthesopathy 2 trials · 4 incl. sub-types Sub-types →
- Ochronosis disorder 1 trial Sub-types →
- Ainhum 0 trials
- Interstitial keratitis 0 trials Sub-types →
-
Integumentary system disorder 0 trials · 4,553 incl. sub-types
36 sub-types
- Skin disorder 138 trials · 3,961 incl. sub-types Sub-types →
- Integumentary system cancer 0 trials · 1,084 incl. sub-types Sub-types →
- Disorder of pilosebaceous unit 7 trials · 340 incl. sub-types Sub-types →
- Skin appendage disorder 0 trials · 244 incl. sub-types Sub-types →
- Integumentary system benign neoplasm 0 trials · 120 incl. sub-types Sub-types →
- Cutaneous mycosis 1 trial · 118 incl. sub-types Sub-types →
- Subcutaneous tissue disorder 0 trials · 64 incl. sub-types Sub-types →
- Cutis laxa 37 trials · 39 incl. sub-types Sub-types →
- X-linked ichthyosis syndrome 0 trials · 37 incl. sub-types Sub-types →
- Keratinization disease 1 trial · 31 incl. sub-types Sub-types →
- Nail disorder 2 trials · 18 incl. sub-types Sub-types →
- Pseudoxanthoma elasticum (inherited or acquired) 5 trials · 7 incl. sub-types Sub-types →
- Demodicidosis 5 trials · 6 incl. sub-types Sub-types →
- Panniculitis 3 trials · 6 incl. sub-types Sub-types →
- Mucosulfatidosis 4 trials
- Sjogren-Larsson syndrome 3 trials
- Familial atypical multiple mole melanoma syndrome 3 trials Sub-types →
- Breast fibrosis 2 trials
- Bartholin gland neoplasm 0 trials · 1 incl. sub-types Sub-types →
- Rombo syndrome 1 trial
- Familial tumoral calcinosis 1 trial Sub-types →
- Ichthyosis prematurity syndrome 1 trial
- ANE syndrome 0 trials
- Bartholin duct cyst 0 trials
- Neu-Laxova syndrome 0 trials Sub-types →
- Proteus-like syndrome 0 trials
- Alopecia-epilepsy-pyorrhea-intellectual disability syndrome 0 trials
- Autosomal dominant deafness - onychodystrophy syndrome 0 trials
- Benign mammary dysplasia 0 trials
- Breast mucosa-associated lymphoid tissue lymphoma 0 trials
- Frontonasal dysplasia with alopecia and genital anomaly 0 trials
- Keratoderma hereditarium mutilans 0 trials
- Mandibulofacial dysostosis with alopecia 0 trials
- Nipple neoplasm 0 trials Sub-types →
- Paraneoplastic cutaneous syndrome 0 trials Sub-types →
- Peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome 0 trials
-
Disorder of visual system 1 trial · 3,476 incl. sub-types
30 sub-types
- Eye disorder 104 trials · 3,068 incl. sub-types Sub-types →
- Vision disorder 105 trials · 382 incl. sub-types Sub-types →
- Optic nerve disorder 23 trials · 95 incl. sub-types Sub-types →
- Oculomotor nerve paralysis 1 trial · 86 incl. sub-types Sub-types →
- Kearns-Sayre syndrome 5 trials
- Myopathy of extraocular muscle 1 trial · 5 incl. sub-types Sub-types →
- Jaw-winking syndrome 2 trials Sub-types →
- Ocular albinism 1 trial · 2 incl. sub-types Sub-types →
- EEC syndrome 1 trial Sub-types →
- Joubert syndrome with oculorenal defect 1 trial Sub-types →
- RHYNS syndrome 1 trial
- CHIME syndrome 0 trials
- Joubert syndrome with ocular defect 0 trials Sub-types →
- Mietens syndrome 0 trials
- Stern-Lubinsky-Durrie syndrome 0 trials
- Aniridia-renal agenesis-psychomotor retardation syndrome 0 trials
- Ankyloblepharon filiforme-imperforate anus syndrome 0 trials
- Atrioventricular defect-blepharophimosis-radial and anal defect syndrome 0 trials
- Cataract-glaucoma syndrome 0 trials
- Colobomatous macrophthalmia-microcornea syndrome 0 trials
- Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome 0 trials
- Cortical blindness-intellectual disability-polydactyly syndrome 0 trials
- Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome 0 trials
- Intellectual disability-strabismus syndrome 0 trials
- Maternally-inherited progressive external ophthalmoplegia 0 trials
- Microcephaly-microcornea syndrome, Seemanova type 0 trials
- Microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome 0 trials
- Oculogastrointestinal muscular dystrophy 0 trials
- Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome 0 trials
- Spastic ataxia-corneal dystrophy syndrome 0 trials
-
Disorder of orbital region 3 trials · 3,149 incl. sub-types
4 sub-types
- Eye disorder 104 trials · 3,068 incl. sub-types Sub-types →
- Eye adnexa disorder 0 trials · 600 incl. sub-types Sub-types →
- Orbit neoplasm 0 trials · 2 incl. sub-types Sub-types →
- Orbital dermoid cyst 0 trials
-
Mouth disorder 21 trials · 1,910 incl. sub-types
27 sub-types
- Tooth disorder 37 trials · 890 incl. sub-types Sub-types →
- Mouth mucosa disorder 4 trials · 476 incl. sub-types Sub-types →
- Oral cavity neoplasm 13 trials · 296 incl. sub-types Sub-types →
- Salivary gland disorder 4 trials · 255 incl. sub-types Sub-types →
- Tongue disorder 2 trials · 52 incl. sub-types Sub-types →
- Lichen planus, oral 30 trials
- Adenoid hypertrophy 22 trials
- Lip disorder 0 trials · 20 incl. sub-types Sub-types →
- Alveolar periostitis 16 trials
- Burning mouth syndrome 9 trials Sub-types →
- Neoplasm of jaw 1 trial · 9 incl. sub-types Sub-types →
- Maxillary sinusitis 5 trials · 7 incl. sub-types Sub-types →
- Osteoradionecrosis of the mandible 5 trials
- Oral candidiasis 4 trials
- Oral submucous fibrosis 4 trials
- Neoplasm of floor of mouth 0 trials · 2 incl. sub-types Sub-types →
- Florid cemento-osseous dysplasia 1 trial
- Ludwig's angina 0 trials
- Commissural lip fistula 0 trials
- Maxillary sinus cholesteatoma 0 trials
- Odontoma 0 trials
- Oral Crohn disease 0 trials
- Oral hairy leukoplakia 0 trials
- Oral leukoedema 0 trials
- Oral tuberculosis 0 trials
- Polyp of maxillary sinus 0 trials
- Uvulitis 0 trials
-
Otorhinolaryngologic disease 15 trials · 1,319 incl. sub-types
40 sub-types
- Disorder of pharynx 3 trials · 596 incl. sub-types Sub-types →
- Nasal disorder 3 trials · 372 incl. sub-types Sub-types →
- Disorder of ear 8 trials · 254 incl. sub-types Sub-types →
- Lip and oral cavity squamous cell carcinoma 21 trials · 157 incl. sub-types Sub-types →
- Hereditary otorhinolaryngologic disease 0 trials · 102 incl. sub-types Sub-types →
- Idiopathic bilateral vestibulopathy 14 trials
- Laryngeal abductor paralysis 10 trials
- Recurrent respiratory papillomatosis 8 trials · 9 incl. sub-types Sub-types →
- Microtia 8 trials Sub-types →
- Congenital tracheomalacia 6 trials
- Congenital velopharyngeal incompetence 6 trials
- Autoimmune disease of ear, nose and throat 0 trials · 4 incl. sub-types Sub-types →
- Cysts and fistulae of the face and oral cavity 0 trials · 3 incl. sub-types Sub-types →
- Semicircular canal dehiscence syndrome 3 trials
- Mal de Debarquement 2 trials
- Anotia 1 trial
- Bifid nose 0 trials · 1 incl. sub-types Sub-types →
- Juvenile nasopharyngeal angiofibroma 1 trial
- Arrhinia 0 trials
- Atresia of external auditory canal and conductive deafness 0 trials
- Congenital nasal pyriform aperture stenosis with holoprosencephaly 0 trials
- Congenital tracheal stenosis 0 trials
- Epignathus 0 trials
- External auditory canal atresia-vertical talus-hypertelorism syndrome 0 trials
- Isolated congenital nasal pyriform aperture stenosis 0 trials
- Isolated congenital syngnathia 0 trials
- Laryngeal neuroendocrine neoplasm 0 trials Sub-types →
- Laryngotracheal angioma 0 trials
- Larynx atresia 0 trials
- Middle ear anomaly 0 trials Sub-types →
- Nasal encephalocele 0 trials
- Nasal ganglioglioma 0 trials
- Nasal glial heterotopia 0 trials
- Nasolacrimal duct cyst 0 trials
- Polyrrhinia 0 trials
- Proboscis lateralis 0 trials
- Silent sinus syndrome 0 trials
- Supernumerary nostril 0 trials
- Supratip dysplasia 0 trials
- Tracheal agenesis 0 trials
-
Auditory system disorder 0 trials · 705 incl. sub-types
11 sub-types
- Hearing disorder 24 trials · 529 incl. sub-types Sub-types →
- Inner ear disorder 8 trials · 149 incl. sub-types Sub-types →
- Inherited auditory system disease 0 trials · 120 incl. sub-types Sub-types →
- Middle ear disorder 3 trials · 75 incl. sub-types Sub-types →
- Retrocochlear disease 3 trials · 14 incl. sub-types Sub-types →
- External ear disorder 0 trials · 13 incl. sub-types Sub-types →
- Auditory system cancer 0 trials · 2 incl. sub-types Sub-types →
- Discharging ear 2 trials
- Adhesive otitis media 0 trials
- Auditory system benign neoplasm 0 trials
- Dislocation of ear ossicle 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 34213 trials in this tab.
-
Gene therapy aims to cure inherited immune disorder
Cure Recruiting nowChronic granulomatous disease (CGD) caused by p47phox deficiency is a rare, life-threatening genetic disorder that leaves people vulnerable to severe infections. Standard treatments include daily antibiotics and antifungal drugs, but they do not fix the underlying genetic defect.…
Phase 1/2 • Sponsor: Somagenetix AG • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Viagra-Like drug tested to repair Newborns' brain damage
Cure Recruiting nowWhen babies lack oxygen around birth, they can suffer lasting brain damage. No treatment currently repairs that injury. Researchers are testing whether oral sildenafil, a drug already used safely in babies for lung blood pressure, can help. In this Phase 2 trial, 60 newborns with…
Phase 2 • Sponsor: Pia Wintermark • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
New universal flu vaccine enters human testing
Vaccine Recruiting nowThis study tests an experimental flu vaccine called BPL-1357, given as a shot or nasal spray, to see if it is safe and can protect against multiple flu types. About 129 healthy adults aged 18-55 will receive the vaccine or a placebo, then be exposed to a flu virus in a controlled…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Can mRNA technology outsmart the flu in older adults?
Vaccine Recruiting nowThis large phase 3 trial compares an investigational mRNA flu vaccine with a licensed flu vaccine in adults aged 65 and older. Each participant receives a single injection and is followed through the flu season. Researchers measure how well the mRNA vaccine prevents laboratory-co…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New HIV vaccine booster trial launches: could it strengthen immunity?
Vaccine Recruiting nowThis early-stage trial is testing a new HIV vaccine booster called VRIPRO, given with an immune-boosting adjuvant, in 40 healthy adults aged 18-60 who previously received an HIV vaccine in the HVTN 706 study. Participants will get three shots over 24 weeks. The main goals are to …
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Targeted radiation plus hormone therapy may slow Low-Volume prostate cancer spread
Disease control Recruiting nowThis phase II trial tests whether adding a targeted radiation drug (177Lu-PSMA-617) to standard hormone therapy, with or without additional hormone-blocking pills, can better control low-volume metastatic hormone-sensitive prostate cancer. The study enrolls men whose cancer has s…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims to wipe out stubborn leukemia traces
Disease control Recruiting nowThis study tests whether two drugs, venetoclax and revumenib, can control minimal residual disease (MRD) in people with acute myeloid leukemia (AML). MRD means small numbers of cancer cells remain after initial treatment, raising the risk of relapse. The trial enrolls about 8 par…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to tame tough lung cancer
Disease control Recruiting nowThis study tests a new drug combination (alisertib plus paclitaxel) in people with small cell lung cancer who have already tried other treatments. The main goal is to find safe doses and see what side effects occur. About 50 adults will take alisertib pills and receive paclitaxel…
Phase 2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Watch and wait: could immunotherapy let some GI cancer patients avoid surgery?
Disease control Recruiting nowThis study looks at people with early-stage gastrointestinal cancers that have a mismatch repair deficiency, a feature that can make tumors respond well to immunotherapy. Part A is a registry that tracks all such patients, whether they have surgery or immunotherapy. Part B follow…
Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to tame rare bleeding disorder
Disease control Recruiting nowThis study tests a new biologic drug called ianalumab combined with a standard platelet-boosting drug (TPO-RA) in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The trial includes 164 adults who have tried at l…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to boost remission in rare blood cancer
Disease control Recruiting nowThis study tests whether adding enasidenib to standard treatment (ASTX727) improves outcomes for people with a high-risk form of myelodysplastic syndrome (MDS) that has a specific gene mutation (IDH2). About 54 adults who have not had prior cancer therapy will be randomly assigne…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to control Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new combination of two drugs (tulmimetostat and JSB462) in men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. The trial has two parts: first, finding the safest dose, then comparing the combination to usual car…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Two-Drug combo targets leukemia that outsmarted its first treatment
Disease control Recruiting nowResearchers are testing whether adding an experimental drug called RVU120 to venetoclax can help adults with acute myeloid leukemia (AML) that has come back or stopped responding to earlier venetoclax-based treatment. The trial enrolls about 98 adults who have already failed a hy…
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could Two-Drug cocktails tame stubborn inflammatory bowel disease?
Disease control Recruiting nowThis study tests whether combining risankizumab with either trosunilimab or ABBV-701 can safely reduce inflammation and improve symptoms in adults with moderately to severely active Crohn's disease or ulcerative colitis. Participants are randomly assigned to one of the combinatio…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental drug aims to reverse liver scarring in MASH cirrhosis
Disease control Recruiting nowThis Phase 3 trial tests whether efimosfermin alfa can improve liver fibrosis in adults with compensated cirrhosis caused by MASH (a fatty liver disease). Participants receive either the drug or a placebo via injection. The main goal is to see if liver scarring improves by at lea…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lifeline for cancer patients: rollover study extends access to targeted drug opnurasib
Disease control Recruiting nowThis rollover study allows up to 40 people with KRAS G12C-mutated lung or other solid tumors who are already benefiting from opnurasib in a Novartis trial to keep receiving the drug. Participants continue their current dose of opnurasib alone or with TNO155 or trametinib. The goa…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Electric pulses aim to zap breast cancer tumors in early safety trial
Disease control Recruiting nowThis pilot study tests a device that uses short, high-frequency electrical pulses to shrink or destroy soft tissue tumors in people with metastatic breast cancer. The trial will enroll 20 adults with tumors near the skin that are at least 1 cm but no larger than 5 cm. The main go…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could an immunotherapy drug keep early lung cancer from returning?
Disease control Recruiting nowThis phase III trial is testing whether the immunotherapy drug atezolizumab, given after surgery, can prevent stage I non-small cell lung cancer from returning. About 336 patients who have had their tumor completely removed will be randomly assigned to receive either atezolizumab…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Immunotherapy boost before surgery shows promise for rare urinary tract cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy before surgery helps shrink tumors in people with high-grade upper urinary tract cancer. About 131 adults will be randomly assigned to receive either chemo alone or chemo plus durvalumab be…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New shot aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowThis study tests whether MK-8690, a drug given as a shot, can help people with moderate-to-severe ulcerative colitis achieve remission. About 100 adults who haven't responded well to other treatments will receive either MK-8690 or a placebo. The main goal is to see if more people…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug trial aims to shrink painful lymphatic growths in kids and adults
Disease control Recruiting nowThis study tests alpelisib, a drug that targets a specific gene mutation (PIK3CA), in people with lymphatic malformations—abnormal growths of lymph vessels. The trial includes children and adults and compares alpelisib to a placebo to see if it can shrink the growths and ease sym…
Phase 2/3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill combo aims to tackle tough leukemia
Disease control Recruiting nowThis early-stage trial tests two oral drugs, ziftomenib and quizartinib, together in adults with relapsed or hard-to-treat acute myeloid leukemia (AML) that has certain genetic markers. The goal is to find a safe and effective all-pill treatment for common AML subtypes. About 44 …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Hope for stargardt patients: new drug aims to slow blindness
Disease control Recruiting nowThis Phase 3 trial tests an oral drug called gildeuretinol acetate (ALK 001) in 230 people aged 8 to 45 with Stargardt disease, a genetic condition that causes progressive vision loss. Participants take the drug or a placebo daily for 24 months. The goal is to see if the drug can…
Phase 3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New immunotherapy combo aims to wipe out hidden colorectal cancer cells
Disease control Recruiting nowThis phase 2 trial tests whether two immunotherapy drugs, botensilimab and balstilimab, can clear tiny amounts of cancer DNA from the blood of people with stage II or III colorectal cancer who have completed standard treatment. The study enrolls 20 adults whose blood still shows …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for uncontrolled muscle movements: valbenazine trial targets stubborn TD symptoms
Disease control Recruiting nowThis study tests whether valbenazine can reduce involuntary muscle movements (tardive dyskinesia) in adults who still have symptoms while taking or after stopping another similar drug. About 50 people with schizophrenia, bipolar disorder, or major depression will take valbenazine…
Phase 4 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill aims to tame back inflammation in axial spondyloarthritis
Disease control Recruiting nowThis study tests an experimental oral drug called GRWD0715 for axial spondyloarthritis, a chronic inflammatory condition affecting the spine and pelvis. The trial starts with healthy volunteers to check safety, then moves to patients to see if the drug reduces inflammation and im…
Phase 1/2 • Sponsor: Grey Wolf Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug could stop knee infections after replacement
Disease control Recruiting nowThis study tests whether an investigational drug called PLG0206 can prevent infections from coming back after knee replacement surgery. About 240 adults who need a special cleaning surgery (DAIR) for an infected knee joint will receive either PLG0206 or a placebo during the proce…
Phase 2/3 • Sponsor: Peptilogics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to stop bleeding in kidney stone surgery
Disease control Recruiting nowThis study tests whether using a hemostatic agent (a substance that stops bleeding) during kidney stone surgery can reduce blood loss compared to standard care. About 92 adults with kidney stones will be randomly assigned to receive either a hemostatic agent or no agent during th…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study tests if asthma drug can stop symptoms Long-Term
Disease control Recruiting nowThis study follows 335 adults with severe eosinophilic asthma who are taking benralizumab. Researchers want to see if the drug helps patients achieve partial or complete clinical remission—meaning fewer symptoms, no need for steroid pills, and better lung function—over 12 to 24 m…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to ease daily struggles of myasthenia gravis
Disease control Recruiting nowThis study tests an experimental drug called empasiprubart in people with a specific type of generalized myasthenia gravis (gMG) who have AChR antibodies. The goal is to see if the drug is safe and can improve symptoms like muscle weakness that affect daily activities. Participan…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for tough prostate cancer: Immune-Engaging drug enters human trials
Disease control Recruiting nowThis early-phase trial tests a new drug, GSK5458514, designed to help the immune system attack prostate cancer cells. It is for men with metastatic castration-resistant prostate cancer that has spread and stopped responding to hormone therapy. The study will first find a safe dos…
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug rilvegostomig takes on keytruda in lung cancer showdown
Disease control Recruiting nowThis phase 3 study compares two immunotherapy drugs—rilvegostomig and pembrolizumab (Keytruda)—each combined with standard chemotherapy, as a first treatment for people with advanced squamous non-small cell lung cancer that has a specific protein (PD-L1). About 880 participants w…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Promising drug cocktail targets tough blood cancers in kids
Disease control Recruiting nowThis study tests whether a combination of three drugs—calaspargase pegol-mknl, decitabine, and venetoclax—can help control relapsed or treatment-resistant T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LLy) in patients aged 1 month to 21 years. T…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a weekly shot fix hormone chaos in teens with PCOS?
Disease control Recruiting nowThis study tests whether a weekly injection of semaglutide (a GLP-1 drug used for obesity) can improve the brain's reproductive hormone signals in obese adolescent girls with polycystic ovary syndrome (PCOS). Twenty girls aged 12–18 will receive the drug plus lifestyle advice for…
Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Tiny pacemaker, no wires: new trial tests LivIQ for heart rhythm control
Disease control Recruiting nowThis study is testing a new, wire-free pacemaker called LivIQ in 325 people who need a pacemaker for a slow heartbeat. The goal is to see if it is safe and works well to keep the heart beating at the right pace. Participants will be followed for several months to check the device…
Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New electric pulse therapy could replace radiation boost for prostate cancer
Disease control Recruiting nowThis study compares a new boost approach called irreversible electroporation (IRE) using the NanoKnife system against the standard radiation boost for men with intermediate-risk prostate cancer. All participants will receive standard stereotactic body radiation therapy (SBRT), bu…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a gentle brain zap help adults with lazy eye see better?
Disease control Recruiting nowThis trial tests whether adding a mild electrical brain stimulation to augmented reality-based vision therapy can improve vision in adults aged 18 to 35 with lazy eye (anisometropic amblyopia). Participants will use special augmented reality glasses that encourage both eyes to wo…
Sponsor: Polytechnic Institute of Porto • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Poop pills? stool transplants may ease immunotherapy side effects
Disease control Recruiting nowThis early-stage trial tests whether a stool transplant (FMT) can help cancer patients who develop severe diarrhea or colon inflammation from immune-checkpoint inhibitor drugs. About 40 patients with various cancers will receive the transplant via colonoscopy. The main goal is to…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called SHY-ONC6 in people with advanced or metastatic solid tumors (including breast, colon, lung, pancreatic, and others) that have stopped responding to standard treatments. The study aims to find a safe dose and check for …
Phase 1 • Sponsor: SHY Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug targets Hard-to-Treat lung cancer in early trial
Disease control Recruiting nowThis phase 2 trial tests a drug called navlimetostat in about 130 people with advanced or metastatic non-small cell lung cancer that has a specific genetic change (MTAP deletion) and has worsened after other treatments. The main goal is to see if the drug can shrink tumors. Resea…
Phase 2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a common antihistamine boost multiple sclerosis treatment?
Disease control Recruiting nowResearchers are testing whether adding terfenadine to standard first-line disease-modifying therapy is safe and may improve outcomes for adults with relapsing-remitting multiple sclerosis. About 100 participants aged 18 to 65 will be randomly assigned to receive either terfenadin…
Phase 2 • Sponsor: Chuan Qin • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Smart bomb for kidney cancer: imaging and radiation combo targets tough tumors
Disease control Recruiting nowThis trial tests a two-part approach for advanced clear cell kidney cancer that has stopped responding to standard treatments. First, an imaging injection (PD-32766D) lights up cancer cells that have a specific marker (CA9). If the scan shows the marker is present, participants t…
Phase 1 • Sponsor: PeptiDream Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Targeted therapy boost for aggressive uterine cancer under study
Disease control Recruiting nowThis phase 3 trial tests whether adding targeted drugs (trastuzumab and pertuzumab) to standard chemotherapy can better shrink tumors in people with HER2-positive endometrial cancer. The study plans to enroll 360 participants with various stages of the disease. However, the trial…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Injectable hydrogel could ease back pain without surgery
Disease control Recruiting nowThis study tests a hydrogel implant injected into damaged spinal discs to treat degenerative disc disease. About 225 adults with chronic low back pain will receive either the implant or standard care like physical therapy. The goal is to see if the implant safely improves pain an…
Sponsor: ReGelTec, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug targets tough pancreatic cancer in early trial
Disease control Recruiting nowThis phase 2 study tests an experimental drug called BT5528 in adults with metastatic pancreatic cancer that has spread and worsened after one prior treatment. The drug targets a specific protein on cancer cells. Researchers will measure how well it shrinks tumors and track side …
Phase 2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to lighten heavy periods for bleeding disorder patients
Disease control Recruiting nowThis study tests an investigational drug called ALN-6400 in 24 women and teens with von Willebrand disease who have heavy menstrual bleeding. The goal is to see if the drug is safe and can reduce bleeding. Participants will receive multiple doses and be monitored for side effects…
Phase 2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radiation boosts cancer drug in Tough-to-Treat myeloma
Disease control Recruiting nowThis study tests whether adding low-dose radiation to the drug elranatamab can better kill cancer cells in people with multiple myeloma that has come back or not responded to treatment and has spread outside the bone. About 34 adults will receive the combination. The goal is to s…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare kidney cancer: drug trial targets tough tumors
Disease control Recruiting nowThis study tests a drug called sacituzumab tirumotecan in 20 people with a rare and aggressive kidney cancer (SMARCB1-deficient renal medullary carcinoma) that has worsened after at least one prior treatment. The goal is to see if the drug can shrink or control the cancer. Resear…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Caffeine boost may shield preterm Babies' kidneys
Disease control Recruiting nowThis study tests whether giving extra caffeine to very premature babies (born before 30 weeks) can improve kidney oxygen levels and reduce kidney injury. About 114 babies already receiving standard caffeine will get either an extra dose or a placebo. Researchers will monitor kidn…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New trial aims to improve radiation for large brain tumors
Disease control Recruiting nowThis phase 2 trial compares two standard radiation approaches for people with large brain metastases (tumors that spread from other cancers). One method gives two radiation doses a month apart; the other gives three daily doses. The study will track tumor control, side effects, a…
Phase 2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New antibody combo shows promise in early cancer trial
Disease control Recruiting nowThis early-phase trial is testing an experimental drug called BI-1808, alone or with the immunotherapy pembrolizumab (Keytruda), in people with advanced cancers like ovarian cancer, T-cell lymphoma, and melanoma. The main goals are to check safety, find the best dose, and see how…
Phase 1/2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a new drug ASP388B take on advanced solid tumors?
Disease control Recruiting nowThis trial tests an experimental drug called ASP388B, given alone or alongside standard cancer therapies, in people with advanced solid tumors that have spread or cannot be removed by surgery. The study has two parts: the first finds a safe dose, and the second tests that dose in…
Phase 1/2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug TAK-360 tested for Long-Term safety in sleep disorders
Disease control Recruiting nowThis study looks at the long-term safety and tolerability of the drug TAK-360 in people with narcolepsy (type 1 or 2) or idiopathic hypersomnia — conditions that cause severe daytime sleepiness. Participants who completed a previous TAK-360 study can join and will continue taking…
Phase 2/3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New mRNA vaccine combo aims to prevent lung cancer recurrence in High-Risk patients
Disease control Recruiting nowThis phase 3 trial tests whether a personalized mRNA cancer vaccine (intismeran) alone or combined with an immunotherapy drug (pembrolizumab) can prevent non-small cell lung cancer from coming back after complete surgical removal. About 876 people with high-risk stage I lung canc…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a common arthritis drug tame rare immune disease symptoms?
Disease control Recruiting nowThis early study tests baricitinib, a drug already approved for other immune conditions, in 20 people with Job syndrome who also have lupus-like disease or eczema. Participants take the pill daily for 6 months. The main goal is to see if it is safe and tolerable, while also check…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare leukemia: Four-Drug cocktail targets cancer cells
Disease control Recruiting nowThis phase 2 trial tests a new drug combination for adults newly diagnosed with primary plasma cell leukemia, a rare and aggressive blood cancer. The treatment includes CM336 (a bispecific antibody) plus three other drugs. The study aims to see how many patients achieve deep remi…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo shows promise in AML fight
Disease control Recruiting nowThis study tests whether adding the drug venetoclax to standard chemotherapy can better treat acute myeloid leukemia (AML) that is newly diagnosed or has come back. About 116 adults with AML or high-risk MDS will receive the combination. The goal is to see if the combo improves r…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a higher dose of this pill regrow hair in severe alopecia?
Disease control Recruiting nowThis study tests two daily doses (50 mg and 100 mg) of the medicine ritlecitinib in about 550 people aged 12 and older with severe alopecia areata, a condition causing significant hair loss on the scalp and body. The 50 mg dose is already approved, and researchers want to see if …
Phase 3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims for deeper remission in older leukemia patients
Disease control Recruiting nowThis phase II trial tests whether adding gilteritinib to the usual two-drug therapy (azacitidine and venetoclax) can help older or frail adults with a specific type of acute myeloid leukemia (FLT3-mutated) achieve deeper remission. About 147 participants will be randomly assigned…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Two ways to quiet a racing heart: trial pits hybrid ablation against standard catheter treatment
Disease control Recruiting nowResearchers compare two procedures for people with persistent atrial fibrillation that has not responded to at least one antiarrhythmic drug. One group receives standard catheter ablation, which burns or freezes small areas inside the heart. The other receives a hybrid procedure …
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a COPD inhaler also help your heart?
Disease control Recruiting nowThis study tests a triple-combination inhaler (budesonide, glycopyrronium, and formoterol) against a placebo in 56 people with COPD and lung hyperinflation. The goal is to see if the inhaler improves both lung function and heart function, measured by MRI. Participants will receiv…
Phase 4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Blood test may tell who needs extra immunotherapy after bladder cancer surgery
Disease control Recruiting nowThis large trial is testing whether a blood test that looks for tumor DNA can help decide who needs immunotherapy after surgery for muscle-invasive urothelial cancer. About 992 participants will be assigned to different treatment plans based on their blood test results. The goal …
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can hormone patches and pills help teens with ovarian failure?
Disease control Recruiting nowThis study looks at how hormone replacement therapy (HRT) affects adolescents aged 11-19 with premature ovarian insufficiency (POI), a condition where ovaries stop working before age 40. Participants receive estrogen patches and progesterone pills over 2 years, with regular check…
Phase 3 • Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can WhatsApp alerts tame blood sugar swings in kids with type 1 diabetes?
Disease control Recruiting nowResearchers at Sheba Medical Center are studying a tele-diabetes remote monitoring system for children and teens with type 1 diabetes. The system analyzes real-time glucose data from continuous monitors and sends automated WhatsApp alerts when it detects high or low patterns. The…
Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Tiny implant aims to restore sight in eyes that resist standard AMD therapy
Disease control Recruiting nowResearchers are testing a new treatment called PAL-222 for people with neovascular age-related macular degeneration (AMD) whose disease has not responded to existing therapies. The study will enroll up to 10 adults aged 18 to 85 with this condition. Each participant will have a s…
Sponsor: PharmaBio Corporation • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New Alzheimer's drug ABBV-1758 enters early human trials
Disease control Recruiting nowThis study tests an experimental drug called ABBV-1758 in about 210 people with Alzheimer's disease. The drug is given by IV or injection every 4 weeks for 24 weeks. Researchers are checking if it is safe and whether it can reduce amyloid plaques in the brain, a hallmark of Alzhe…
Phase 1/2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a gut bacteria transplant ease autism symptoms? new trial aims to find out
Disease control Recruiting nowThis early-phase trial tests whether transplanting healthy donor gut bacteria (washed microbiota transplantation) can improve autism and ADHD symptoms in 80 children aged 3-17. The approach targets the 'gut-brain axis,' since many children with autism have gut microbiome imbalanc…
Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cell therapy trial aims to tame stubborn autoimmune diseases
Disease control Recruiting nowThis early-phase trial is testing an injection called GT719 in 10 adults with moderate to severe autoimmune diseases that haven't responded to other treatments. The main goal is to check safety and find the right dose. Researchers will also look for signs that the therapy might h…
Early phase 1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a pill replace chemo for some breast cancers? major trial launches
Disease control Recruiting nowThis study compares two treatments for people with high-stage, estrogen-positive, HER2-negative breast cancer that has a low genetic risk of returning. One group gets standard hormone therapy plus a targeted pill (ribociclib), while the other gets chemotherapy first, then the sam…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Gene test could tailor chemo doses for rare cancer
Disease control Recruiting nowThis phase 2 trial is testing whether adjusting the dose of the drug belinostat based on a person's genetics can make treatment safer and more effective for high-grade neuroendocrine carcinoma. About 60 adults will receive belinostat along with two other chemotherapy drugs, cispl…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New weekly shot aims to stop liver disease from getting worse
Disease control Recruiting nowThis Phase 3 trial tests whether survodutide, a weekly injection, can improve liver outcomes in 1590 adults with NASH or MASH cirrhosis. Participants are randomly assigned to receive survodutide or a placebo, along with diet and exercise counseling. The study will track serious l…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a daily nail film clear stubborn toenail fungus?
Disease control Recruiting nowResearchers are testing a topical filmogel device called URGO MICKAEL on mild to moderate toenail fungus. About 54 adults with one or two damaged big toenails apply the device daily for up to six months. The study measures whether fungal cultures from the treated nail turn negati…
Sponsor: CEN Biotech • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New Immune-Targeting drug surovatamig enters first human tests for arthritis and lupus
Disease control Recruiting nowThis Phase 1 trial tests surovatamig, a bispecific T-cell engager, in 48 adults with rheumatoid arthritis or systemic lupus erythematosus. The study gives the drug as injections in increasing doses to check safety, side effects, and how the body processes it. It is too early to k…
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple-Drug cocktail targets kidney cancer brain metastases
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of three drugs—nivolumab, ipilimumab, and cabozantinib—can help people with kidney cancer that has spread to the brain. The study will enroll 20 participants who have not had prior treatment for their brain metastases. The main …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New stent aims to ease dangerous liver complications
Disease control Recruiting nowThis study tracks 152 adults with cirrhosis who receive a special stent to treat complications like fluid buildup in the belly or bleeding from enlarged veins. The stent creates a new blood-flow path in the liver. Researchers will monitor how well it works and its safety over 2 y…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill could transform leukemia treatment, phase 3 trial begins
Disease control Recruiting nowThis study tests a new oral drug, QTX-2101, combined with standard ATRA therapy for adults newly diagnosed with a low-risk form of acute promyelocytic leukemia (APL). The goal is to see if the oral capsule works as well as the current intravenous treatment. About 150 participants…
Phase 3 • Sponsor: Quetzal Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study to track gene Therapy's Real-World impact on spinal muscular atrophy
Disease control Recruiting nowThis study will follow 36 people with spinal muscular atrophy (SMA) who receive a gene therapy called onasemnogene abeparvovec (ITVISMA) injected into the spinal fluid. The goal is to see how well it works and how safe it is in everyday medical practice. Participants must be at l…
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers with RAS mutations
Disease control Recruiting nowThis study tests an experimental oral drug, BPI-572270, in 120 adults with advanced solid tumors (lung, colorectal, or pancreatic cancer) that have specific RAS gene mutations. The trial has two phases: first to find a safe dose and check for side effects, then to see if the drug…
Phase 1/2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug trial aims to improve lung function in fibrosis patients
Disease control Recruiting nowThis study tests a new medicine called BI 765423 in 71 adults with idiopathic pulmonary fibrosis (IPF), a lung disease that causes scarring and breathing problems. Participants receive either the drug or a placebo by infusion every four weeks for about 3 months. The main goal is …
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug cocktail aims to outsmart recurrent glioblastoma
Disease control Recruiting nowThis study tests whether adding the drug selinexor to standard chemotherapy (temozolomide) can better control recurrent glioblastoma, an aggressive brain cancer. About 97 adults whose tumor has returned after initial treatment will receive either the combo or chemotherapy alone. …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a targeted drug boost chemo success in leukemia?
Disease control Recruiting nowThis phase II trial is testing whether adding the drug venetoclax to standard chemotherapy can improve remission rates in younger patients with intermediate-risk acute myeloid leukemia (AML). About 153 participants will receive either standard chemo or a combination with venetocl…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a single inhaler outperform adding extra medications for asthma?
Disease control Recruiting nowThis study looks at whether switching from a rescue inhaler (albuterol) to a combination inhaler (albuterol/budesonide) is better at preventing severe asthma attacks than adding another daily controller medication while keeping albuterol. Researchers will analyze health records f…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New injection aims to tackle Alzheimer's at its roots
Disease control Recruiting nowThis study tests a new drug called ARO-MAPT-SC in healthy people and those with early Alzheimer's. The goal is to check if it is safe and how the body processes it. Participants receive either the drug or a placebo by injection under the skin. The trial is still in early stages, …
Phase 1/2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New device aims to stop strokes in High-Risk heart patients
Disease control Recruiting nowThis study tests if a catheter-based device that closes a small pouch in the heart (left atrial appendage) can prevent strokes or blood clots in people with atrial fibrillation who are already taking blood thinners. About 4000 participants at high risk of stroke will be enrolled.…
Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can doctors watch brain metastases instead of zapping them?
Disease control Recruiting nowResearchers at the University of California, Irvine are testing whether patients with brain metastases can safely skip immediate surgery or radiation and instead have their tumors monitored with regular imaging, cognitive tests, and quality-of-life questionnaires. All participant…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for Hard-to-Treat lung cancer? osimertinib trial launches
Disease control Recruiting nowThis phase II trial is testing the drug osimertinib in 46 people with advanced non-small cell lung cancer that has a specific genetic change (EGFR exon 20 insertion). The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants will take osimertinib …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for HIV patients with blood cancer: safer bone marrow transplants on the horizon?
Disease control Recruiting nowThis study tests whether a combination of three drugs (cyclophosphamide, bortezomib, and maraviroc) can safely prevent graft-versus-host disease after a half-matched bone marrow transplant in people living with HIV who also have a blood cancer. The trial involves 265 participants…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a common arthritis drug tame a rare, fatal blood vessel disease?
Disease control Recruiting nowThis study tests whether baricitinib, a drug already approved for arthritis, can help people with Kohlmeier-Degos (KD) disease that affects the brain and spine. KD causes inflammation and blood clots that damage small blood vessels, and there is currently no treatment. The trial …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to stop kidney transplant rejection without antibodies
Disease control Recruiting nowThis study tests a drug called felzartamab in people who received a kidney transplant and later developed microvascular inflammation (MVI), a type of injury to small blood vessels in the new kidney that can lead to serious problems. The trial includes 81 participants who will rec…
Phase 2 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for Tough-to-Treat colorectal cancer: phase 3 trial launches
Disease control Recruiting nowThis Phase 3 study tests a new drug, telisotuzumab adizutecan, combined with bevacizumab, against the standard treatment (LONSURF plus bevacizumab) in 700 adults with advanced colorectal cancer that has stopped responding to prior therapies. The goal is to see if the new combo sh…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a diabetes drug boost chemo for tough cancers?
Disease control Recruiting nowThis early-phase trial will test whether adding semaglutide (a GLP-1 drug used for diabetes and weight loss) to standard chemotherapy is safe and tolerable for people with metastatic pancreatic, colorectal, or liver cancer. About 30 participants will receive weekly semaglutide in…
Early phase 1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New blood test and treatment could stop hidden malaria from coming back
Disease control Recruiting nowThis study tests a new way to find and treat a type of malaria (P. vivax) that can hide in the liver and come back months later. Researchers will use a simple blood test to find people who have been infected recently, then give them a treatment to clear the hidden parasites. The …
Phase 3 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill for duchenne MD enters Mid-Stage trial in young boys
Disease control Recruiting nowThis study tests an oral drug called SAT-3247 in 51 boys aged 7 to 10 with Duchenne muscular dystrophy who can still walk. The goal is to find the best dose, check safety, and see if it helps muscle strength. Participants take the drug or a placebo for 12 weeks, and all continue …
Phase 2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New ultrasound technique aims to save limbs in artery disease patients
Disease control Recruiting nowThis study tests whether using a tiny ultrasound camera inside the leg arteries during a procedure to open blockages can prevent major problems like amputation or the artery narrowing again. About 772 adults with severe peripheral artery disease (chronic limb-threatening ischemia…
Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for leukemia patients: olverembatinib trial launches
Disease control Recruiting nowThis phase 2 trial tests whether the drug olverembatinib can safely control chronic myeloid leukemia (CML) in people who are newly diagnosed. About 50 adults will take the drug by mouth. Researchers will track side effects and how well the drug works. The study is currently recru…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Heart fix combo: ablation plus exercise may boost oxygen in stiff heart failure
Disease control Recruiting nowThis study looks at whether combining a heart procedure called ablation with a 12-week home exercise program can improve how well the body uses oxygen in people with a type of heart failure (HFpEF) and a common heart rhythm problem (atrial fibrillation). About 40 participants wil…
Sponsor: Technical University of Munich • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill plus chemo aims to tackle tough pancreatic cancer
Disease control Recruiting nowThis Phase 3 trial tests whether adding an experimental oral drug called atebimetinib to a modified chemotherapy regimen helps people with metastatic pancreatic cancer live longer. About 510 adults who have not had prior treatment will receive either the new combination or standa…
Phase 3 • Sponsor: Immuneering Corporation • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New eye drug aims to restore vision in Diabetes-Related swelling
Disease control Recruiting nowThis phase 3 trial tests whether an experimental drug called MK-8748 can treat diabetic macular edema (DME), a condition where fluid builds up in the retina and blurs vision. About 960 adults with DME will receive either MK-8748 or the standard treatment aflibercept via eye injec…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New injection aims to stabilize platelets in chronic ITP patients
Disease control Recruiting nowThis Phase 3 trial tests whether mezagitamab, given as a shot under the skin, can safely keep platelet counts stable in adults with chronic ITP. ITP is a condition where the immune system destroys platelets, leading to easy bruising and bleeding. The study will compare mezagitama…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Boosting transplants with donor immune cells to fight blood cancer relapse
Disease control Recruiting nowThis study tests whether giving donor white blood cells (lymphocytes) soon after a stem cell transplant can lower the chance of cancer returning in people with high-risk blood cancers like leukemia or lymphoma. Participants receive chemotherapy, a stem cell transplant, and then a…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cocktail of 5 drugs targets tough leukemia
Disease control Recruiting nowThis phase 2 trial is testing a combination of five drugs (fludarabine, cytarabine, filgrastim-sndz, gemtuzumab ozogamicin, and idarubicin) in 270 people with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome that have specific genetic changes. The goal…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to tame kidney disease
Disease control Recruiting nowThis Phase 2 trial tests whether adding belimumab to standard rituximab treatment helps more people with primary membranous nephropathy achieve remission. The study enrolls 58 adults with confirmed disease. Belimumab targets new immune cells, while rituximab depletes existing one…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New lung cancer drug ivonescimab takes on pembrolizumab in major trial
Disease control Recruiting nowThis phase 3 study compares ivonescimab, an experimental immunotherapy, to the standard drug pembrolizumab in 780 people with advanced non-small cell lung cancer that has high PD-L1 levels. Participants receive one of the two drugs as their first treatment. The study measures how…
Phase 3 • Sponsor: Summit Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to help kidney patients fight acid and stay strong
Disease control Recruiting nowThis study tests a drug called veverimer in 150 adults with moderate-to-severe chronic kidney disease (CKD) and a condition called metabolic acidosis, where acid builds up in the blood. The goal is to see if the drug can raise blood bicarbonate levels and improve physical functio…
Phase 3 • Sponsor: Renibus Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for tough colorectal cancer: experimental drug combo enters human testing
Disease control Recruiting nowThis early-phase trial is testing whether adding an experimental drug called ZEN003694 to two approved cancer drugs (cetuximab and encorafenib) can help patients with a specific type of advanced colorectal cancer that has not responded to prior treatments. The study involves 30 a…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug cocktail takes on rare adrenal cancer
Disease control Recruiting nowThis phase II trial tests whether adding the immunotherapy cemiplimab to the targeted drug cabozantinib works better than cabozantinib alone for advanced adrenocortical cancer. About 48 adolescents and adults whose cancer has spread or cannot be removed will take part. The study …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for tough prostate cancer: BNT324 takes on chemo
Disease control Recruiting nowThis study tests a new drug called BNT324 against standard chemotherapy (docetaxel) in men with metastatic castration-resistant prostate cancer that has progressed after hormone therapy. The goal is to see if BNT324 helps patients live longer without their cancer worsening. About…
Phase 3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a nurse and a neighbor help tame chronic disease?
Disease control Recruiting nowResearchers at the University of South Carolina are testing a program that pairs nurses with community health workers to coach adults who have chronic conditions like diabetes, high blood pressure, heart disease, kidney disease, or a prior stroke. Each patient joins with a carepa…
Sponsor: University of South Carolina • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New antibody combo takes on Hard-to-Treat myeloma
Disease control Recruiting nowThis study tests a new antibody drug called HuL001, given together with two standard myeloma drugs (lenalidomide and dexamethasone), in 21 adults whose multiple myeloma has returned or stopped responding to prior treatments. The goal is to see if the combination is safe and can s…
Phase 1/2 • Sponsor: HuniLife Biotechnology, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a simple head tilt save stroke Patients' brains?
Disease control Recruiting nowThis study is testing whether placing stroke patients in a head-down position (Trendelenburg) before a clot-removal procedure can improve their recovery. Researchers will enroll 210 adults with a severe stroke caused by a large blocked artery. The goal is to see if this simple po…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo targets Hard-to-Treat cancers with genetic weakness
Disease control Recruiting nowThis early-stage trial is testing a new drug called IDE892, alone or with another drug (IDE397), in people with advanced solid tumors that have a specific genetic deletion (MTAP). The study aims to find safe doses and see if the drugs shrink tumors. It includes 260 adults with ca…
Phase 1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to ease muscle weakness in myasthenia gravis
Disease control Recruiting nowThis study tests whether adding empasiprubart to the existing drug efgartigimod can improve symptoms and daily function in people with generalized myasthenia gravis who still have symptoms on efgartigimod alone. About 70 participants will receive both drugs intravenously. The mai…
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cocktail aims to tame tough lymphoma
Disease control Recruiting nowThis study tests a combination of four drugs (mosunetuzumab, polatuzumab, tafasitamab, and lenalidomide) in people with relapsed B-cell non-Hodgkin lymphoma. The goal is to see if this mix can shrink tumors or stop the cancer from growing. About 36 adults who have already tried o…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental cell therapy takes on tough leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment called TSLPR-CART for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has come back or not responded to treatment. The therapy uses a patient's own immune cells, modified in a lab to target a protein called TSLPR found on …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lupus drug may shield heart and arteries
Disease control Recruiting nowThis study tests whether anifrolumab, a drug that blocks certain immune signals, can improve blood vessel function and reduce inflammation in people with lupus. About 45 adults with lupus will receive either the drug or a placebo over 8 months. Researchers will measure changes in…
Phase 2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to supercharge immune system against prostate cancer
Disease control Recruiting nowThis phase II trial tests whether adding an experimental drug called PDS01ADC to standard radiation and hormone therapy can help the immune system fight prostate cancer. About 65 men with high- or intermediate-risk prostate cancer that hasn't spread will take part. Some will get …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can donated immune cells calm the cytokine storm?
Disease control Recruiting nowResearchers are testing whether regulatory T cells taken from donated thymus tissue can control the dangerous immune overreaction that occurs in severe COVID-19 and acute respiratory distress syndrome (ARDS). The trial enrolls adults aged 18 to 65 who are hospitalized with acute …
Phase 1/2 • Sponsor: Hospital General Universitario Gregorio Marañon • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Robots take on tricuspid valve repair in tiny early trial
Disease control Recruiting nowThis early study tests a robotic catheter system to replace the tricuspid valve in 10 patients with severe leakage (regurgitation) who are too high-risk for open surgery. The robot aims to improve precision and safety while reducing radiation exposure for doctors. The main goal i…
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for aggressive brain cancer? early trial of ERAS-801 begins
Disease control Recruiting nowThis early-phase trial tests the safety of a drug called ERAS-801 in 10 adults with recurrent glioblastoma, a fast-growing brain cancer. The drug targets a protein called EGFR that is overactive in many of these tumors. Researchers will also check if the drug affects tumor activi…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can daily adaptive radiotherapy spare healthy tissue in prostate cancer?
Disease control Recruiting nowResearchers are testing whether daily adaptive radiotherapy, which adjusts the radiation plan to each day's anatomy, causes fewer bladder and bowel side effects than standard radiotherapy in people with intermediate or high risk localized prostate cancer. The trial also compares …
Phase 2 • Sponsor: Scott Tyldesley • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New radiation approach before surgery for rare adrenal cancer
Disease control Recruiting nowThis early-phase trial tests giving radiation therapy before surgery to people whose adrenal cancer has come back. The goal is to find a safe radiation dose and see if it helps shrink tumors before removal. About 32 adults with resectable recurrent ACC will receive daily radiatio…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to tackle rare nasal cancer
Disease control Recruiting nowThis phase 2 trial tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can shrink advanced squamous cell cancers of the nasal cavity and sinuses better than chemotherapy alone. About 35 adults with newly diagnosed, untreated stage II to IVb disease …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug shows promise in slowing spread of aggressive prostate cancer
Disease control Recruiting nowThis study tests whether adding the drug saruparib to standard radiation and hormone therapy can delay the spread of cancer in 700 men with high-risk prostate cancer that has a BRCA gene mutation. Participants will receive either saruparib or a placebo alongside their usual treat…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New implant aims to quiet bladder urgency for years
Disease control Recruiting nowThis study is checking how well the Altaviva™ device works over five years for people with sudden, strong urges to urinate (urge incontinence). The device sends mild electrical pulses to a nerve in the ankle to calm bladder signals. Researchers will track 256 adults to see if at …
Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to boost remission in IDH2-Mutated AML
Disease control Recruiting nowThis phase II trial tests whether adding enasidenib to standard ASTX727 and venetoclax improves remission rates in older adults (or younger unfit patients) with newly diagnosed IDH2-mutated acute myeloid leukemia (AML). About 93 participants will be randomly assigned to receive e…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radiation boost may tame untreatable kidney cancer
Disease control Recruiting nowThis phase II trial tests whether adding precise, high-dose radiation (SABR) to the main kidney tumor improves outcomes for people with metastatic kidney cancer that cannot be surgically removed. Participants receive standard immunotherapy drugs (avelumab, axitinib, or cabozantin…
Phase 2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for blood disorder patients: Long-Term safety check for etavopivat
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of etavopivat, an experimental medicine for sickle cell disease and thalassemia. It involves 480 adults, adolescents, and children who have already benefited from etavopivat in a previous study. Participants will continue…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare blood cancers: first human trial of PRT12396 begins
Disease control Recruiting nowThis early-stage study tests a new drug, PRT12396, in about 100 people with polycythemia vera or myelofibrosis—rare blood cancers. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs that the drug controls the disease, but this …
Phase 1 • Sponsor: Prelude Therapeutics Incorporated • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a compound in grapes help Parkinson's? new trial launches
Disease control Recruiting nowThis early-phase trial will test whether a special form of resveratrol (JOTROL) is safe and tolerable for people with Parkinson's disease. About 30 participants will receive either a low dose, high dose, or placebo daily for three months. The study will also measure how the drug …
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a structured care plan keep NMOSD relapses at bay?
Disease control Recruiting nowResearchers at Huashan Hospital are studying a practical management model for Chinese patients with neuromyelitis optica spectrum disorder (NMOSD) who receive satralizumab. The study follows about 100 patients aged 12 and older who test positive for AQP4 antibodies and have had r…
Sponsor: Huashan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a simple sugar powder help save kidneys? new trial underway for FSGS
Disease control Recruiting nowThis phase 2 trial tests an oral drug called ManNAc in 30 adults with primary focal segmental glomerulosclerosis (FSGS), a kidney disease that causes scarring and protein loss. Participants take ManNAc powder dissolved in water twice daily for 14 weeks. The study aims to see if t…
Phase 2 • Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo targets tough prostate cancer
Disease control Recruiting nowThis study is testing a new drug called ADI-PEG20, which breaks down arginine (a nutrient cancer cells need), together with two chemotherapy drugs (carboplatin and cabazitaxel) in men with aggressive variant prostate cancer. The goal is to find the safest dose and check for side …
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New antibody AU-007 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called AU-007 in people with advanced solid tumors that have spread or cannot be removed by surgery. The drug is designed to help the immune system fight cancer. About 159 participants will receive AU-007 alone or with other medicines to find the safes…
Phase 1/2 • Sponsor: Aulos Bioscience, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for kids with rare blood disorders: benralizumab trial launches
Disease control Recruiting nowThis Phase 3 trial tests the drug benralizumab (Fasenra) in children aged 6 to 17 with two rare eosinophilic diseases: EGPA and HES. The study aims to see if the drug is safe, how it works in the body, and whether it can help control the disease. Fourteen children will receive in…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill hopes to slow rare brain disease in kids
Disease control Recruiting nowThis study tests an oral drug called nizubaglustat in children and teens aged 4 and older with Niemann-Pick type C disease, a rare genetic disorder that affects movement and thinking. Participants will take the drug or a placebo for 18 months to see if it slows the disease and im…
Phase 3 • Sponsor: Azafaros B.V. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to boost survival in hodgkin lymphoma
Disease control Recruiting nowThis phase 3 trial is testing whether adding immunotherapy drugs (brentuximab vedotin and nivolumab) to standard chemotherapy (with or without radiation) improves survival for people aged 5 to 60 with newly diagnosed stage I or II classical Hodgkin lymphoma. About 1,875 participa…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage study is testing an experimental oral drug, VVD-133214, in people with advanced solid tumors that have specific genetic features (MSI or dMMR). The drug works by blocking a protein that helps these cancers grow. The study will check safety and how well the drug w…
Phase 1 • Sponsor: Vividion Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill aims to cut dangerous lung Flare-Ups in bronchiectasis
Disease control Recruiting nowThis study tests a daily pill called BI 1291583 (Verducatib) in 1755 adults and teens with bronchiectasis, a lung condition causing frequent infections and coughing. Participants take either the drug or a placebo for up to 76 weeks. The main goal is to see if the drug reduces the…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
CRISPR therapy takes aim at stubborn high cholesterol in first human trial
Disease control Recruiting nowThis early-stage trial tests a new CRISPR-based treatment called CTX310 for people with severe cholesterol and triglyceride problems that don't improve with standard therapies. The treatment uses a tiny fat bubble to deliver gene-editing tools that turn off a gene linked to high …
Phase 1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a daily pill replace needles for hemophilia a?
Disease control Recruiting nowThis study tests an experimental oral medicine called Inno8 in 30 adults with hemophilia A. The goal is to see if it is safe and how the body processes it. Participants will take multiple doses over about 11 weeks. If successful, Inno8 could offer a more convenient way to control…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a flexible dosing schedule improve esophageal cancer treatment?
Disease control Recruiting nowThis phase 2 trial is testing whether giving the immunotherapy drug tislelizumab every 2 weeks or every 4 weeks, alongside standard chemotherapy, is safe and effective for Japanese patients with advanced esophageal cancer that cannot be removed by surgery. The study aims to find …
Phase 2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to cut blood transfusions for MDS patients
Disease control Recruiting nowThis Phase 3 trial compares elritercept to epoetin alfa in 300 adults with low- to intermediate-risk myelodysplastic syndromes (MDS) who need red blood cell transfusions. The main goal is to see if elritercept can help patients go without transfusions for at least 12 weeks while …
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
One-Shot hope for blinding eye disease? new trial underway
Disease control Recruiting nowThis study tests a single injection into the eye of a new drug (SAR446597) for people with geographic atrophy, a progressive form of age-related macular degeneration that causes vision loss. About 104 participants aged 60 and older will be followed for 2 years, with an optional 3…
Phase 1/2 • Sponsor: Sanofi • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Targeted pill takes on rare skull base cancers
Disease control Recruiting nowThis phase 2 trial tests enasidenib, a daily pill that targets the IDH2 gene mutation, in 40 adults with rare cancers of the nasal cavity or skull base that have spread or come back. Participants take the drug once daily in 28-day cycles, and researchers will track how long the c…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Sleep pill may shield brain from Alzheimer's damage
Disease control Recruiting nowThis study tests whether the insomnia medication lemborexant (Dayvigo) can lower blood markers of brain damage in adults aged 40–65 with insomnia. Twenty participants will take the drug or a placebo for two weeks each, then have their blood tested for proteins linked to Alzheimer…
Phase 2 • Sponsor: Woolcock Institute of Medical Research • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for rare blood cancers: pacritinib trial opens for teens and adults
Disease control Recruiting nowThis study tests an oral drug called pacritinib in people aged 12 and older with myelodysplastic syndromes (MDS) or related blood cancers (MDS/MPN). The goal is to find the best dose and see if it can shrink or control the disease. Participants take capsules twice daily for up to…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a Rose-Scented oil replace standard fillings in Kids' cavities?
Disease control Recruiting nowThis study looks at whether an essential oil from Pelargonium graveolens (a type of geranium) can be used to treat deep cavities in children's baby teeth. The goal is to see if it works as well as current materials to relieve pain and prevent infection. Thirty children will recei…
Sponsor: Tanta University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
Disease control Recruiting nowResearchers compare empagliflozin and dapagliflozin, two similar diabetes drugs, to see which works better at preventing death, heart problems, and kidney damage in adults with type 2 diabetes, heart failure, or chronic kidney disease. The trial uses electronic health records to …
Phase 4 • Sponsor: Herlev and Gentofte Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
A temporary wire that keeps hearts beating on cue
Disease control Recruiting nowResearchers are studying the SPIKE FLOW endocardial lead, a temporary wire placed inside the heart to keep it beating during surgery or while doctors check a slow heart rhythm. The study enrolls 131 adults who need short-term cardiac pacing. Doctors implant the lead, measure how …
Sponsor: FIAB SpA • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New eye drug tiespectus takes on aflibercept in major wet AMD trial
Disease control Recruiting nowThis study tests a new medicine called tiespectus (EYE201) for wet age-related macular degeneration, a leading cause of vision loss. About 960 people will receive either tiespectus or the standard treatment aflibercept via eye injections. The goal is to see if tiespectus can impr…
Phase 2/3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Second radiation after surgery or laser therapy shows promise for recurrent brain tumors
Disease control Recruiting nowThis study is for people whose brain metastases have returned after initial radiation. It combines either laser ablation or surgery with a second round of targeted radiation. The goal is to control the disease and monitor side effects in 155 participants.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could cutting back on IV fluids save lives in septic shock?
Disease control Recruiting nowThis study is testing whether giving fewer non-essential fluids to adults with septic shock can improve outcomes. The trial will enroll 1,850 patients in intensive care, comparing a restrictive fluid strategy to usual care. The main goal is to see if this approach reduces deaths …
Sponsor: Region Skane • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
Disease control Recruiting nowThis trial compares two common diuretics—furosemide and mannitol—given during kidney transplant surgery to see which better prevents delayed graft function, a condition where the new kidney does not work right away and requires dialysis. The study enrolls adults receiving a decea…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug afimkibart tested for Long-Term arthritis control
Disease control Recruiting nowThis study is testing the long-term safety and effectiveness of a drug called afimkibart in people with moderate to severe rheumatoid arthritis. Participants have already taken afimkibart in a previous study and will continue taking it. The goal is to see if the drug remains safe…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for Tough-to-Treat leukemia: multiple drug cocktails tested
Disease control Recruiting nowThis phase II trial tests several experimental drug combinations against the standard treatment for high-risk acute myeloid leukemia (AML) in patients aged 59 or younger. The goal is to see if newer regimens, including venetoclax and liposome formulations, can better shrink cance…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to halt blinding eye disease
Disease control Recruiting nowThis phase 3 trial tests two injectable drugs, pozelimab and cemdisiran, alone or together, to slow the growth of geographic atrophy—an advanced form of dry age-related macular degeneration that causes central vision loss. About 975 participants will receive either the drugs or a…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for ALK lung cancer: first human trial of AQUA07 begins
Disease control Recruiting nowThis early-stage trial tests a new oral drug called AQUA07, alone or with another drug (lorlatinib), in about 102 people with ALK-positive non-small cell lung cancer that has spread or cannot be removed. The main goals are to check safety, find the right dose, and see how the bod…
Phase 1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug mosunetuzumab takes on standard therapy in lymphoma trial
Disease control Recruiting nowThis phase 3 trial tests whether mosunetuzumab works better than rituximab for people with a slow-growing type of lymphoma that has not spread much. Both drugs are lab-made antibodies that help the immune system attack cancer cells. About 600 adults with low tumor burden follicul…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a new pill bring back skin color in vitiligo?
Disease control Recruiting nowThis study tests a drug called zasocitinib in adults with nonsegmental vitiligo, an autoimmune condition that causes white patches on the skin. About 200 participants will take either the drug or a placebo for up to a year. The main goal is to see if the drug can improve skin col…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to shrink HER2-Positive tumors
Disease control Recruiting nowThis study tests whether adding palbociclib to neratinib works better than neratinib alone for people with HER2-positive solid tumors (excluding breast cancer). Both drugs block signals that help cancer cells grow. The trial enrolls 70 adults with advanced or recurrent gynecologi…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Eye injection vs. surgery: which is better for diabetic retinopathy?
Disease control Recruiting nowThis study tests two ways to treat proliferative diabetic retinopathy, a serious eye problem caused by diabetes. One group gets eye injections of faricimab plus laser treatment; the other gets vitrectomy surgery with laser. Researchers will track vision and how many extra treatme…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Fish oil capsules could ease rare muscle disease
Disease control Recruiting nowThis study tests whether omega-3 fatty acid supplements from fish oil, combined with a healthy diet, can reduce disease activity in adults with dermatomyositis, a rare autoimmune disease causing muscle weakness and skin rashes. About 300 participants will take either fish oil cap…
Phase 2 • Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New cell therapy GT719 targets tough blood cancers in early trial
Disease control Recruiting nowThis early-phase trial is testing an experimental cell therapy called GT719 in 46 adults with relapsed or treatment-resistant B-cell lymphoma or leukemia that tests positive for CD19. The study aims to see if the treatment is safe and how well it works. Participants receive a sin…
Phase 1/2 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to ease myasthenia gravis symptoms
Disease control Recruiting nowThis study is testing two drugs, efgartigimod and empasiprubart, given by IV, to see if they are safe and work well for people with myasthenia gravis (MG). The goal is to reduce side effects and improve quality of life. About 70 adults with MG are being recruited.
Sponsor: argenx • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New blood thinners may be safer after heart surgery
Disease control Recruiting nowThis study compares newer blood thinners (DOACs) to the standard drug warfarin in patients who need anticoagulation after open-heart surgery. About 3500 adults with atrial fibrillation will be randomly assigned to receive either a DOAC or warfarin for 30 days. The main goal is to…
Phase 3 • Sponsor: Population Health Research Institute • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to stop High-Risk breast cancer from coming back
Disease control Recruiting nowThis phase III trial is testing whether adding the immunotherapy drug durvalumab to standard chemotherapy can prevent breast cancer from returning in people with a specific high-risk type of hormone receptor-positive, HER2-negative breast cancer. About 3,680 participants with sta…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for Tough-to-Treat lymphoma: Two-Drug combo enters Mid-Stage trial
Disease control Recruiting nowThis Phase 2 trial is testing a new drug called MEN1703, both alone and combined with another drug called glofitamab, in 178 adults with aggressive B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments. The study aims to see if the drugs…
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental drug aims to stop liver failure in MASH cirrhosis
Disease control Recruiting nowThis phase 3 study tests whether an experimental drug called efimosfermin alfa can prevent serious liver complications in adults with compensated cirrhosis due to MASH (metabolic dysfunction-associated steatohepatitis). Participants receive either the drug or a placebo as a shot …
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Scientists train immune cells to hunt down mutated blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized treatment for people with blood cancers like leukemia. Doctors take a patient's own T cells, modify them in the lab to recognize unique cancer mutations, and infuse them back after a short course of chemotherapy. The goal is to see if t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for kidney patients: experimental drug takes on standard therapy
Disease control Recruiting nowThis study tests a new drug, povetacicept, against a standard treatment (calcineurin inhibitor) in 176 adults with primary membranous nephropathy, a kidney disease that can lead to kidney failure. The goal is to see if the new drug can put the disease into remission more safely a…
Phase 2/3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a cementless hip stem hold up in asian patients?
Disease control Recruiting nowResearchers at a Korean hospital are following 210 adults who receive a cementless total hip replacement using the collarless Actis femoral stem. The study focuses on Asian patients, who tend to be younger at surgery and more often need the operation because of lost blood supply …
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New heart catheter aims to tame Life-Threatening rhythm disorder
Disease control Recruiting nowThis study tests a new device (Sphere-9 catheter and Affera system) to treat ventricular tachycardia, a fast, dangerous heart rhythm, in 260 adults who have had a heart attack. Participants must have had repeated episodes despite medication or a defibrillator. The goal is to see …
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Gene-Silencing drug tame a rare heart disease?
Disease control Recruiting nowThis trial tests an investigational medicine called ATR 1072 in adults with PRKAG2 syndrome, a genetic condition that causes abnormal heart muscle thickening and rhythm problems. The drug is designed to reduce the activity of the faulty PRKAG2 gene. Researchers are evaluating its…
Phase 1/2 • Sponsor: Atrium Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo pill aims to shrink spleens and ease symptoms in bone marrow cancer
Disease control Recruiting nowThis phase 3 trial tests whether adding pelabresib to the standard drug ruxolitinib works better than ruxolitinib alone for people with myelofibrosis, a type of bone marrow cancer. About 460 adults who have not taken JAK inhibitors before will receive either the combination or a …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a donor stem cell transplant fix broken immune systems?
Disease control Recruiting nowThis study tests whether a stem cell transplant from a healthy donor can help people with severe primary immunodeficiencies. Participants aged 4 to 75 receive chemotherapy before the transplant to prepare their body. The goal is to see if the procedure is safe and can improve imm…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Prison program aims to alert partners of HIV risk
Disease control Recruiting nowThis study tests whether a program that helps incarcerated men with HIV notify their sex and drug-use partners about possible HIV exposure can increase testing and treatment. Participants can choose to tell partners themselves or have a trained notifier do it anonymously. The goa…
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a simpler HIV pill protect moms and babies?
Disease control Recruiting nowThis study will test a two-drug HIV pill (Dolutegravir/Lamivudine) in 210 pregnant women who have never taken HIV medication. The goal is to see if it controls the virus and prevents passing HIV to their babies. Participants will be compared to those on standard three-drug therap…
Phase 4 • Sponsor: Fundación Huésped • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker trial aims to tame Parkinson's symptoms
Disease control Recruiting nowThis study follows 300 adults with Parkinson's disease, essential tremor, or dystonia who receive deep brain stimulation (DBS). DBS uses a device implanted in the chest to send electrical pulses to brain areas controlling movement. Researchers will track symptom severity, medicat…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could detoxing metals boost chemo for leukemia?
Disease control Recruiting nowThis early-stage trial is testing whether two drugs that lower metal levels in the body can help people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) respond better to chemotherapy. The study will enroll 58 adults and aims to find the safest dose and check f…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New daily pill could ease sickle cell pain for kids
Disease control Recruiting nowThis study tests a once-daily pill called etavopivat in children (6 months to 18 years) with sickle cell disease. The main goals are to check safety and how the drug works in the body, and to see if it can raise hemoglobin levels and reduce painful crises. About 95 children will …
Phase 2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Twice-Yearly shot prevent heart attacks in Tough-to-Treat hypertension?
Disease control Recruiting nowThis phase 3 study is testing an injectable drug called zilebesiran in about 11,000 adults whose high blood pressure is not well controlled despite taking at least two standard medications. Participants also have heart disease or are at high risk for it. The goal is to see if add…
Phase 3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for advanced penile cancer: drug combo targets tough cases
Disease control Recruiting nowThis study tests a new combination of two drugs (becotatug vedotin and pucotenlimab) in 20 adults with advanced penile cancer that has spread and is EGFR-positive. Participants must have failed or be unable to tolerate chemotherapy. The goal is to see if the treatment can shrink …
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple threat: new combo aims to tackle Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new drug, AMO959, combined with a targeted radiation therapy (Pluvicto) and a hormone therapy in men with a specific type of advanced prostate cancer (PSMA-positive mCRPC) that has stopped responding to prior hormone treatment. The trial has two phases: first t…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lung cancer vaccine trial aims to stop tumors from coming back
Disease control Recruiting nowThis study tests whether adding an experimental mRNA vaccine (V940) to the immunotherapy drug pembrolizumab (Keytruda) can keep lung cancer from returning after surgery. It includes 680 people with stage II to IIIB non-small cell lung cancer whose tumors did not fully respond to …
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims to stop early breast cancer in its tracks
Disease control Recruiting nowThis phase 3 trial is testing whether adding the targeted drug ribociclib to standard hormone therapy can help prevent invasive breast cancer from returning in people with HR+ HER2- early breast cancer. About 1,400 participants will receive the combination for up to 3 years. The …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo therapy aims to shrink lung tumors without chemo or surgery
Disease control Recruiting nowThis study tests a drug called NBTXR3 given with radiation therapy for people with locally-advanced non-small cell lung cancer who cannot have chemotherapy or surgery. The goal is to see if the combination is safe and helps control the cancer. About 40 adults with stage I to III …
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Brain cancer breakthrough? GammaTile trial aims to boost survival
Disease control Recruiting nowThis Phase 3 trial tests whether adding a special radiation tile (GammaTile) during brain surgery improves survival for people with newly diagnosed glioblastoma, a fast-growing brain cancer. About 766 participants will be randomly assigned to standard treatment (surgery, radiatio…
Phase 3 • Sponsor: GT Medical Technologies, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo aims to tackle Alzheimer's brain fog
Disease control Recruiting nowThis study tests whether a combination of two drugs, KarXT and KarX-EC, can improve cognitive impairment in people with mild to moderate Alzheimer's disease. About 586 participants will receive either the drug combo or a placebo. The trial measures changes in thinking, daily func…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug combo aims to tackle bipolar depression and suicidal thoughts
Disease control Expanded accessThis study offers NRX-101, a combination of two drugs, to adults aged 18-65 with treatment-resistant bipolar depression and suicidal thoughts. Participants receive the medication from their own psychiatrist and undergo regular check-ins on mood, suicidal ideation, and side effect…
Sponsor: NeuroRx, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for pancreatic cancer: targeted drug may delay return in BRCA patients
Disease control Recruiting nowThis phase II trial is testing whether the drug olaparib can help prevent pancreatic cancer from coming back in people who have already had surgery and chemotherapy and carry a BRCA1, BRCA2, or PALB2 mutation. Olaparib is a targeted therapy that blocks a repair enzyme cancer cell…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Keytruda's Long-Term safety under the microscope in massive cancer trial
Disease control Recruiting nowThis study is checking the long-term safety and effectiveness of the cancer drug pembrolizumab (Keytruda) in 3500 people with various solid tumors or blood cancers. Participants are moving from earlier Merck studies into this one, continuing their treatment or follow-up. The goal…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New stroke drug enters final testing phase – could improve recovery
Disease control Recruiting nowThis study tests a drug called sovateltide in 160 people who have had an ischemic stroke (a stroke caused by a blood clot). The goal is to see if the drug helps patients recover better and is safe. Participants receive either the drug or a placebo within 24 hours of their stroke,…
Phase 4 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two-Drug combo targets prostate cancer that outsmarts hormone therapy
Disease control Recruiting nowResearchers are testing a combination of two experimental drugs, JANX013 and JANX007, in men with metastatic castration-resistant prostate cancer, an advanced form that keeps growing despite hormone-lowering treatment. The Phase 1 trial gives both drugs by intravenous infusion to…
Phase 1 • Sponsor: Janux Therapeutics • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could your own bone marrow cells save your hip from collapse?
Disease control Recruiting nowThis study tests whether adding a patient's own concentrated bone marrow cells to a standard hip surgery (core decompression) can prevent the hip ball from collapsing and delay or avoid the need for a hip replacement. It includes 192 adults with early-stage osteonecrosis (before …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug could replace standard infusions for nerve disorder
Disease control Recruiting nowThis study tests a new medicine called empasiprubart against the standard treatment (IVIg) for people with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disease that causes weakness and numbness. About 218 adults who have used IVIg before will receive either t…
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Special lenses may curb worsening eyesight in children
Disease control Recruiting nowThis study tests two types of modified spectacle lenses designed to slow the progression of myopia (nearsightedness) in children aged 6 to 13. Over one year, researchers will measure changes in the back of the eye (choroid), eye length, and prescription strength. The goal is to s…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug targets Hard-to-Treat cancers with genetic weakness
Disease control Recruiting nowThis study tests a new drug, TER-2013, in people with advanced solid tumors (like breast, ovarian, or lung cancer) that have specific genetic changes in the AKT/PI3K/PTEN pathway. The goal is to see if the drug is safe and can shrink tumors. About 205 participants will receive th…
Phase 1/2 • Sponsor: Terremoto Biosciences Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new drug ease the joint pain of psoriatic arthritis?
Disease control Recruiting nowThis trial tests an experimental drug called DDY391 in about 220 adults with moderate to severe psoriatic arthritis, a condition that causes joint pain, swelling, and skin patches. Researchers want to see whether DDY391 can reduce joint symptoms better than a placebo and at what …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for kids with colitis: risankizumab trial launches
Disease control Recruiting nowThis phase 3 study tests the drug risankizumab in about 120 children aged 2 to 18 with moderate to severe ulcerative colitis. The trial has three parts: an initial 12-week IV treatment period, a 52-week maintenance phase where patients get one of two doses by injection, and a lon…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Engineered immune cells take on muscle disease
Disease control Recruiting nowThis study tests a one-time treatment called CABA-201, made from a patient's own immune cells, for people with active inflammatory muscle diseases like dermatomyositis. The therapy aims to reset the immune system by targeting and removing certain immune cells. Researchers will ch…
Phase 2/3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a blast of testosterone shrink hard-to-treat prostate cancer?
Disease control Recruiting nowThis trial investigates whether high doses of testosterone can shrink tumors in men with metastatic prostate cancer that no longer responds to standard hormone therapy and has mutations in DNA repair genes like ATM or CDK12. Participants receive monthly injections of high-dose te…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a lung cancer drug work against other rare neuroendocrine tumors?
Disease control Recruiting nowResearchers are testing tarlatamab in people with advanced extrapulmonary small cell carcinoma or neuroendocrine carcinoma that has worsened after platinum-based chemotherapy. These rare cancers often carry high levels of a protein called DLL3, which tarlatamab targets by linking…
Phase 2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for Tough-to-Treat blood cancers: NX-5948 trial opens
Disease control Recruiting nowThis study tests an experimental drug called NX-5948 in adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to prior treatments, including BTK and BCL-2 inhibitors. The main goal is to see if the drug can shrink o…
Phase 2 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Experimental drug combo aims to extend cancer control in lung cancer
Disease control Recruiting nowThis trial tests whether adding the experimental drug iadademstat to standard immunotherapy (atezolizumab or durvalumab) can help keep extensive-stage small cell lung cancer from growing. About 45 adults whose cancer responded to initial chemo-immunotherapy will receive the combi…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug hopes to halt liver damage in MASH patients
Disease control Recruiting nowThis phase 3 trial tests a drug called efimosfermin alfa in 1250 adults with MASH (a fatty liver disease) and moderate liver scarring. The main goal is to check safety and side effects. Participants will receive either the drug or a placebo, and researchers will monitor liver hea…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug combo aims to outperform standard care in aggressive lung cancer
Disease control Recruiting nowThis Phase 3 trial will test whether a new drug called BL-M14D1 combined with atezolizumab works better than the current standard treatment for people with extensive-stage small cell lung cancer who have not had prior therapy. About 550 adults will be randomly assigned to receive…
Phase 3 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Biomarker-Guided combo aims to outsmart tough cancers
Disease control Recruiting nowThis phase II trial is testing whether the combination of cabozantinib (a targeted therapy) and nivolumab (an immunotherapy) can shrink or stabilize advanced melanoma and head and neck cancers that have stopped responding to prior immunotherapy. Researchers are also checking if t…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New antibody combo shows promise for Hard-to-Treat myeloma
Disease control Recruiting nowThis early-phase trial is testing an experimental antibody called cevostamab, either alone or combined with other drugs (pomalidomide, daratumumab, and dexamethasone), in 126 people with multiple myeloma that has returned or stopped responding to treatment. The main goals are to …
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Promising new combo aims to beat aggressive leukemia
Disease control Recruiting nowThis phase 2 trial is testing a combination of blinatumomab (an immune-boosting drug) with dasatinib or imatinib (targeted pills) and standard chemotherapy for people with a specific type of leukemia called Philadelphia chromosome-positive or Philadelphia chromosome-like B-ALL. T…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a home device slow dementia? pilot trial tests pulsed electromagnetic therapy
Disease control Recruiting nowResearchers are testing whether a home-use pulsed electromagnetic therapy device can slow cognitive decline in people with mild to moderate Alzheimer's disease, Lewy body dementia, or vascular dementia. About 48 participants will use the device three times a day for 15 minutes ov…
Sponsor: Herrick Medical LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for kids with tough cancers: targeted radiation trial launches
Disease control Recruiting nowThis early-stage trial tests a radioactive drug (Lu-177 edotreotide) in children aged 2 to 17 with cancers that have a specific marker (SSTR-positive). The goal is to find the right dose and check safety. About 20 children whose cancer has returned or not responded to prior treat…
Phase 1 • Sponsor: ITM Solucin GmbH • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a simple shot replace an IV for this aggressive lung cancer?
Disease control Recruiting nowThis phase 3 trial is testing whether tarlatamab, an immunotherapy drug, can be given as a quick injection under the skin instead of a slow intravenous drip for people with relapsed extensive-stage small cell lung cancer. The study will compare the two methods to see if the injec…
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo therapy aims to tackle breast cancer brain metastases
Disease control Recruiting nowThis study is testing whether combining a targeted drug (abemaciclib) with precise radiation (stereotactic radiosurgery) can better control brain tumors in people with a common type of breast cancer (HR+/HER2-). About 31 participants will receive both treatments along with hormon…
Phase 1/2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for stroke prevention in heart patients who Can't use standard meds
Disease control Recruiting nowThis study tests two experimental drugs, REGN7508 and REGN9933, to prevent strokes in people with atrial fibrillation (an irregular heartbeat) who cannot or choose not to take standard blood thinners. About 2,628 participants will receive one of the drugs or a placebo to see if t…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Five-Fraction radiation plus hormone therapy tested against High-Risk prostate cancer
Disease control Recruiting nowResearchers are testing a treatment plan for men with high-risk localized prostate cancer that combines whole-pelvis radiation given in five sessions, a high-dose radiation boost directly to the prostate, and two years of androgen deprivation therapy. The study aims to see how of…
Phase 2 • Sponsor: German Oncology Center, Cyprus • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Should High-Risk CLL patients start treatment early? major trial aims to find out
Disease control Recruiting nowThis phase 3 trial compares starting treatment with venetoclax and obinutuzumab right away versus waiting until symptoms appear in people with newly diagnosed, high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. About 247 participants will be randomly assigned t…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Immune boosters take on brain cancer: new trial launches
Disease control Recruiting nowThis phase 2 trial tests two immunotherapy drugs, nivolumab and relatlimab, in people with newly diagnosed glioblastoma, a fast-growing brain cancer. About 92 participants will receive the drugs before and after surgery to see if they are safe and help the immune system attack th…
Phase 2 • Sponsor: Duke University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Precision radiation may tame prostate cancer with fewer side effects
Disease control Recruiting nowThis phase II trial is testing a focused, high-dose radiation therapy (SBRT) given in just two sessions for men with early-stage prostate cancer that hasn't spread. The goal is to see if this approach can destroy the tumor while avoiding the side effects of treating the whole pro…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New combo aims to boost transplant success in rare blood cancer
Disease control Recruiting nowThis study tests whether giving a chemotherapy drug (decitabine) plus a targeted therapy (ruxolitinib, fedratinib, or pacritinib) before a stem cell transplant helps people with advanced myeloproliferative neoplasms (MPN) get to transplant and have better outcomes. About 25 adult…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Radioactive One-Two punch takes on returning prostate cancer
Disease control Recruiting nowThis phase II trial is testing two radioactive drugs, 225Ac-PSMA-617 and 177Lu-PSMA-617, combined with precise radiation therapy for prostate cancer that has returned and spread to a few spots in the body. The drugs target a protein on cancer cells and deliver radiation to kill t…
Phase 2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill targets Hard-to-Treat lung cancer mutation
Disease control Recruiting nowThis trial tests an experimental daily pill, VS-7375, for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12D. Participants must have already tried chemotherapy and an immunotherapy drug. The study looks at whether the drug can shri…
Phase 2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a tailored diet boost brain and body health in denture-wearers?
Disease control Recruiting nowThis study tests a 6-month nutritional program for adults aged 60–80 who wear complete dentures. Participants receive personalized dietary advice, meal plans, cooking workshops, and a mobile app. The goal is to see if the program improves diet quality, chewing ability, muscle str…
Sponsor: Universidad de La Frontera • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two-Drug combo aims to stall advanced breast cancer
Disease control Recruiting nowResearchers are testing whether dalpiciclib, a targeted cancer drug, combined with toremifene, a hormonal therapy, can slow the growth of advanced HR-positive, HER2-negative breast cancer when used as a first-line treatment. The trial plans to enroll 36 women who have not yet rec…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Chemo combo tested as backup for bladder cancer that outsmarts First-Line therapy
Disease control Recruiting nowResearchers are testing whether a chemotherapy combination called gemcitabine and carboplatin can help people with advanced urothelial cancer whose disease has worsened after treatment with enfortumab vedotin and pembrolizumab. The trial enrolls about 55 participants who receive …
Phase 2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug ease rett syndrome? early trial launches
Disease control Recruiting nowThis early-stage trial is testing the drug vorinostat in 15 girls and young women with Rett syndrome, a rare genetic disorder that affects brain development. Each participant will receive placebo and two different doses of vorinostat, acting as their own control. The study aims t…
Phase 1 • Sponsor: Unravel Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Triple threat: immunotherapy, chemo, and radiation take on rectal cancer
Disease control Recruiting nowThis phase 2 trial is testing whether adding an immunotherapy drug (adebrelimab) to a chemotherapy combo (NALIRIFOX) and radiation can improve outcomes for people with a certain type of locally advanced rectal cancer (pMMR/MSS). About 84 participants will be randomly assigned to …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New contact lenses aim to curb childhood myopia epidemic
Disease control Recruiting nowThis study tests two types of daily disposable contact lenses designed to slow the progression of myopia (nearsightedness) in children aged 7 to 12. Over two years, 126 Hong Kong Chinese children will wear either a special lens or a standard single-vision lens, with their eyes me…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for tough leukemia: MK-1045 takes on standard therapy
Disease control Recruiting nowThis study compares a new immunotherapy, MK-1045, to the standard drug blinatumomab in people whose B-cell acute lymphoblastic leukemia has returned or stopped responding to treatment. About 340 adults with CD19-positive leukemia will receive one of the two treatments. The goal i…
Phase 2/3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug combo aims to keep ovarian cancer at bay
Disease control Recruiting nowThis Phase 3 trial tests whether a targeted therapy called sacituzumab tirumotecan (Sac-TMT), given alone or with bevacizumab, can help people with advanced ovarian cancer live longer without their cancer growing. About 900 participants who have finished initial chemotherapy will…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can turbocharged immune cells stop liver cancer from coming back?
Disease control Recruiting nowResearchers are testing whether combining microwave ablation with infusions of a patient's own expanded immune cells helps people with small liver tumors. The trial enrolls adults with up to three tumors, each no larger than 5 cm, who are not eligible for surgery. After ablation,…
Phase 2/3 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Engineered t cells target hidden leukemia cells in new trial
Disease control Recruiting nowThis phase I trial tests a new treatment for adults with acute myeloid leukemia (AML) who have minimal residual disease (MRD) — small amounts of cancer cells that remain after standard therapy. The treatment uses the patient's own T cells, genetically modified to recognize a prot…
Phase 1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill could ease psoriatic arthritis without biologics
Disease control Recruiting nowThis Phase 3 study tests whether the oral drug zasocitinib (TAK-279) can improve symptoms of active psoriatic arthritis in people who have never used biologic treatments. About 1,088 adults will receive either zasocitinib, an active comparator, or a placebo for up to 60 weeks. Th…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New shot aims to help kids with rare heart-muscle disease move easier
Disease control Recruiting nowThis study tests a daily injection called elamipretide in 48 people with genetically confirmed Barth syndrome, a rare condition that causes muscle weakness and heart problems. Participants will receive either the drug or a placebo for 72 weeks. The main goal is to see if the drug…
Phase 4 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New chemo formula aims to keep lung cancer away after surgery
Disease control Recruiting nowThis study tests a drug called SMS001, a new version of the chemotherapy paclitaxel, in 42 people with non-small cell lung cancer (stages Ib to IIIa). The goal is to see if a single dose after surgery can safely prevent the cancer from coming back. Researchers will monitor side e…
Phase 2 • Sponsor: ToLymph Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for Triple-Negative breast cancer: combo aims to stop recurrence
Disease control Recruiting nowThis phase 3 trial tests whether adding the experimental drug sacituzumab tirumotecan (MK-2870) to the immunotherapy pembrolizumab can better prevent breast cancer from coming back in people with triple-negative breast cancer who still had tumor after initial treatment. About 1,5…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Hope for scleroderma: new pill aims to halt disease progression
Disease control Recruiting nowThis Phase 3 trial tests whether the oral drug nerandomilast can slow disease progression in adults with systemic sclerosis (scleroderma). About 448 participants will be randomly assigned to receive either nerandomilast or a placebo twice daily for up to 4 years. Researchers will…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Foam plug could open door to lung valve therapy for thousands
Disease control Recruiting nowThis study tests a foam called AeriSeal that is squirted into damaged parts of the lung to block tiny air leaks. After the foam, doctors check if the lung is now sealed enough to place a one-way valve that lets trapped air escape. The goal is to help people with severe emphysema …
Sponsor: Pulmonx Corporation • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for multiple myeloma: phase 3 trial launches
Disease control Recruiting nowThis Phase 3 trial tests a new drug called IBI3003 against standard treatments for people with multiple myeloma that has returned or is not responding to therapy. About 255 participants will be randomly assigned to receive either IBI3003 or a standard treatment chosen by their do…
Phase 3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New PET tracer could spot hidden fungal infections
Diagnosis Recruiting nowThis Phase 1 trial tests a new radioactive tracer called [18F]-Fluorocellobiose ([18F]FCB) for PET/CT scans. The goal is to see if it can help find invasive mold infections in the body. The study includes healthy volunteers and people with known fungal infections. Participants re…
Phase 1 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Tiny magnetic seeds could guide surgeons to the right lymph node
Diagnosis Recruiting nowResearchers are testing whether a small implantable marker called Magseed, along with a handheld magnetic probe called Sentimag, can help surgeons locate and remove a specific axillary lymph node in breast cancer patients who have had chemotherapy before surgery. The study enroll…
Sponsor: Endomagnetics Ltd. • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
New blood test may take the guesswork out of shrimp allergy diagnosis in kids
Diagnosis Recruiting nowThis study will check if measuring IgE antibodies to two shrimp proteins (tropomyosin and hemocyanin) in the blood can accurately diagnose shrimp allergy in children. About 129 kids with suspected shrimp allergy will take part. They will have a food challenge, skin test, and bloo…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can AI learn to spot endometriosis and fibroids on ultrasound?
Diagnosis Recruiting nowResearchers at Semmelweis University are building and testing artificial intelligence algorithms that read standardized transvaginal ultrasound images. The study includes women aged 18 to 45 who have suspected endometriosis or adenomyosis, a confirmed uterine mass scheduled for s…
Sponsor: Semmelweis University • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
New scan could spot hidden scarring in heart and lungs before It's too late
Diagnosis Recruiting nowThis study tests a new radioactive tracer called 18F-FAPI-74 that may help detect scar tissue (fibrosis) in the heart and lungs earlier than current methods. Researchers will compare this new PET/CT scan to standard imaging in 210 adults with conditions like lung disease or heart…
Phase 3 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Blowing away breast cancer: a breath test could spot the disease early
Diagnosis Recruiting nowThis study is testing whether a breath test can detect breast cancer in women aged 40 to 74. Researchers will collect breath samples from over 5,000 women before their standard biopsy or MRI and compare the chemical patterns between those found to have cancer and those who do not…
Sponsor: Breathe BioMedical Inc • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can a Brain-Tumor dye light up kidney cancer during surgery?
Diagnosis Recruiting nowResearchers are testing whether a drug called 5-aminolevulinic acid (5-ALA) can make kidney tumors glow under blue light during surgery. Adults with suspected kidney cancer take the drug by mouth before a partial nephrectomy, a procedure that removes part of the kidney. Surgeons …
Phase 2 • Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Blood, eye, and brain scans team up to spot Alzheimer's earlier
Diagnosis Recruiting nowResearchers are studying whether a combination of blood tests, retinal imaging, and brain scans can improve the detection and staging of Alzheimer's disease in Chinese adults. The study enrolls 300 people, including those with probable Alzheimer's dementia and those without. Part…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Pen-Like device could help surgeons detect cancer in real time
Diagnosis Recruiting nowThis study tests whether a handheld device called the MasSpec Pen can tell the difference between cancerous MPNST, benign neurofibromas, and normal tissue during surgery. About 60 people with MPNST or neurofibroma will take part. The goal is to see if the device is safe and accur…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive tracer lights up Oxygen-Starved brain tumors
Diagnosis Recruiting nowResearchers are testing a radioactive tracer called FMISO with PET/MRI scans to map oxygen levels inside malignant brain tumors. Adults with a suspected glioma receive the tracer by IV, then undergo brain scans that combine PET and MRI, sometimes with contrast dyes. The study che…
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Scoring system may spare appendicitis patients unnecessary scans and surgery
Diagnosis Recruiting nowResearchers compare selective imaging guided by clinical scores to routine imaging in adults with suspected appendicitis. Participants are assigned to one of three groups: selective imaging based on the Adult Appendicitis Score, selective observation plus selective imaging, or ro…
Sponsor: Helsinki University Central Hospital • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Could a string swallowed in a pill replace endoscopy for EoE?
Diagnosis Recruiting nowThis study tests whether a simple esophageal string test (EST) can diagnose eosinophilic esophagitis (EoE) in people who have trouble swallowing. Participants swallow a capsule with a nylon string that collects fluid from the esophagus, which is then analyzed. The results will be…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Glow-in-the-dark dye could help surgeons find hidden cancers
Diagnosis Recruiting nowThis study tests whether a medication called 5-ALA, already used in brain surgery, can make upper urinary tract tumors glow under blue light during surgery. About 10 adults with known or suspected tumors will take 5-ALA before their procedure. The goal is to see if this technique…
Phase 2 • Sponsor: Henry Ford Health System • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
New PET tracer aims to light up HER2 breast cancer
Diagnosis Recruiting nowResearchers are testing a new PET imaging tracer called 18F-HER2 Affibody to see how well it detects HER2-expressing breast cancer. The study includes 40 adults with confirmed or suspected HER2-positive breast cancer. Participants receive the tracer and then undergo a PET scan. T…
Sponsor: The Affiliated Hospital of Qingdao University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
New imaging agent could reveal prostate cancer treatment success in real time
Diagnosis Recruiting nowThis phase 2 trial is testing whether a special PET scan tracer called 18F-DCFPyL can accurately show how prostate cancer responds to standard radiation therapy. About 130 adults with newly diagnosed, localized prostate cancer will receive the tracer and undergo PET/CT scans at s…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a risk score plus a blood test catch dangerous leg clots after heart surgery?
Diagnosis Recruiting nowResearchers in Baghdad are studying whether combining the Modified Caprini Score, a checklist of risk factors, with a D-Dimer blood test predicts lower extremity venous thrombosis better than either tool alone in patients recovering from heart and chest surgery. About 112 hospita…
Sponsor: Al-Nahrain University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Green dye vs blue dye: which finds Cancer-Linked lymph nodes better?
Diagnosis Recruiting nowResearchers compare two tracers, indocyanine green (ICG) and blue patent dye, for locating lymph nodes during targeted axillary dissection in breast cancer patients who have received chemotherapy before surgery. The trial measures how often each tracer successfully identifies the…
Sponsor: Hospital Universitari de Bellvitge • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Personalized navigation may boost cancer screening in high-risk communities
Prevention Recruiting nowThis study tests whether giving people a personalized report about their cancer risk and screening options helps them complete recommended cancer tests. Adults aged 45 to 74 who are at high risk for lung, breast, colorectal, upper gastrointestinal, or liver cancer are invited to …
Sponsor: Hunan Cancer Hospital • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a family program stop diabetes before it starts?
Prevention Recruiting nowResearchers are testing a weekly family-based lifestyle program called Family DPP+ to see if it helps parents with prediabetes lose weight and adopt healthier habits. The trial enrolls African American and Hispanic parents and their children in Georgia. Parents attend sessions fo…
Sponsor: Morehouse School of Medicine • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a simple wash stop the bacteria behind shoulder surgery infections?
Prevention Recruiting nowResearchers are testing whether washing the surgical site with antimicrobial solutions after the first cut lowers the amount of Cutibacterium acnes, a bacterium commonly found on the skin, during shoulder replacement surgery. Adults scheduled for a first shoulder replacement are …
Sponsor: Henry Ford Health System • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
New model aims to eliminate HIV transmission from mothers to infants in malawi
Prevention Recruiting nowThis study is testing a new approach called PAC-Man to help prevent HIV from passing from mothers to their babies. About 2,426 mothers and infants in Malawi will take part. The goal is to see if this model helps more babies get tested for HIV early and ensures mothers receive pro…
Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Could STI testing be the key to getting more women on HIV prevention?
Prevention Recruiting nowThis study in Uganda tests whether adding lab tests for common sexually transmitted infections (STIs) to standard HIV risk screening helps more women start and stick with PrEP, a daily pill that prevents HIV. About 4,500 HIV-negative women aged 15-39 will be randomly assigned to …
Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Monthly HIV prevention pill could replace daily dose
Prevention Recruiting nowThis phase 3 trial tests MK-8527, a once-monthly oral pill, to prevent HIV-1 infection in women. About 4580 HIV-negative women will take either MK-8527 monthly or a daily PrEP pill (Truvada) to see which works better and is safer. The goal is to offer a more convenient prevention…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can immunotherapy given around liver cancer surgery stop the disease from coming back?
Prevention Recruiting nowResearchers are testing whether a combination immunotherapy called iparomlimab and tuvonralimab can prevent liver cancer from returning after surgery in patients whose tumors are at high risk of coming back. Participants receive one dose of the immunotherapy before surgery to rem…
Phase 2 • Sponsor: Tongji Hospital • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Burning the edges: a new way to stop colon polyps from coming back
Prevention Recruiting nowLarge colorectal polyps can turn into cancer, so doctors remove them during a colonoscopy. Even after removal, polyps often grow back. This trial compares two methods for sealing the area where the polyp was removed: one uses a water jet to lift tissue and then burns it with argo…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Thymus cells may teach a new heart to be left alone
Prevention Recruiting nowChildren who receive a heart transplant need powerful drugs to stop their immune system from attacking the new organ. Researchers are testing a different approach: they collect regulatory T cells, a type of immune cell that dampens rejection, from thymus tissue that is normally d…
Phase 1/2 • Sponsor: Rafael Correa-Rocha • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a Three-Session couples program cut drug use and HIV risk?
Prevention Recruiting nowResearchers are testing whether a three-session couples motivational interviewing program helps male couples reduce illicit drug use and behaviors that raise HIV transmission risk. The trial enrolls 360 male couples where at least one partner is HIV negative and at least one has …
Sponsor: Hunter College of City University of New York • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can a sedative plus ear stimulation stop PTSD before it starts?
Prevention Recruiting nowPeople who need emergency surgery after a traumatic event like a car crash or fall face a higher risk of developing post-traumatic stress disorder. This trial tests whether giving the sedative dexmedetomidine during surgery, with or without adding a non-invasive ear stimulation c…
Sponsor: Affiliated Hospital of Nantong University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
Prevention Recruiting nowResearchers in Pakistan are testing whether a mobile app that uses artificial intelligence to send personalized heat-risk alerts can reduce heat-related illness symptoms in adults with chronic conditions such as hypertension, diabetes, kidney disease, heart disease, or obesity. T…
Sponsor: National University of Medical Sciences, Pakistan • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Could everyday supplements turn back the clock on aging?
Prevention Recruiting nowThis trial tests whether two natural supplements—quercetin (from foods like apples and onions) and coenzyme Q10 (a substance your body makes)—can reduce inflammation and improve metabolic health in older adults. Over 12 weeks, participants aged 50 to 75 who are sedentary will tak…
Sponsor: Applied Science & Performance Institute • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
A lens that could let cataract patients see near and far without glasses
Symptom relief Recruiting nowCataracts cloud the eye's lens and blur vision, and presbyopia makes it hard to focus up close after age 50. Researchers are testing an intraocular lens with a virtual aperture optic, implanted during cataract surgery, to see if it improves vision at distance, intermediate, and n…
Sponsor: Z Optics, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a phone app help veterans tame chronic pain?
Symptom relief Recruiting nowResearchers are gathering feedback from Canadian Veterans with chronic pain and from clinicians who treat them. The goal is to adapt an existing digital psychology program, based on Acceptance and Commitment Therapy and delivered through the Manage My Pain app, so it better fits …
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Brain pacemaker tweak could help stroke and tremor patients speak and swallow better
Symptom relief Recruiting nowThis study looks at whether adjusting deep brain stimulation (DBS) can improve movement, speech, and swallowing in people already implanted with DBS for conditions like tremor, stroke, or traumatic brain injury. Researchers will test hand dexterity, grip strength, facial movement…
Sponsor: Jorge Gonzalez-Martinez • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can nature sounds ease grief? new study tests meditation for cancer caregivers
Symptom relief Recruiting nowThis study tests whether a nature-based healing meditation program can help friends and family caregivers who are grieving the loss of a loved one to cancer. The program includes six audio meditation modules available online. Researchers will measure how feasible and acceptable t…
Sponsor: Michigan State University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can virtual visits replace In-Person pain care for rural patients?
Symptom relief Recruiting nowThis study tests whether virtual lifestyle-focused pain care works as well as in-person care for adults with chronic back, knee, or hip pain living in rural areas. Participants will receive up to 10 sessions over six months, either in-person with a physiotherapist or virtually wi…
Sponsor: University of Sydney • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a cancer drug calm the nosebleeds of a rare bleeding disorder?
Symptom relief Recruiting nowHereditary hemorrhagic telangiectasia (HHT) causes tangled blood vessels that lead to frequent, hard-to-stop nosebleeds and low hemoglobin. Researchers are testing whether intravenous bevacizumab, given once or twice a year after nasal electrocoagulation, reduces nosebleed severi…
Phase 2 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New nasal spray aims to ease sinus troubles in teens
Symptom relief Recruiting nowThis study tests whether a nasal spray called OPN-375 can reduce symptoms of chronic sinusitis (like stuffy nose, discharge, and facial pain) in adolescents aged 12 to 17. About 84 teens will receive either the spray or a placebo twice daily for 12 weeks. The main goal is to see …
Phase 3 • Sponsor: Optinose US Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can magnetic brain zaps ease the pain of a sleepless body?
Symptom relief Recruiting nowPeople with insomnia often feel pain more intensely and recover from muscle strain more slowly. This pilot trial tests whether repetitive transcranial magnetic stimulation (rTMS), a non-invasive technique that alters brain activity, can reduce pain sensitivity and speed recovery …
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Exercise with or without compression: a new hope for leg swelling?
Symptom relief Recruiting nowThis study looks at whether doing resistance exercises (like leg presses) can reduce swelling in the lower legs of people with lymphedema. It also checks if wearing compression garments during exercise makes a difference. Thirty-six adults with lower limb lymphedema will exercise…
Sponsor: Carsten Bogh Juhl • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Zapping two brain regions may ease Schizophrenia's toughest symptoms
Symptom relief Recruiting nowResearchers at Hannover Medical School are testing whether intermittent theta-burst stimulation (iTBS), a non-invasive brain stimulation technique, can reduce negative symptoms and improve thinking in people with schizophrenia. The trial enrolls 60 adults aged 18 to 65 with a sch…
Sponsor: Hannover Medical School • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
5-Day brain zaps aim to ease postpartum depression
Symptom relief Recruiting nowThis study tests an accelerated form of Transcranial Magnetic Stimulation (TMS) for depression in pregnant and postpartum individuals. Instead of daily sessions for weeks, participants receive multiple treatments over just 5 days. The goal is to see if this faster approach is saf…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Weight-Loss drug ease rett syndrome?
Symptom relief Recruiting nowThis Phase 3 trial tests whether fenfluramine (Fintepla) can reduce behavioral and emotional symptoms in people with Rett syndrome. About 200 participants will receive either the drug or a placebo for 14 weeks. The study measures changes in behavior, sleep, and overall condition …
Phase 3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Could licorice root be the next skin soother?
Symptom relief Recruiting nowThis study looks at whether a natural compound from licorice root, called glycyrrhetinic acid, can help calm irritated skin and repair the skin barrier. Researchers will apply a mild irritant to the skin of 30 healthy adults, then treat the area with a cream containing the compou…
Sponsor: University of Split, School of Medicine • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a gentle electric current calm the mind in Alzheimer's?
Symptom relief Recruiting nowResearchers are testing whether transcranial random noise stimulation (tRNS), a non-invasive brain stimulation technique, can improve behavioral and psychological symptoms in people with early Alzheimer's disease. The trial enrolls 40 participants who receive either active tRNS o…
Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Could a 5-Day brain stimulation blitz ease depression in PTSD?
Symptom relief Recruiting nowThis pilot study tests whether a faster schedule of non-invasive magnetic brain stimulation, called accelerated intermittent theta burst stimulation (iTBS), is practical and safe for adults with both PTSD and major depression. Participants receive six short sessions per day for f…
Sponsor: Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Mind over movement: mental walking practice tested for MS
Symptom relief Recruiting nowThis study tests whether mentally practicing walking while watching videos of people walking can improve gait in people with multiple sclerosis. Twenty participants will either watch walking videos and imagine themselves walking, or watch nature scenes. Researchers will measure m…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can ozone gas ease Chemo's lasting numbness?
Symptom relief Recruiting nowResearchers test whether adding rectal ozone therapy to usual care can reduce numbness and tingling in people with chemotherapy-induced peripheral neuropathy. The trial enrolls 42 adults whose cancer is stable or in remission and who have had persistent numbness or tingling for a…
Phase 2/3 • Sponsor: Bernardino Clavo, MD, PhD • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Pre-Radiation pelvic therapy may ease pain and sexual issues for women with pelvic cancers
Symptom relief Recruiting nowThis study looks at whether adding pelvic floor physical therapy before standard radiation treatment can help reduce pain and sexual problems in women with cervical, vaginal, vulvar, uterine, or anal cancer. About 20 participants will receive education on using a vaginal dilator …
Sponsor: Indiana University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New therapy aims to help kids with speech disorder speak in phrases
Symptom relief Recruiting nowThis study tests a speech therapy called DTTC-Connect for children aged 3 to 12 with childhood apraxia of speech, a disorder that makes it hard to say words clearly. The therapy focuses on helping children move from saying single words to speaking in phrases. Sixty-eight children…
Sponsor: New York University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can VR games protect your brain from Diabetes-Related memory decline?
Symptom relief Recruiting nowThis pilot study is testing whether a virtual reality (VR) cognitive training program can help protect memory and thinking skills in adults aged 45-80 with type 2 diabetes and mild cognitive impairment. Forty participants will be randomly assigned to either 16 weeks of VR-based t…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Counseling plus exercise may beat exercise alone for TOS pain
Symptom relief Recruiting nowThis study tests whether adding motivational interviewing (a type of counseling) to a home exercise program can improve pain and arm function in people with thoracic outlet syndrome (TOS). Seventy adults with TOS will be randomly assigned to either exercise alone or exercise plus…
Sponsor: Hacettepe University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a smartphone app replace the clinic for hearing aid tuning?
Symptom relief Recruiting nowResearchers in Denmark are testing whether people with hearing aids can fine-tune them remotely using a smartphone app instead of visiting a clinic. The trial enrolls 120 adults with hearing loss who are comfortable using smartphones. Participants are randomly assigned to either …
Sponsor: Zealand University Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Mixed-Reality headset trains eyes to work together in adults with lazy eye
Symptom relief Recruiting nowResearchers are testing whether a home-based augmented reality therapy can improve vision in adults with anisometropic amblyopia, a type of lazy eye. Participants use a mixed-reality headset during daily activities, with the image to the stronger eye dimmed to encourage the weake…
Sponsor: Polytechnic Institute of Porto • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Headband may ease withdrawal after cushing surgery
Symptom relief Recruiting nowThis study looks at how people recover from Cushing syndrome after surgery. Researchers want to understand what affects recovery and whether using a MUSE biofeedback headband can help ease withdrawal symptoms. The study will include 700 adults who are planning to have curative su…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can orange-tinted glasses fix teen sleep troubles?
Symptom relief Recruiting nowThis study tests whether wearing blue-blocking glasses at night can help teenagers (ages 12-18) with insomnia or delayed sleep phase disorder who are already receiving psychiatric care. Forty participants will wear the glasses or use real darkness for one week. The goal is to see…
Sponsor: Helse Fonna • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Ankle glide vs. standard exercise: which helps diabetic stiffness?
Symptom relief Recruiting nowPeople with type 2 diabetes often develop stiff ankles, pain, and walking problems. This trial compares two physiotherapy approaches: Mulligan Mobilization with Movement, where a therapist applies a gentle glide to the ankle during active movement, and conventional physiotherapy …
Sponsor: Ibadat International University, Islamabad • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Simple change in injection technique could spare heart patients pain and bruising
Symptom relief Recruiting nowThis study tests whether a standardized, step-by-step protocol for giving blood thinner injections (low-molecular-weight heparin) can reduce bruising and pain in heart patients. About 180 patients in cardiac care units will be randomly assigned to receive injections either by the…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can video games calm anxious teens?
Symptom relief Recruiting nowResearchers are testing whether playing video games can reduce anxiety in adolescents aged 11 to 15 with elevated anxiety symptoms. The trial compares an action game designed to boost attention control, a casual puzzle game, and no game at all. Teens play at home online for six w…
Sponsor: School of Health Sciences Geneva • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can video games rewire young brains after injury?
Symptom relief Recruiting nowResearchers test whether a brain-computer interface neurofeedback program can improve attention, memory, and thinking in children and teens aged 7 to 21 with acquired brain injury or epilepsy. Participants play 3D computer games while wearing an EEG headset that responds to their…
Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can AI tailor recovery instructions after lung cancer surgery?
Symptom relief Recruiting nowResearchers are testing whether an AI-generated, personalized discharge plan improves the quality of discharge teaching and recovery for people who had lung cancer surgery. The trial enrolls 156 adults who had surgery for stage I to III lung cancer and are going home to recover. …
Sponsor: Xiamen University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Magnetic brain zaps may quiet anxiety: device trial puts it to the test
Symptom relief Recruiting nowResearchers are testing whether an accelerated protocol of transcranial magnetic stimulation using the BTL-699-2 device can reduce anxiety symptoms in adults with generalized anxiety disorder. The trial enrolls 40 adults aged 22 and older who receive 16 stimulation sessions over …
Sponsor: BTL Industries Ltd. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can balance training keep neuropathy patients on their feet?
Symptom relief Recruiting nowResearchers compare two exercise programs to see which better improves posture and stability in adults with diabetic peripheral neuropathy, a nerve condition that raises fall risk. Thirty-six participants aged 40 and older with type 2 diabetes and diagnosed neuropathy join the si…
Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a broader rehab programme help people with low vision live better?
Symptom relief Recruiting nowResearchers are testing whether a multidisciplinary vision rehabilitation programme improves quality of life more than low vision training alone for adults with visual impairment. The trial enrolls 1,000 Cantonese-speaking adults in Hong Kong aged 18 to 80 who have a clinical dia…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Could a wearable device at home tame overactive bladder?
Symptom relief Recruiting nowThis study tests whether a small, portable nerve stimulation device worn at home can reduce urgent bathroom trips in people with overactive bladder. Sixty adults aged 18 to 65 will either use the device during daily life when they feel urgency or receive standard clinic-based ses…
Sponsor: SEZGIN • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Natural capsule tested as Add-On for stroke recovery
Symptom relief Recruiting nowResearchers are testing whether MLC901 (NeuroAiD II), a natural capsule, helps people recover after a mild to moderate ischemic stroke. The trial enrolls 80 adults aged 18 to 80 who are within 2 to 10 days of their stroke. Participants receive either MLC901 plus standard stroke c…
Phase 4 • Sponsor: EVD Pharmacy and Medical Company Limited • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Massive pain trial aims to find new relief options
Symptom relief Recruiting nowThis Phase 2 trial is testing four experimental drugs (taken orally or by IV) against placebo in 10,000 people with chronic pain from knee osteoarthritis, diabetic nerve damage, or low-back pain. The goal is to see if any of these drugs can safely reduce pain. The study uses a fl…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Zapping the spine: a Non-Invasive device aims to loosen stiff muscles and improve walking in cerebral palsy
Symptom relief Recruiting nowResearchers at the University of Washington are testing whether non-invasive spinal stimulation can temporarily reduce muscle stiffness and improve walking in people with cerebral palsy. The study includes 20 participants aged 4 to 65 who can walk for at least 10 minutes. Partici…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Tiny One-Way valves for emphysema under close watch in japan
Symptom relief Recruiting nowResearchers in Japan are observing 140 people with severe emphysema who receive Zephyr Endobronchial Valves, tiny one-way valves placed in the lungs to reduce hyperinflation. The surveillance follows participants for 12 months across up to 20 centers. The main goal is to measure …
Sponsor: Pulmonx Corporation • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New study could spare breast cancer patients from underarm surgery
Symptom relief Recruiting nowThis study compares two approaches for breast cancer patients who still have cancer in their sentinel lymph node after chemotherapy: removing the underarm lymph nodes (surgery) or treating them with radiation. The goal is to see if radiation can reduce the risk of arm swelling (l…
Sponsor: Hospital Universitari de Bellvitge • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a common anxiety drug help autistic youth? new trial aims to find out.
Symptom relief Recruiting nowThis study tests whether buspirone, a medication used for anxiety, is safe and effective for autistic youth aged 7 to 17 who also have anxiety disorders. Researchers will measure changes in anxiety symptoms over 16 weeks. The goal is to see if this drug can ease anxiety in this s…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New shot could ease IBS-D symptoms in major trial
Symptom relief Recruiting nowThis Phase 2 study tests whether brenipatide, given as an injection under the skin, can safely reduce abdominal pain and improve stool consistency in adults with diarrhea-predominant irritable bowel syndrome (IBS-D). About 531 participants will receive either the drug or a placeb…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Sound waves zap knee pain without needles
Symptom relief Recruiting nowThis study tests a device that uses focused sound waves to block pain signals in the knee, offering a needle-free option for people with chronic osteoarthritis pain. Ten adults with moderate to severe knee pain will receive a one-hour treatment and be followed for six months. The…
Sponsor: FUSMobile Inc. • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a tiny electric zapper beat pills for IBS pain?
Symptom relief Recruiting nowThis study compares two treatments for abdominal pain in people with irritable bowel syndrome with constipation (IBS-C): a home-use device that delivers mild electrical stimulation (TEA) and the drug escitalopram (Lexapro). About 160 participants will be randomly assigned to one …
Phase 2/3 • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Three shots, one wrist: which injection best eases carpal tunnel?
Symptom relief Recruiting nowCarpal tunnel syndrome happens when the median nerve gets squeezed at the wrist, causing numbness, tingling, and pain in the hand. This study compares three ultrasound-guided injections for adults with mild to moderate cases: hyaluronic acid, corticosteroid, and 5% glucose. Sixty…
Early phase 1 • Sponsor: Tanta University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can your own blood and fat heal aching joints? new trial aims to find out
Symptom relief Recruiting nowThis early-phase trial will test four orthobiologic treatments—PRP, bone marrow concentrate, hyaluronic acid, and nanofat—in 300 adults with various muscle, joint, tendon, or bone conditions. The goal is to see if these natural substances can reduce pain and improve joint functio…
Early phase 1 • Sponsor: PROREGEN • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can an art app help young cancer survivors feel better?
Symptom relief Recruiting nowThis study tests whether a digital art therapy app called ARTCan is practical and acceptable for young adults aged 18-25 who survived childhood cancer. Participants use the app for 6 weeks to create art and complete mood surveys. The goal is to see if at least 10 out of 15 partic…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Infant brain recovery study seeks clues to heal stroke damage
Knowledge-focused Recruiting nowThis study follows 65 infants who had a stroke around birth, tracking their brain development and motor skills over two years. Researchers use MRI scans, brain stimulation, and movement tests to find markers of recovery. The goal is to understand how the brain heals, which could …
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can alerts and training boost asthma treatment in kids?
Knowledge-focused Recruiting nowThis study tests whether giving doctors extra training and electronic reminders helps them prescribe a modern asthma treatment called SMART for children with moderate to severe asthma. The study involves 18 children ages 5 to 18 at primary care clinics. Researchers will compare h…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to boost smart asthma care for children
Knowledge-focused Recruiting nowThis study tests two strategies to help doctors prescribe SMART therapy—a single inhaler for daily control and quick relief—for children with moderate to severe asthma. Researchers will use electronic reminders and education, plus a community health worker and nurse care manager,…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
NIH launches deep dive into gulf war illness mystery
Knowledge-focused Recruiting nowThis study aims to understand Gulf War Illness (GWI), a condition affecting up to 210,000 veterans with symptoms like fatigue, pain, and memory problems. Researchers will compare 85 Gulf War veterans—some with GWI and some without—through extensive tests including blood draws, sc…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Could a dye reveal hidden scarring in Crohn's patients?
Knowledge-focused Recruiting nowThis study tests a new imaging method using a special dye (FAPI) to detect bowel scarring in people with Crohn's disease. Scarring affects up to half of patients and often leads to surgery, but current tests can't spot it early. The study will involve 30 adults starting biologic …
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch national study to track immune weakness linked to severe COVID
Knowledge-focused Recruiting nowThis study follows 500 adults in France who have either a genetic defect or autoantibodies that weaken their type I interferon immune response. Researchers will collect blood samples and health data over 1 to 4 years to track infections, autoimmune diseases, and cancers. The goal…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch major study to unravel hormone disorders
Knowledge-focused Recruiting nowThis study enrolls adults with known or suspected endocrine (hormone gland) disorders, such as diabetes or thyroid disease, to help researchers learn more about these conditions. Participants will undergo medical exams, blood and imaging tests, and possibly genetic testing. The m…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a massive data registry crack the code of Parkinson's and related brain diseases?
Knowledge-focused Recruiting nowResearchers are building a large database of cognitive, behavioral, lifestyle, and genetic information from people with neurodegenerative diseases such as Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. The goal is to find biomarkers that help do…
Sponsor: Vincent Mok • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a better scan of a tiny jaw artery prevent bleeding during dental surgery?
Knowledge-focused Recruiting nowThis study uses cone-beam CT scans to map the alveolar antral artery, a small blood vessel in the upper jaw that can be injured during dental implant or sinus lift procedures. Researchers will analyze 1,000 existing scans to document the artery's typical location, size, and varia…
Sponsor: Hospital of the Ministry of Interior, Kielce, Poland • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can Fine-Tuning brain pressure save hearts and minds?
Knowledge-focused Recruiting nowAfter a cardiac arrest, the brain can suffer from dangerous pressure changes. This pilot study at National Taiwan University Hospital is testing a method to directly monitor brain pressure and blood flow in 50 patients who remain in a coma after their heart is restarted. Research…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study aims to unlock secrets of rare vascular diseases
Knowledge-focused Recruiting nowThis study is collecting medical data and biological samples from people with genetic conditions affecting the heart and blood vessels, their relatives, and healthy volunteers. The goal is to better understand these diseases, improve diagnosis, and lay the groundwork for future t…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Ovarian Cancer's spread: scientists probe abdominal fluid for clues
Knowledge-focused Recruiting nowResearchers at the University of New Mexico collect ascites fluid, the liquid that builds up in the abdomen, from women undergoing surgery for ovarian cancer. They study this fluid and tumor tissue in the lab to learn how the tumor environment helps cancer spread within the perit…
Sponsor: New Mexico Cancer Research Alliance • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Reading the Brain's signals to predict who benefits from deep brain stimulation
Knowledge-focused Recruiting nowDeep brain stimulation uses implanted electrodes to send electrical pulses to specific brain regions, and doctors are still working out how to tune it for each patient. This study records brain activity while adults with neurological or psychiatric conditions perform cognitive an…
Sponsor: Centre Hospitalier St Anne • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Gum width key to root coverage success, new study finds
Knowledge-focused Recruiting nowThis study looks at how the width of healthy gum tissue affects the success of covering exposed tooth roots in 30 adults with gum recession. Participants will receive a minimally invasive gum graft surgery. The goal is to see if wider gum tissue leads to better root coverage and …
Sponsor: Postgraduate Institute of Dental Sciences Rohtak • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Queensland study reveals why parents say yes or no to RSV shot for babies
Knowledge-focused Recruiting nowThis study observes how many eligible infants in Queensland receive the RSV immunisation (nirsevimab) during their first RSV season. Researchers will survey 1,200 parents to understand why they chose for or against the shot, and look at factors like location and health risks. No …
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can poor sleep make you hurt more? study probes Insomnia's link to pain
Knowledge-focused Recruiting nowResearchers at The Hong Kong Polytechnic University are investigating how insomnia affects pain sensitivity and the soreness that follows exercise. The study compares healthy adults with insomnia to those without, measuring their responses to heat, pressure, and pinprick stimuli.…
Sponsor: The Hong Kong Polytechnic University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can what you eat help sickle cell? new study investigates diet and symptoms
Knowledge-focused Recruiting nowThis study looks at how diet and eating habits affect the health of adults with sickle cell disease. Researchers will interview participants about their food intake and behaviors, and collect blood and urine samples. The goal is to understand links between nutrition and symptoms …
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Brain scans seek clues to Kids' severe mood swings
Knowledge-focused Recruiting nowThis study looks at children and teens ages 7-17 who have severe mood problems like chronic anger, sadness, or irritability, along with extreme tantrums. Researchers will use interviews, tests, and brain imaging to understand what happens in the brain. Up to 2,350 participants wi…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Heart safety of asthma drug tezepelumab under scrutiny in massive study
Knowledge-focused Recruiting nowThis study tracks over 16,000 teens and adults with severe asthma to see if the drug tezepelumab raises the risk of serious heart problems like heart attack, stroke, or heart-related death. Researchers will compare those taking tezepelumab to those on standard asthma treatments. …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive device registry aims to improve patient safety
Knowledge-focused Recruiting nowThis study is a registry that collects information on the safety and effectiveness of Medtronic medical devices already on the market. It will include up to 100,000 people who have or will receive a Medtronic product for conditions like heart, nerve, or digestive disorders. The g…
Sponsor: Medtronic • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Liver function may change how inavolisib works
Knowledge-focused Recruiting nowThis early-phase study looks at how a single dose of the drug inavolisib behaves in people with moderate or severe liver impairment compared to healthy volunteers. Researchers will measure drug levels in the blood and check for side effects. The goal is to understand if liver pro…
Phase 1 • Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study aims to unlock secrets of movement disorders
Knowledge-focused Recruiting nowThis natural history study is collecting information from up to 4,000 people with movement disorders (like Parkinson's disease or tremor) and their family members. Participants undergo exams, blood tests, and imaging, but receive no new treatments. The goal is to gather data that…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Eye test may predict who benefits from depression therapy
Knowledge-focused Recruiting nowThis study looks at whether a simple eye test can predict how well people with treatment-resistant depression will respond to a brain stimulation therapy called TMS. Researchers will measure how the pupils react to light before and after TMS treatment in 44 adults. The goal is to…
Sponsor: Polytechnic Institute of Porto • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Spinal fluid may hold clues to breast cancer brain spread
Knowledge-focused Recruiting nowThis study collects spinal fluid, blood, saliva, and tumor samples from 139 adults with HER2-positive or triple-negative breast cancer that has spread to other organs but not yet to the brain. Researchers will analyze these samples for tumor DNA that might predict when the cancer…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New registry to study safer heart valve fixes in asian patients
Knowledge-focused Recruiting nowThis study will collect information from 15 patients in Asia-Pacific who have had or will have a less invasive procedure to fix a failed mitral or tricuspid heart valve. The goal is to learn how well these procedures work in this population, since most existing data comes from We…
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Smart testing after CAR t: could it spare kids from unneeded transplants?
Knowledge-focused Recruiting nowThis study tests whether regular blood and bone marrow tests using advanced DNA sequencing can better monitor children with B-cell acute lymphoblastic leukemia (B-ALL) after they achieve remission with CAR T therapy. The goal is to see if these tests can identify who is truly cur…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists use brain scans to watch aging in action
Knowledge-focused Recruiting nowThis study uses yearly PET scans to track amyloid protein buildup in the brains of 400 adults aged 55 and older over 5 years. Participants are already part of the Baltimore Longitudinal Study of Aging. The goal is to see how these brain changes relate to memory loss and other thi…
Sponsor: National Institute on Aging (NIA) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Biomarker-Guided breast cancer trial aims to personalize therapy
Knowledge-focused Recruiting nowThis study is for people with metastatic breast cancer, including estrogen receptor-positive and triple-negative types. It uses biomarkers from tumors and blood to guide treatment choices, comparing how long the cancer stays controlled on the new therapy versus the previous one. …
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Lyme disease mystery: do bacteria lurk after antibiotics?
Knowledge-focused Recruiting nowThis study investigates whether the bacteria causing Lyme disease can survive antibiotic treatment and cause ongoing symptoms. Researchers will follow 700 participants, including those with chronic Lyme disease, recovered individuals, and healthy volunteers, using blood tests, sp…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists watch and treat eye diseases to unlock their secrets
Knowledge-focused Recruiting nowThis study aims to learn more about eye diseases by observing and providing standard care to up to 1,000 people over 5 years. Participants receive regular eye exams, tests, and treatments as needed. The goal is to better understand how eye diseases progress and are inherited, not…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Is chronic elbow pain really a Whole-Body nerve problem?
Knowledge-focused Recruiting nowLateral epicondylitis, often called tennis elbow, causes pain and tenderness on the outside of the elbow and can linger despite treatment. Researchers are comparing 128 people with chronic lateral epicondylitis to healthy controls to see whether those with elbow pain have lower p…
Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New brain scans aim to spot inflammation in Alzheimer's and Parkinson's
Knowledge-focused Recruiting nowThis study uses special PET scans to measure inflammation in the brains of people with Alzheimer's, Parkinson's, ALS, and other neurodegenerative diseases. Researchers will compare these scans to those from healthy volunteers to see if inflammation levels differ. The goal is to d…
Phase 1 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Liver biopsies reveal Fat-Busting secrets in alcohol detox
Knowledge-focused Recruiting nowThis study looks at how the liver processes fat in people with alcohol use disorder who are quitting drinking. Researchers will take two small liver samples—one early in detox and one after four weeks—to compare gene activity. The goal is to understand how the liver clears fat wh…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study aims to unlock genetic secrets of movement disorders
Knowledge-focused Recruiting nowThis study aims to understand the link between genes and symptoms in people with inherited movement disorders. Researchers will study up to 2,500 participants, including patients and their family members, to identify new disease-causing genes and improve diagnosis. The goal is to…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Brain scans reveal hidden thinking problems in anemia patients
Knowledge-focused Recruiting nowThis study uses a non-invasive brain imaging technique called fNIRS to see how anemia affects thinking and memory. Researchers will measure brain activity in 323 adults with different types of anemia and compare it to cognitive test scores. The goal is to identify which brain reg…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Flat or elevated? major trial tests simple head position to boost stroke recovery
Knowledge-focused Recruiting nowThis study looks at whether lying flat (0 degrees) or with the head raised (30 degrees or more) after a stroke clot removal procedure helps people recover better. About 2240 adults who had a stroke from a large blood vessel blockage will be randomly assigned to one of the two hea…
Sponsor: Population Health Research Institute • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
A simple test could flag kidney danger in cirrhosis patients
Knowledge-focused Recruiting nowResearchers are developing a new equation to predict major adverse kidney events in people with cirrhosis and ascites, a buildup of fluid in the belly. The study follows 400 patients for a year to see who develops serious kidney decline, chronic kidney disease, or dies. The goal …
Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Brain wave test may finally distinguish real tics from functional ones
Knowledge-focused Recruiting nowThis study aims to find differences between organic tics (related to diagnosed disorders) and functional tics (caused by problems in brain-body communication). Researchers will use sensors to measure muscle activity and brain waves in 75 adults with tics and healthy volunteers. P…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a Vitamin-Like pill boost fat burning on a keto diet?
Knowledge-focused Recruiting nowThis study looks at how a supplement called nicotinamide riboside (NR) and a low-carb, high-fat 'ketogenic' diet affect the way the body burns fat and uses energy. Researchers will measure changes in metabolism in 100 overweight or obese adults. Participants will eat a standard d…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can fixing your sleep schedule prevent diabetes? new study investigates
Knowledge-focused Recruiting nowThis study looks at how losing sleep and having a disrupted body clock (like shift workers) can make the body less responsive to insulin, a key step toward obesity and type 2 diabetes. Researchers will test 48 healthy adults aged 18-45 to see how the timing of the stress hormone …
Phase 4 • Sponsor: Washington State University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can six weeks of leg presses recharge aging muscles?
Knowledge-focused Recruiting nowResearchers are investigating how mitochondria, the energy-producing structures inside muscle cells, relate to frailty in older adults. The study includes about 120 people: older adults with type 2 diabetes, healthy older adults, and healthy young adults. Everyone does a six-week…
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists use new tracer to peek at brain inflammation in Alzheimer's
Knowledge-focused Recruiting nowThis study tests a new radioactive tracer to see if it can measure brain inflammation in people with Alzheimer's disease or mild cognitive impairment. Researchers will compare scans from 90 volunteers (patients and healthy older adults) to understand how inflammation relates to m…
Phase 1 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Healthy volunteers willingly catch the flu for science
Knowledge-focused Recruiting nowThis study aims to find the safest and most effective dose of a specific flu virus to give to healthy adults in a controlled setting. About 90 volunteers aged 18 to 55 will be exposed to the virus or a placebo and closely monitored. The goal is to create a reliable model for test…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Digital sensor maps how jaw surgery moves the jaw joint
Knowledge-focused Recruiting nowResearchers at Semmelweis University are studying how orthognathic surgery, which realigns the upper and lower jaws, affects the temporomandibular joint and jaw movement. Fifty adults aged 18 to 45 with severe dentofacial deformities take part. Using a digital facebow device call…
Sponsor: Semmelweis University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Heartburn drug under the microscope: registry tracks thousands of pregnancies
Knowledge-focused Recruiting nowResearchers are running an observational registry to study whether vonoprazan, an oral drug for heartburn and acid reflux, is safe to take during pregnancy. The study follows women aged 15 to 50 who took vonoprazan while pregnant and compares their outcomes with women who did not…
Sponsor: Phathom Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study tracks thyroid cancer patients outside clinical trials
Knowledge-focused Recruiting nowThis study observes adults with advanced thyroid cancer who are receiving standard treatments in real-world settings, not in clinical trials. Researchers aim to understand barriers to accessing care and how well patients tolerate and respond to available medications. About 459 pa…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Gene hunt in peru: could ancestry hold key to autoimmune diseases?
Knowledge-focused Recruiting nowThis study aims to uncover genetic changes that cause autoimmune diseases in people native to Peru. Researchers will collect blood, urine, and stool samples from 300 participants, including patients with conditions like lupus and rheumatoid arthritis, their family members, and he…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists zap brain during surgery to uncover movement secrets
Knowledge-focused Recruiting nowThis study looks at how deep brain stimulation (DBS) changes movement in people with conditions like Parkinson's disease or essential tremor. About 60 people scheduled for DBS surgery will have extra temporary electrodes placed on the brain to measure muscle activity during stimu…
Sponsor: Jorge Gonzalez-Martinez • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Lupus drug anifrolumab under pregnancy safety spotlight
Knowledge-focused Recruiting nowThis study is tracking 500 pregnant women with lupus to see if the drug anifrolumab is linked to birth defects or pregnancy loss. Researchers will compare women who took anifrolumab during early pregnancy to those who did not. The goal is to gather real-world safety data, not to …
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists use advanced scans to peek inside artery plaques
Knowledge-focused Recruiting nowThis observational study aims to better understand what happens inside artery plaques in people with peripheral artery disease (PAD). Researchers will use special PET-CT scans to look for signs of inflammation, calcium buildup, and blood clots in the legs and other parts of the b…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists use manganese to peek inside 'Broken Hearts'
Knowledge-focused Recruiting nowThis study aims to better understand takotsubo cardiomyopathy, also known as broken heart syndrome, by using manganese-enhanced MRI scans. Researchers will test how different heart medications affect manganese uptake in the heart muscle. The study involves 100 adults who have had…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New screening trial aims to speed up matching of cancer patients to the right treatments
Knowledge-focused Recruiting nowThis study tests a new way to screen patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) by analyzing their bone marrow and blood for specific biomarkers. The goal is to quickly match patients with a treatment trial that targets their cancer's unique mark…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New ulcerative colitis drug put through drug interaction test
Knowledge-focused Recruiting nowThis early-phase study is testing whether afimkibart, an experimental drug for ulcerative colitis, changes how the body processes common medications like caffeine, warfarin, and omeprazole. About 25 people with moderate to severe active ulcerative colitis will receive afimkibart …
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can imaging reveal how radiation shapes marrow recovery?
Knowledge-focused Recruiting nowThis study builds a registry of people who are receiving or have received radiation therapy for blood-related conditions. Researchers will gather medical records, imaging scans, lab results, and treatment data to see how radiation affects bone marrow reserve and patient outcomes.…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study checks how liver issues affect cancer drug pelabresib
Knowledge-focused Recruiting nowThis early-phase study is testing the cancer drug pelabresib in 24 people with advanced cancers who also have liver problems. The goal is to see how the liver affects the drug levels in the body. Participants will take the drug daily for 14 days, then have a week off. This resear…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Simple skin test may spot Parkinson's risk years early
Knowledge-focused Recruiting nowThis study is testing whether a skin biopsy can detect abnormal proteins linked to Parkinson's disease in people with essential tremor, a common movement disorder. Researchers will follow 300 participants aged 50-85 for two years to see who develops Parkinson's. The goal is to fi…
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a simple questionnaire reveal why some cystic fibrosis patients skip physiotherapy?
Knowledge-focused Recruiting nowResearchers are translating the AdT-Physio scale into French and testing it in 121 adults with cystic fibrosis. The scale asks 15 questions about how often patients do their physiotherapy and what they believe about the treatment and their therapist. Participants also fill out qu…
Sponsor: Pole Sante Grace de Dieu • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Study seeks to uncover why 1 in 4 kids act differently after sedation
Knowledge-focused Recruiting nowThis study aims to understand why some children develop sleep issues, anxiety, or aggression for up to two weeks after being sedated for medical procedures. Researchers will follow over 2,000 children aged 1-17 in emergency rooms and dental clinics. By identifying risk factors li…
Sponsor: London Health Sciences Centre Research Institute • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists scour lungs for clues to why some get infections
Knowledge-focused Recruiting nowThis study gathers fluid and tissue from the lungs and nose of healthy volunteers and people with a history of lung infections. Researchers will compare samples to find differences in immune function that might explain why some people are more prone to infections. Participants un…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists scan brains to unravel why effort hurts in chronic fatigue
Knowledge-focused Recruiting nowThis study uses functional MRI to see how the brain processes unpleasant sensations like pain and physical effort in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy volunteers. Researchers will apply mild heat and ask participants to sq…
Early phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Researchers track Insulin-Making cells in type 1 diabetes over years
Knowledge-focused Recruiting nowThis study follows people who previously took part in type 1 diabetes trials to see how long their bodies continue to produce insulin. Researchers will also look at how immune system changes relate to insulin production. The goal is to gather information that could lead to better…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to sharpen eye tests for diabetes patients
Knowledge-focused Recruiting nowThis study follows 100 adults with diabetic eye disease who are already receiving standard anti-VEGF injections for swelling in the center of the retina. Researchers will use advanced vision tests and imaging to track changes over time. The goal is not to test a new drug, but to …
Phase 4 • Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Home c-peptide tests could reveal hidden insulin production in diabetes
Knowledge-focused Recruiting nowResearchers want to learn how the body's own remaining insulin production, measured by a marker called C-peptide, affects quality of life and health outcomes in people with insulin-treated diabetes. The study follows about 700 adults, including some from a previous diabetes study…
Sponsor: Royal Devon and Exeter NHS Foundation Trust • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study checks drug levels in breast milk for nursing moms
Knowledge-focused Recruiting nowThis study looks at how much of the drug bimekizumab passes into breast milk. Researchers will collect milk samples from 20 breastfeeding mothers with conditions like psoriasis or arthritis over several weeks. The goal is to understand potential exposure for nursing infants, not …
Phase 1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
After a stroke, does the heart inflame? MRI study probes the link
Knowledge-focused Recruiting nowResearchers are studying whether an ischemic stroke in the middle cerebral artery territory triggers inflammation and scarring in the heart muscle. The trial enrolls 44 adults with acute stroke and 24 people with stroke-like symptoms but no brain infarct as a comparison group. Pa…
Sponsor: Luciano A. Sposato • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New trial uses DNA tests to match cancer patients to targeted drug cocktails
Knowledge-focused Recruiting nowThis large screening trial enrolls up to 2,900 people with advanced solid tumors that have spread or not responded to standard treatment. Researchers use genetic tests on tumor samples to find specific mutations, then assign patients to treatment trials testing drug combinations …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a simple blood test and CT scan predict bypass success?
Knowledge-focused Recruiting nowThis study follows 100 people who had heart bypass surgery guided by a special CT scan, to see if imaging details and a blood fat called Lp(a) can predict how well they do afterward. Researchers will track symptoms, quality of life, and major heart events like heart attacks or st…
Sponsor: Centro Cardiologico Monzino • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New imaging study seeks to unlock muscle fatigue in cancer survivors
Knowledge-focused Recruiting nowThis study uses non-invasive MRI and MRS scans to measure how well muscle cells produce energy in adults who survived childhood acute lymphoblastic leukemia (ALL). Researchers will compare 60 survivors with low muscle mass to healthy volunteers. The goal is to understand why many…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Why some beekeepers shrug off stings while others react
Knowledge-focused Recruiting nowBeekeepers get stung often, and many develop antibodies to bee venom. Only a few have severe allergic reactions. This study compares blood and skin test results from beekeepers who tolerate stings, beekeepers who are allergic, and people who are not beekeepers. Researchers aim to…
Sponsor: University Hospital Plymouth NHS Trust • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The heart rhythm threat hiding in heart attack wards
Knowledge-focused Recruiting nowPeople admitted for acute coronary syndrome, which includes heart attacks and unstable angina, face a higher risk of dangerous heart rhythms such as sustained ventricular tachycardia and ventricular fibrillation. Hospitals monitor these patients, but the exact rate of these rhyth…
Sponsor: Catharina Ziekenhuis Eindhoven • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Gum fluid proteins eyed as link between smoking and periodontitis
Knowledge-focused Recruiting nowResearchers are studying whether cigarette smoking is linked to levels of two proteins, MFN1 and NLRP3, in the fluid between the teeth and gums. The study includes 88 adults aged 25 to 65, split into four groups: nonsmokers and smokers with healthy gums, and nonsmokers and smoker…
Sponsor: Abant Izzet Baysal University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists dig into DNA of moles to uncover hidden mutations
Knowledge-focused Recruiting nowThis study collects moles and blood samples from 50 adults to analyze the genetic mutations that cause moles to form. Researchers will compare DNA from mole tissue with normal DNA from blood to find specific changes. No treatments or interventions are given—the goal is purely to …
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Kidney function may alter how a cancer drug works — a trial investigates
Knowledge-focused Recruiting nowThis study examines how the body processes nemtabrutinib in people with severe kidney impairment compared to healthy volunteers. By measuring drug levels in the blood after a single dose, researchers aim to understand whether kidney function changes how the drug is handled. The r…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Massive study aims to unlock secrets of parathyroid diseases
Knowledge-focused Recruiting nowThis study follows up to 3,000 people who have, are at risk for, or are related to someone with a parathyroid disorder. Researchers will collect medical records, questionnaires, and samples like blood and saliva to learn what causes these conditions and how they change over time.…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists launch major study to unravel mysteries of rare lung infections
Knowledge-focused Recruiting nowThis study aims to learn more about non-tuberculous mycobacterial (NTM) infections, which cause repeated lung and other organ infections. Researchers will study up to 1,000 participants to understand the genetics, symptoms, and best treatments for these infections. The study also…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Major study tracks rare muscle disease to pave way for future treatments
Knowledge-focused Recruiting nowThis observational study aims to better understand primary mitochondrial myopathy, a rare muscle disease. Researchers will follow 1300 patients and healthy controls, measuring muscle strength, balance, and daily function over time. The goal is to develop and validate tools to tra…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Do all kids with pneumonia need antibiotics? study tracks Real-World decisions
Knowledge-focused Recruiting nowResearchers are observing how often children hospitalized with non-severe pneumonia receive antibiotics and how doctors decide whether a child needs them. The study follows 200 children admitted to two German hospitals, recording treatment choices, medical complications, and pare…
Sponsor: ARCIM Institute Academic Research in Complementary and Integrative Medicine • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can tissue clues predict which Crohn's patients relapse after surgery?
Knowledge-focused Recruiting nowResearchers are building a tool to predict which Crohn's disease patients will have their disease return after intestinal surgery. The study follows 250 people who undergo intestinal resection as part of routine care, collecting leftover surgical tissue, clinical data, and blood …
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New test could spot liver trouble early in fontan patients
Knowledge-focused Recruiting nowThis study is testing a new way to measure liver function in adults who have had the Fontan procedure, a surgery for certain heart defects. Researchers will use a dual cholate clearance test (a special blood test) and a heart MRI to see how well the liver is working. They will co…
Sponsor: HepQuant, LLC • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Brain injury study uses virtual reality to uncover hidden walking struggles
Knowledge-focused Recruiting nowThis study looks at how people with moderate to severe traumatic brain injury (TBI) walk and navigate in complex, real-life-like virtual environments, such as streets with other people. Researchers want to understand the specific difficulties these individuals face during everyda…
Sponsor: Pôle Saint Hélier • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Young hearts at risk: 25-Year study launches to uncover Diabetes-Heart link
Knowledge-focused Recruiting nowThis study aims to learn how type 2 diabetes and obesity in young people affect heart and blood vessel health over time. About 930 participants aged 12 to 25, including those with diabetes, overweight but not diabetic, and healthy lean individuals, will be followed for up to 25 y…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can PET scan signals predict who beats lung cancer with immunotherapy?
Knowledge-focused Recruiting nowResearchers are investigating whether metabolic markers measured by PET/CT scans and tumor tissue tests can predict how well early-stage non-small cell lung cancer responds to immunotherapy given before surgery. Thirty patients with stage IB to IIIA NSCLC that lacks EGFR and ALK …
Phase 2 • Sponsor: Hospital das Clínicas de Ribeirão Preto • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists hunt for prostate cancer clues in tissue and blood samples
Knowledge-focused Recruiting nowThis study collects blood, urine, saliva, and tumor tissue from 3,000 men with prostate cancer to investigate genetic changes that cause the disease. Participants may also undergo imaging and answer quality-of-life questions. The goal is to better understand prostate cancer and l…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists map HIV's hiding spots in early infection
Knowledge-focused Recruiting nowResearchers want to understand how HIV builds a hidden reservoir in the body when someone starts treatment during the earliest stage of infection. The study follows 70 recently infected people who begin combination antiretroviral therapy right away. Over two years, participants g…
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists track rare eye disease to pave way for future treatments
Knowledge-focused Recruiting nowThis study follows 25 people aged 10 and older with Stargardt-like macular dystrophy (STDG3), a rare inherited eye disease that causes vision loss. Over three years, researchers will measure changes in the retina using eye exams, imaging, and vision tests. The goal is to understa…
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Does your sleep shape how generous you are? new study investigates
Knowledge-focused Recruiting nowThis observational study looks at whether adults' sleep quality, sleep timing, and natural chronotype (morning vs. evening preference) are linked to how they share resources with others. Participants fill out sleep questionnaires, keep a 7-day sleep diary, and play a brief comput…
Sponsor: The Hong Kong Polytechnic University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC